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Carbohydrate and lipid are important substrates during exercise, and their relative 
contribution is heavily dependent on exercise intensity and duration. Not only this, but 
it now appears that the utilisation of muscle glycogen and lipid (intramuscular 
triglyceride; IMTG) is specific to muscle fibre type and/or the subcellular location of 
these substrates. However, to date, our understanding of muscle substrate use stems 
largely from lab-based research.  The first aim of this thesis was, therefore, to 
investigate muscle glycogen and IMTG utilisation on a fibre type and subcellular-
specific basis in exercise undertaken in the field.  The exercise-induced decrease in 
muscle glycogen and IMTG necessitates a replenishment of these substrates in the 
post-exercise period, where traditionally carbohydrate ingestion is the focus.  
However, the mechanisms regulating post-exercise IMTG resynthesis, especially in 
the face of carbohydrate ingestion is not well understood.  Therefore, a second aim of 
this thesis was to examine the influence of post-exercise carbohydrate consumption 
on IMTG resynthesis and the muscle mechanisms regulating this. 
 
Study 1 aimed to quantify glycogen and lipid utilisation in the vastus lateralis and 
gastrocnemius muscle of 11 recreationally active male runners during either steady 
state endurance exercise (10-mile trial) or high intensity interval exercise (8x800m 
trial) in a field-based training environment. Using transmission electron microscopy 
(TEM), this study identified 1) a preferential use of intramyofibrillar glycogen during 
exercise, independent of exercise trial, and 2) lipid utilisation occurred primarily in the 
intermyofibrillar region of type I fibres during steady state exercise. These data 
highlight a novel pattern of muscle glycogen and lipid utilisation during field-based 
exercise which is dependent on exercise intensity and duration.  
 
Study 2 aimed to examine if immunofluorescence microscopy could be used to 
investigate changes in IMTG on a subcellular level, and additionally compared the 
agreement between immunofluorescence microscopy with TEM. This study continued 
the field-based ‘theme’ examining IMTG utilization during a competitive endurance 
event. ~1 hour of cross-country skiing in a field-based environment reduced IMTG 
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content in both type I and type IIa fibres, and in both the peripheral and central 
subcellular regions. When assessing the agreement between the two microscopy 
methods, it appears that immunofluorescence microscopy provides a suitable method 
to quantify IMTG content, but not LD morphology. Therefore, these data have 
important implications for future studies aiming to understand the mechanisms 
regulating subcellular LD pools. As such, this directly influenced the methodology for 
study 3 of this thesis.  
 
Finally, study 3 aimed to investigate the hypothesis that post-exercise IMTG 
resynthesis would be accelerated under conditions of acute CHO restriction in elite 
endurance athletes, with a secondary aim to investigate changes in the distribution of 
perilipin proteins relative to LDs during exercise and in the post-exercise period. IMTG 
resynthesis was shown to occur rapidly by 4 h post-exercise in the central region of 
type I fibres following prolonged exercise in highly-trained individuals, independent of 
CHO availability. Further, increases in IMTG content following exercise preceded an 
increase in the association of LDs with regulatory perilipin proteins. These data, 
therefore, suggest that the perilipin proteins do not play a key role in the mechanism 
of IMTG synthesis, as originally believed.  
 
Overall, this thesis expands our knowledge on the effect of exercise intensity and 
duration on substrate utilisation by investigating this on a fibre and subcellular basis, 
whilst also providing an insight into the field-based demands of training and 
competition on substrate utilization. Furthermore, the work deepens our understanding 
of the proposed role of the LD regulatory perilipin proteins during IMTG breakdown 
and resynthesis by providing key insights into the mechanisms underpinning IMTG 
resynthesis. From a research perspective, it is hoped that this thesis will elicit further 
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1.1 Overview  
 
In 1967, a seminal study by Bergstrom et al, (1967) first reported that a carbohydrate 
(CHO)-rich diet enhanced muscle glycogen concentration to twice that observed 
following a normal mixed-macronutrient diet, and that the muscle glycogen stores 
were directly related to time-to-exhaustion during prolonged exercise using their novel 
muscle biopsy technique. Since then, the muscle biopsy technique has been heavily-
utilised to demonstrate the importance of muscle glycogen in determining exercise 
capacity. Enhancing exogenous CHO availability (through gels, bars or drinks) can 
augment exercise performance (Cermak & Van Loon, 2013), mediated by liver 
(Gonzalez et al, 2015) and/or muscle glycogen sparing (Yasperlkis et al, 1993), 
maintaining plasma glucose and CHO oxidation rates (Coyle et al, 1986; McConell et 
al, 2000) and through direct effects on the central nervous system (Jeukendrup et al, 
1997). Whilst high CHO diets may lead to greater rates of CHO oxidation, they also 
lead to reductions in fat oxidation (Coyle et al, 2001), which can be attributed to a 
decrease in the oxidation of both plasma-derived fatty acids and intramuscular 
triglyceride (IMTG) stores. IMTG are an important substrate during moderate-intensity 
exercise, particularly in the overnight fasted state, due to their close proximity to 
muscle mitochondria (Hoppeler et al, 1985). Further to this, research has 
demonstrated that diets high in CHO and low in fat can reduce IMTG storage after 1 
week (Coyle et al, 2001), 48 h (Johnson et al, 2003) or 12 h (Startling et al, 1997). 
Taken together, it is evident that nutritional status influences intramuscular substrate 
turnover.  
 
Since these studies in the 1960-1970’s, various methods have been used to analyse 
muscle biopsies which have become the standard approach to examine glycogen 
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utilisation during exercise and can also be used to examine net changes in IMTG 
content. Multiple biopsies can be taken from one subject, quickly and safely when the 
correct preparation is in place (Shanely et al, 2014) and allows for direct measures of 
glycogen and IMTG to be examined pre, mid and post-exercise. As well as substrate 
utilisation, biopsies allow the assessment of muscle damage, mitochondrial 
biogenesis, enzyme activity, shifts in metabolites, protein synthesis and fibre typing 
(Shanely et al, 2014). Due to the insights provided by the data generated by muscle 
biopsy studies, current sports nutrition guidelines highlight the importance of CHO 
consumption 1) before exercise to optimise endogenous CHO stores, 2) during 
exercise to support fuelling and performance, and 3) after exercise to promote 
resynthesis of muscle glycogen stores. The overall effect of high CHO availability on 
endurance exercise performance has been well documented (Cermak & Van Loon 
2013; Hawley et al, 1997), thereby leading to the practice of CHO loading to super-
compensate muscle and liver glycogen stores in the days prior to an endurance event. 
Specifically, with the days prior to aiming to maximise muscle glycogen stores, whilst 
the CHO intake a few hours before an event will optimise liver glycogen.This became 
the foundation on which many additional nutritional strategies to optimise endurance 
performance are based (Burke et al, 2018). Overall, the main aim of the current CHO 
guidelines is to augment performance via sparing muscle glycogen, maintaining 
plasma glucose and CHO oxidation rates.  
 
Despite decades of research examining glycogen utilisation during exercise, it is still 
difficult to provide guidelines for CHO consumption in relation to fuelling exact training 
sessions due to the varying metabolic demands of training and competition. Burke et 
al, (2018) highlighted that key CHO guidelines being used by athletic populations are 
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not underpinned by data from field-based environments but rather strict laboratory-
based conditions. Subsequently, the majority of studies currently influencing sports 
nutrition guidelines to date are based on laboratory-based protocols (Burke et al, 
2011). This restriction in our knowledge also applies to the utilisation of IMTG during 
exercise with our understanding again being underpinned by data from studies based 
under strict laboratory-based environments. The primary benefit of the laboratory-
based protocols (e.g. fasted exercise at a fixed relative intensity for a given duration, 
such as 1 h at 70% VO2max) is the rigorous control measures put in place to ensure 
reproducibility and reliability such as set workloads, intensities and durations. 
However, this does not take into account factors such as changes in terrain and 
incline, environmental influences such as wind speed and rain, all of which will 
influence pace, power, speed, the athlete’s rate of perceived exhaustion, heart rate 
and the intensity of the training. Although an athlete may be prescribed a specific 
training session, external factors such as those listed will alter the metabolic demand 
of a training session considerably. Overall, laboratory-based studies provide complete 
control, which is not representative of training or competition in a field-based 
environment. 
 
To date, much of the data on substrate utilisation during exercise examines changes 
in glycogen and IMTG on a whole muscle level. However, substrate availability in 
muscle is dependent on fibre type, with type I fibres containing three-fold greater lipid 
content than type II muscle fibres (Essen et al, 1975; Malenfant et al, 2001, Van Loon 
et al, 2003). Further to this, the subcellular location of substrates within the muscle 
fibre has been shown to be important in the context of storage and utilisation during 
exercise (Ørtenblad & Nielsen, 2015). For example, glycogen stored within the 
myofibrils (intramyofibrillar), rather than glycogen stored between the myofibrils 
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(intermyofibrillar) or at the outermost part of the myofibril (subsarcolemmal), is 
preferentially used during high intensity exercise (Nielsen et al, 2011). Lipid can also 
be examined in the subsarcolemmal and intermyofibrillar locations, though it is 
important to note the location of IMTG-containing lipid droplets is often in close 
proximity to the mitochondria, which is factor underpinning the importance of IMTG as 
a fuel source. Overall, fibre type and subcellular location are two important factors that 
should not be overlooked when investigating the field-based effect of exercise on both 
glycogen and IMTG utilisation during exercise.  Using microscopy techniques such as 
transmission electron microscopy (TEM) and immunofluorescence confocal 
microscopy permits investigations of glycogen and lipid utilisation on a fibre-type and 
subcellular specific basis, though to date, there has been no comparison between the 
two methods. 
 
CHO guidelines outline the appropriate strategies to maximise glycogen 
replenishment following exercise. Particularly during moderate-intensity exercise, 
though, IMTG is a key fuel source, and therefore resynthesis of the IMTG pool is also 
an important consideration. Moreover, recent proteomic and microscopy-based 
research has identified a distinct proteome associated with IMTG-containing lipid 
droplets. This observation has enhanced our understanding of the regulation of IMTG 
utilisation during exercise (Shaw et al, 2009; Shepherd et al, 2012; 2013; 2017; 
Gemmink et al, 2016). To date, there is a lack of substantial data on the post-exercise 
replenishment of IMTG, and as a consequence a lack of understanding of the 




1.2 Aims and objectives  
 
Overall, this thesis aims to provides a microscopy-based insight into the field-based 
demands of training and competition on substrate utilization, whilst also providing key 
insights into the regulatory mechanisms underpinning IMTG resynthesis. 
This aim will be achieved by completion of the following objectives: 
 
a) Using TEM, assess fibre type and subcellular-specific muscle glycogen and 
lipid utilisation during two field-based training sessions (that differ by exercise 
intensity) typical of middle-to-long distance runners.  
b) Examine fibre type and subcellular-specific muscle lipid utilisation during a field-
based competitive cross-country skiing event using immunofluorescence 
microscopy. 
c) Investigate the agreement between TEM and immunofluorescence microscopy 
techniques for investigating IMTG content and LD morphology on fibre and 
subcellular-specific basis.  
d) Determine the effect of acute carbohydrate restriction on post-exercise IMTG 
repletion.  
e) Examine the role of the perilipin proteins in both IMTG utilization during 












































In humans, the ability to exercise is dependent on the conversion of chemical energy 
to mechanical energy within skeletal muscle. This chemical energy is known as 
adenosine triphosphate (ATP), and our ability to resynthesise ATP during exercise 
relies mainly on the breakdown of carbohydrate (CHO) and fat sources. Indeed, 
sustaining exercise at a desired intensity depends upon a complex interaction 
between CHO and fat metabolism. It is now well established that a number of factors 
influence the relative utilisation of extra- and intramuscular CHO and fat, including 
exercise intensity, duration, sex, feeding status and training status.  
 
The importance of CHO as a substrate for exercise performance has been recognised 
for around a century (Henriksson, 1977; Charlton & Crawford, 1997). One of the first 
studies to highlight this was from Levine et al, (1924), who measured blood glucose 
concentrations of a group of runners participating in the 1923 Boston Marathon and 
reported hypoglycaemia in most individuals following the race, suggesting that 
carbohydrate availability may be a cause of fatigue. In the 1924 Boston Marathon, 
runners were this time encouraged to consume CHO during the event, and this 
subsequently prevented hypoglycaemia. The development of the muscle biopsy 
technique in the 1960’s was another landmark in understanding the importance of 
CHO for exercise performance.  At this time, it was collectively shown that muscle 
glycogen is reduced in an intensity-dependent manner, and that a high CHO diet 
increases muscle glycogen storage and subsequently improves exercise performance 
(Bergstrom et al, 1967). The response of muscle glycogen to exercise and diet are 
now well established in both humans and animals (Bergstrom et al, 1967; Jensen & 
Richter, 2012). For over half a century it has been understood that glycogen stores 
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and CHO availability can compromise exercise capacity, despite other fuel sources 
being available (Bergstrom et al, 1967). Indeed, Bergstrom and Hultman (1966) 
demonstrated a strong correlation between endurance capacity during prolonged 
cycling and the availability of muscle glycogen, and when glycogen stores become 
exhausted there is an inability to continue exercise (Hermansen et al, 1967). 
 
The muscle biopsy technique has not only been used to investigate CHO utilisation 
during exercise, but also intramuscular triglyceride (IMTG) stores. IMTG-containing 
lipid droplets are often located close to the muscle mitochondria (Hoppeler et al, 1985), 
but it was initially unclear whether IMTG made a significant contribution as a fuel 
source during exercise.  Through the use of stable isotope methodology and the 
development of microscopy methods, it is now appreciated that IMTG are an important 
substrate during moderate-intensity exercise (Van Loon et al, 2004). Specifically, the 
development of immunofluorescence microscopy enabled the quantification of IMTG 
utilisation on a fibre type-specific basis (Essen et al, 1975; Howald et al, 1985), and 
this has now been extended to investigations of glycogen utilisation during exercise 
(Schaart et al, 2004).  Moreover, the use of transmission electron microscopy (TEM) 
has provided additional detail, highlighting that different subcellular pools of lipid and 
glycogen are preferentially utilised during exercise (Neilsen et al, 2009; Ørtenblad et 
al, 2011). Collectively, these techniques have informed our understanding of the 
relative importance of intramuscular substrates as a fuel source during exercise of 
varying intensities and durations. 
The present chapter aims to provide an overview of the background and key concepts 
concerning intramuscular substrate turnover during exercise and recovery. In this 
context, the storage and regulation of carbohydrate metabolism is first introduced, 
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which provides important background information for Chapter 4.  Next, the storage 
and regulation of fat metabolism is outlined. This section specifically focuses on IMTG 
and the methods used to determine its role as a substrate during exercise (thereby 
providing critical background information for Chapters 4, 5 and 6).  Moreover, the 
reader is provided a detailed overview of the regulation of IMTG metabolism, with a 
specific focus on the role of lipid droplet (LD) proteins, which provides important 
background information for Chapter 6. The review then closes by highlighting that 
laboratory-exercise trials which underpin exercise nutrition guidelines are grounded 
on are often limited in their translation and application to the field-based environment. 
2.2 Factors affecting intramuscular substrate turnover 
 
2.2.1 Exercise intensity 
 
It is known that both fat (plasma free fatty acids and IMTG) and CHO (plasma glucose 
and muscle glycogen stores) are the primary substrates for oxidative phosphorylation 
and fuel aerobic ATP resynthesis in human skeletal muscle (Hargreaves & Spriet, 
2012). Exercise intensity is a key factor in regulating substrate utilisation during 
exercise. At rest in the overnight fasted state, most energy is derived from the 
oxidation of adipose tissue-derived plasma free fatty acids (FFA). During low intensity 
exercise, energy expenditure is increased several fold in comparison to resting 
conditions. This initiates an increase in both CHO oxidation from plasma glucose and 
muscle glycogen stores, and fat oxidation from plasma free FA and other fat sources 
such as IMTG (van Loon et al, 2001). During moderate intensity exercise, fat oxidation 
is maximal (contributing ~50% to total energy expenditure) with an equal contribution 
from IMTG and plasma free FA. Indeed, maximal rates of lipid oxidation are 
considered to be around 65% VO2max, although this is dependent on other factors such 
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as training status and nutritional status of the individual (Achten & Jeukendrup, 2004).  
In regard to high-intensity exercise, Van Loon et al, (2001) demonstrated male cyclists 
completing 90 min of cycling in three 30 min stages of increasing exercise intensity 
(40, 55 and 75%Wmax), will lead to muscle glycogen becoming the major fuel source 
as exercise intensity increases, with a subsequent decrease in fat oxidation due to 
reductions in both plasma FFA and IMTG oxidation by 75% Wmax, (Fig. 2.1, Van Loon 
et al, 2001).  
 
 
Figure 2.1. Energy expenditure as a function of exercise intensity (expressed as % of 
maximal workload capacity). The contribution of plasma glucose, muscle glycogen, 
plasma free fatty acid, and muscle and plasma triglycerides to total energy 
expenditure. Redrawn from van Loon et al, 2001. 
 
Following high intensity exercise, there is a rapid increase in plasma glycerol 
concentrations suggesting that even during high intensity exercise the rate of adipose 
tissue lipolysis remains high.  This shift between fat and CHO oxidation as exercise 
intensity increases could therefore be explained by a relative reduction in adipose 
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tissue blood flow, such that fatty acids liberated from triglyceride remain trapped within 
adipose tissue. As such, Romijn et al, (1993) examined plasma free FA and glycerol 
during exercise at 25, 65 and 85% VO2max, witnessing reductions in plasma free FA at 
85% VO2max alongside increases in plasma glycerol. Stable isotope methodology 
demonstrated the rate of appearance of glycerol was not reduced at 85% VO2max in 
comparison to 65% VO2max, therefore suggesting the decrease in plasma FFA was due 
to a reduction in adipose tissue blood flow rather than a reduction in lipolysis. Further 
to this, investigations using an intravenous infusion of lipid and heparin during exercise 
at 85% VO2max, thereby maintaining plasma free FA, was compared to control 
conditions (Romijn et al, 1995). There results indicated that lipid oxidation rates were 
enhanced with the lipid and heparin infusion in comparison to the control, though not 
to levels witnessed during exercise at 65% VO2max (Romijn et al, 1995). Therefore, 
only half of the reduced lipid oxidation rates witnessed with increased exercise 
intensity could be explained by this reduction in FFA availability. A further potential 
mechanism to explain this shift between fat and CHO oxidation as exercise intensity 
increases, is that a high glycolytic flux during high-intensity exercise suppress long-
chain FA oxidation (Dyck et al, 1993; Odland et al, 1998). Increases in glycolytic flux 
lead to an accumulation of acetyl-CoA (Constantin-Teodosiu et al, 1991; Dyck et al, 
1993), subsequently causing increases in malonyl-CoA, which has been proposed to 
inhibit carnitine palmitomyltransferase I (CPT1), consequently supressing long-chain 
FA entry into the mitochondria. Though, due to lack of increases in malonyl-CoA in 
both rat and human skeletal muscle during high intensity exercise (Rasmussen & 
Winder, 1997; Odland et al, 1998; Dean et al, 2000), it has been questioned whether 
this mechanism actually functions as proposed. A further mechanism that could 
explain the reduction in fat oxidation during high intensity exercise includes the 
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availability of muscle carnitine. Carnitine is required for the long-chain FA to be 
transported through the inner mitochondrial membrane (Frtiz et al, 1955). The high 
rate of glycolysis during high-intensity exercise results in an increase in acetyl-CoA, 
which is then trapped by carnitine (creating acetyl-carnitine), thereby reducing free 
carnitine availability for long-chain mitochondrial FA transportation (Jeppesen & Kiens 
2012).  
2.2.2 Exercise duration 
 
The duration of exercise is also known to effect substrate utilisation, even when 
exercise intensity remains constant. Prolonged exercise of a moderate intensity is 
associated with time-dependent reduction in CHO oxidation and subsequent 
increases in fat oxidation (Fig. 2.2, Watt et al, 2002; Romijn et al, 1993). After 1-2 h of 
exercise, there is a shift in substrate utilisation, with an increase in the oxidation of 
plasma FFA due to continuous mobilisation from adipose tissue stores, as shown in 
figure 2.2. During prolonged exercise, plasma FFA oxidation increases in parallel with 
decreases in CHO oxidation. This reduction in CHO oxidation in prolonged exercise is 
likely due to a reduction in muscle glycogen stores (Gollnick et al, 1974). The 
enhanced rate of fat oxidation is due to increases in catecholamine (i.e. adrenaline) 
















Figure 2.2. The contribution of endogenous and blood-borne substrates to energy 
production during 240 min of moderate intensity exercise in men. Adapted from Watt 
et al, (2002). 
 
2.2.3 Training and nutritional status 
 
As well as exercise intensity and duration, training status is also known to have an 
effect on substrate metabolism during exercise due to a number of physiological and 
metabolic adaptations. The aim of such adaptations is to improve homeostasis for a 
given exercise intensity and duration, therefore ultimately delaying fatigue. Regular 
endurance training, will lead to a reduced reliance on CHO as a substrate for exercise, 
whilst increasing reliance on lipid particularly during moderate-intensity exercise. As 
the reliance on CHO is decreased with exercise training, fat metabolism is therefore 
increased to enable this sparing of CHO sources (Henriksson, 1977; Turcotte et al, 
1992; Kiens et al, 1993). Further to this, endurance training will increase the muscles 
capacity to store muscle glycogen and IMTG, which will thereby increase substrate 




Altering the diet of an individual has also been shown to modify substrate availability, 
both before, during and after exercise. For example, muscle glycogen availability 
impacts substrate metabolism, since it has been demonstrated that glycogen 
utilisation was increased during exercise at 45% VO2max that began with high muscle 
glycogen concentrations, in comparison to exercise at 70% VO2max started with much 
lower muscle glycogen concentrations (591 and 223 mmol.kg-1 dw, respectively), 
despite the greater exercise intensity (Arkinstall et al, 2004). However, in the same 
study lipid oxidation was greatest when exercise began with reduced muscle glycogen 
stores, independent of exercise intensity.  The effect of diet on IMTG in particular is 
discussed in further detail in section 2.10. This shift toward greater lipid oxidation when 
pre-exercise muscle glycogen levels are low is likely due to a combination of increased 
plasma FFA oxidation due to reduced glycogen availability, and increased adrenaline 
concentrations which favour lipid oxidation and lipolysis in comparison to conditions of 
high glycogen (Arkinstall et al, 2004). However, Roepstorff et al, (2005) observed 
minimal differences in plasma FFA availability and adrenaline following a pre-exercise 
meal and a subsequent glucose infusion during glycogen-depleted exercise, yet lipid 
oxidation was still enhanced. Therefore, regulation may lie within the muscle cell itself 
and specifically carnitine availability (since free carnitine levels were increased) may 
allow greater rates of lipid oxidation to occur (Roepstorff et al, (2005).  
2.3 Carbohydrate metabolism 
 
2.3.1 Carbohydrate storage 
 
 
Within the body, CHO is stored as glycogen in the liver (~100g) and skeletal muscle 
(350 – 700g depending on diet and training status of the individual), and a small 
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amount (~5g) circulates in the blood as glucose. Hepatic glycogen storage is restricted 
due to the size of the liver itself.  Because human skeletal muscle contributes ~20-
30% of total body weight, the amount of glycogen stored in muscle can equate to 
three-to-four times more than the glycogen stored within the liver. Even so, both of 
these endogenous CHO stores are considered relatively small (~5% of total energy 
storage), which underpins the relationship between CHO availability and exercise 
performance with low carbohydrate availability often leading to reduced exercise 
capacity and/or performance (Bergstrom et al, 1967; Hermansen et al, 1967; Jensen 
& Richter, 2012) 
 
In skeletal muscle, the importance of CHO stored as glycogen lies in its ability to be 
utilised without the presence of oxygen and its ability to be rapidly mobilised in the 
presence of elevated energy requirements. Glycogen itself is a branched polymer of 
glucose, which operates as an energy reserve for adenosine triphosphate (ATP) 
production within muscle and liver cells. Glycogen granules, also known as 
“glycosomes”, are considered to be an independent metabolic unit. They are 
composed of protein-glycogen (Meyer et al, 1970), and can be found in three forms 
termed α- and β-granules and γ-particles (Drochmans, 1962; Rybicka, 1996). α- 
granules are found in the liver and made up of multiple β-granules. The β-granules in 
muscle are individual glycogen granules, which include several γ-particles (Prats et al, 
2018), and are considered to be a rapid energy source. The β-granules measure ~20-
30nm in diameter, whilst α- granules in the liver are up to 300nm in diameter 
(Drochmans, 1962; Rybicka, 1996), and are considered a much slower energy source 
(Sullivan et al, 2014). β-granules are known to be organised as concentric layers of 
glucose chains, also known as tiers. As such, the theoretical; maximum size/capacity 
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for an individual β-granule is 42nm, or 12 tiers (Shearer & Graham, 2004). The 
branched structure of glycogen molecules increases the surface area allowing large 
amounts of glucose to be stored without compromising cellular osmolality. The result 
is a vast quantity of readily-available substrate to be used to generate energy for the 
muscle and/or liver (Melendez-Hevia et al, 1993).  
 
Beyond the structure of glycogen, it is important to note that the distribution of 
glycogen may differ between skeletal muscle fibre types. Using biochemical 
quantification, slow-twitch type I fibres, which are capable of prolonged activity, 
contain lower glycogen content at rest than type IIa fibres with ~ 303 and ~ 372 
mmol.kg DM -1 muscle glycogen, respectively (Tsintzas et al, 1995). In contrast, 
through the use of histochemical methodology, muscle glycogen at rest has been 
determined to not be substantially different between type I and type II fibres (Essen & 
Henriksson, 1974; Essen et al, 1975; Stellingwerff et al, 2007).  The requirement to 
identify muscle fibre type is important due to distinct muscle fibre recruitment patterns 
from changes in exercise intensity and duration (Gollnick et al, 1974), as well as 
different modes of exercise such as running and cycling (Millet et al, 2009). In addition, 
it is now recognised that glycogen is located in distinct subcellular locations or 
compartments within muscle fibres.  Optimal energy production requires a fast, 
efficient and continuous conversion of glycogen to ATP. The ATP-producing 
mitochondria are located between the myofibrils and beneath the sarcolemma 
(Ørtenblad & Stephenson, 2003). As such, glycogen and enzymes of the glycolytic 
pathway are localised in these specific regions of the muscle fibre. Evidence for 
compartmentalised glycogen metabolism first became apparent when studies 
demonstrated simultaneous synthesis and utilisation of glycogen through Carbon-13 
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nuclear magnetic resonance (13C NMR) with infusion during aerobic contractions 
(Shulman & Rothman, 2001), and a preferential need for glycolytic ATP to support the 
activity of the Na+-K+ pumps within skeletal muscle (James et al, 1999).  
 
Through the use of transmission electron microscopy (TEM), it is now known that 
glycogen particles are located in three distinct subcellular locations: 1) the 
intermyofibrillar (IMF) region, located between the myofibrils in close proximity to the 
sarcoplasmic reticulum and mitochondria, which contributes to ~75% of the cells total 
glycogen store, 2) the intramyofibrillar (INTRA) region, which is located within the 
myofibrils interspersed within the contractile filaments, and 3) the subsarcolemmal 
(SS) region of the cell which is located just beneath the surface membrane in close 
association with mitochondria, lipids and nuclei (Nielsen and Ørtenblad, 2011). The 
INTRA and SS regions account for the remaining 5 to 15% of the cell’s total glycogen 
respectively (Figure 2.3).  
 
Each of these glycogen pools may play a specific role in providing a substrate for 
energy production to fuel distinct processes within the skeletal muscle (Nielsen et al, 
2009; Ørtenblad, et al, 2011), although at present this concept is not completely 
understood. Neverthless, it is now believed that the link between glycogen 
concentrations and muscle fatigue likely originates from an association specifically 
between INTRA glycogen and sarcoplasmic reticulum calcium release (SR Ca2+) 
(Nielsen et al, 2009; 2014; Ørtenblad et al, 2011). Further to this, INTRA glycogen is 
preferentially depleted during prolonged exercise (Marchand et al, 2007; Nielsen et al, 
2011), thus suggesting a potential explanation for the glycogen-dependent component 
in muscular fatigue (Ørtenblad et al, 2015). In support, Jensen et al, (2020) recently 
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showed that INTRA glycogen is the best predictor of time to exhaustion, but that SS 
glycogen was also reduced during exercise. SS glycogen may contribute energy to 
support Na+-K+ pump activity at the sarcolemma (Nielsen & Ørtenblad, 2013), and in 
this way spare the utilisation of INTRA glycogen to support SR Ca2+ release (Ørtenblad 


















Figure 2.3. Images of a muscle fibre from the vastus lateralis muscle to demonstrate 
compartmental glycogen distribution. 1. Intermyofibrillar, 2. Intramyofibrillar and 3. 
Subsarcolemmal. Image taken at 36,000x.  Scale bar = 0.5µm.  MITO – mitochondria, 









2.3.2 Factors influencing carbohydrate storage  
 
Diet and training status will greatly impact CHO storage. As already mentioned, low 
glycogen availability before exercise compromises exercise capacity, despite other 
fuel sources being available (Bergstrom et al, 1967). Adequate CHO consumption is 
now considered fundamental in the preparation for an event, with the days prior aiming 
to maximise muscle glycogen stores, whilst CHO intake a few hours before an event 
will optimise liver glycogen. When considering the days leading up to an event, the 
overriding message from the large number of studies investigating pre-exercise CHO 
consumption and/or CHO loading over the last 40 years, is that purposely consuming 
a large amount of CHO can improve exercise performance and capacity, particularly 
when exercise is longer than 90 min in duration by increasing glycogen storage 
(Hawley et al, 1997). More specifically, the exact amount of CHO in the diet will reflect 
clearly on resting muscle glycogen concentrations. For example, when deliberately 
withholding CHO after an evening training session, and completing a fasted training 
session the following morning in a model known as ‘sleep low, train low’, muscle 
glycogen concentrations can be <200 mmol/kg dw (Bartlett et al, 2013), in comparison 
to muscle glycogen concentrations of 600 mmol/kg dw on a high CHO diet (8 g kg-1 
BM) the day before exercise (Impey et al, 2016). Training status will also impact CHO 
storage, such that regular endurance training enhances the capacity for muscle 
glycogen storage (Greiwe et al, 1999). As a training adaptation, trained athletes can 





2.4 Lessons from microscopy studies: Muscle glycogen utilisation during 
exercise 
 
As discussed in detail above, glycogen utilisation during exercise is now well-
established to be affected by exercise intensity (Figure 2.1, Van Loon et al, 2001) and 
duration (Figure 2.2, Watt et al, 2002), as well as being affected by the nutritional 
(Arkinstall et al, 2004) and training status of the individual (Saltin et al, 1976; 
Henriksson, 1977). It is now also acknowledged that glycogen utilisation during 
exercise is not only dependent on muscle fibre type (Gollnick et al, 1974), but also on 
the specific subcellular location of glycogen within the muscle fibres (Marchand et al, 
2007; Nielsen et al, 2011; Nielsen and Ørtenblad, 2011), thereby adding another layer 
of complexity in understanding glycogen metabolism during exercise (Ørtenblad & 
Nielsen, 2015).  
 
Glycogen can be measured using biochemical techniques on muscle homogenates, 
though this method cannot discriminate between muscle fibre types. To examine 
glycogen utilisation on a fibre-specific basis histochemical methods have been used, 
providing a highly valuable research tool that enables the collection of 
(semi)quantitative data alongside informative visual images exhibiting spatial 
distributions of cellular structures. To examine glycogen periodic acid-schiff (PAS) 
staining has been used, the validity of which has been investigated by Van Der Laarse 
et al, (1992). PAS staining is based on the reaction of periodic acid with the diol 
functional groups found in glucose and other sugars, causing oxidation to form 
aldehyde. This reacts with the Schiff reagent to produce a purple/magenta stain (Prats 
et al, 2013). Though, this means that the PAS stain is not exclusive to glycogen and 
also will stain glycoproteins and proteoglycans. However, glycogen can be singled out 
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by pre-treating the cryosections with the glycogenolytic enzyme diastace (Baba, 
1993). Despite this, many published studies have not used this process, therefore 
glycogen content can be overestimated (Prats et al, 2013). Research using PAS 
staining has allowed the identification of differences in muscle glycogen depletion 
dependent on muscle fibre type (Vollestad et al, 1984) and demonstrated that in 
endurance trained males only 1 day of CHO (10 g.day(-1).kg(-1))  is required to maximise 
CHO storage in type I, IIa and IIb muscle fibres (Bassau et al, 2002).  
 
There have been reports going back to the 1960’s of electron microscopy being utilised 
to examine glycogen (Revel, 1963) and TEM has enabled direct and detailed 
information to be gathered showing glycogen particles and their localisation in relation 
to the mitochondria and within the muscle fibres (see Figure 2.3). TEM provides great 
detail with regards to the location of muscle glycogen, and using this technique, INTRA 
glycogen has been demonstrated to be preferentially depleted during prolonged 
exercise (Marchand et al, 2007; Nielsen et al, 2011), thus suggesting a potential 
explanation for the glycogen-dependent component in muscular fatigue (Ørtenblad et 
al, 2015). In addition, Jensen et al, (2020) recently showed that INTRA glycogen is the 
best predictor of time to exhaustion. However, TEM investigations rely on 
morphological factors to identify fibre type (z-line width and mitochondria), and 
analysis is only limited to a small number of fibres (~4-8 fibres) due to the time-
consuming procedure which is related to the magnification required to obtain 
measures of glycogen volume fraction, which requires 20 – 30 images per fibre. 
Further to this when identifying fibre type using morphological factors, images of many 
fibres (~10-12 fibres) are collected, though only a few of these fibres which represent 
type I or type II fibres will be used (more on this procedure is included in 3.4.4). This 
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means many more fibres will be imaged than the amount that can actually be analysed 
for glycogen or lipid. There is also a limited number of fibres to image due to the 
ultrathin sections used for TEM analysis. Overall, when choosing methodology to 
examine glycogen utilisation during exercise, both fibre and region-specific analysis 
should be considered.  
 
2.5 Regulation of carbohydrate metabolism during exercise   
 
 
There are a number of key processes that govern the regulation of CHO metabolism. 
Muscle glycogen breakdown occurs through the process of glycogenolysis, where 
glycogen is first broken down into glucose-1-phosphate (G1P) by glycogen 
phosphorylase, and is then transformed into glucose-6-phosphate (G6P) by the 
enzyme phosphoglucomutase. Glycogen phosphorylase is considered the rate-
limiting enzyme in the process of glycogenolysis (Richter et al, 1986) and is regulated 
via hormonal and/or allosteric control. At rest, glycogen phosphorylase is inactive in 
its b form, though when exercise begins, phosphorylase kinase phosphorylates the b 
form into the active a form. This process is initiated by the exercise-induced secretion 
of adrenaline from the adrenal medulla.  Adrenaline binds to the β-adrenergic 
receptors on the sarcolemma, causing the activation of G-protein, which in turn 
activates adenylate cyclase, thus converting ATP into cyclic AMP (cAMP). cAMP then 
activates protein kinase A (PKA), which will subsequently activate phosphorylase 
kinase, resulting in the transformation of glycogen phosphorylase into its active a form. 
The activity of glycogen phosphorylase a can also be modified by allosteric factors, 
including Ca2+ flux, and the accumulation of adenosine diphosphate (ADP), adenosine 




Given that adrenaline leads to phosphorylation and transformation of glycogen 
phosphorylase from the b to a form, it is reasonable to assume that this may explain 
the increase in glycogen utilisation with increasing exercise intensity. This would also 
be in line with the greater sarcoplasmic Ca2+ concentrations apparent during high 
intensity exercise, given the requirement for increased crossbridge cycling, and the 
fact that Ca2+ is a positive allosteric regulator of glycogen phosphorylase activity. 
However, Howlett et al, (1998) observed that glycogen phosphorylase activation was 
not augmented in line with increasing exercise intensity. In fact, the proportion of 
glycogen phosphorylase a was actually reduced after 10 minutes of high intensity 
exercise which was proposed to be due to the reduction in pH associated with higher 
exercise intensities. Although Ca2+-mediated signalling (leading to glycogen 
phosphorylase transformation) may occur within seconds of muscle contraction 
beginning (Parolin et al, 1999), it is likely that post-transformational modifications are 
required during more prolonged high intensity exercise given that glycogenolysis still 
occurs despite a reduction in transformation. In this regard, it seems that the energy 
status of the cell may be more of a controlling factor, with increasing exercise intensity 
augmenting ATP hydrolysis, thereby increasing ADP, AMP and Pi accumulation. 
Specifically, the increase in Pi, will increase glycogenolysis as it provides greater 
amounts of substrate for the reaction to take place.  Furthermore, whilst it is well-
appreciated that glycogen phosphorylase is regulated through hormonal control via 
adrenaline (Jansson et al, 1986; Spriet et al, 1988; Febbraio et al, 1998), this is not 
always the case (Chesley et al, 1995; Wendling et al, 1996).  
 
In addition to muscle glycogen, the contribution of plasma glucose to ATP production 
is also important. Plasma glucose entering skeletal muscle via GLUT4 is first 
25 
 
phosphorylated by hexokinase to form G6P. As such, G6P generated from both 
plasma glucose and muscle glycogen enter the process of glycolysis. Glycolysis is the 
breakdown of glucose leading to the production of pyruvic acid. Once glucose enters 
the glycolytic pathway, the rate-limiting enzyme in glycolysis is considered to be 
phosphofructokinase (PFK), which is allosterically regulated via ADP, AMP and Pi. 
Increased exercise duration will lead to a decrease in CHO metabolism and an 
increase in lipid metabolism. This is likely due to glycogen depletion and reduction in 
glycolytic flux through both glycogenolysis and glycolysis, thereby leading to a 
reduction in pyruvate and therefore the downregulation of pyruvate dehydrogenase 
activity resulting in decreased CHO oxidation.  
 
2.6 Post-exercise muscle glycogen resynthesis 
 
Many sports need athletes to be able to perform for training or competition on 
consecutive days, endurance sports such as cycling, distance running, rowing and 
swimming are prime examples. Therefore, the replenishment of glycogen stores is 
important in order to maximise recovery and subsequent performance capabilities. 
CHO is a key substrate in maximising post-exercise muscle glycogen resynthesis, with 
CHO intake in the first few hours post-exercise being particularly important. During the 
first 30 – 40 minutes following exercise, glycogen is rapidly resynthesized via exercise-
induced translocation of GLUT4 to the cell membrane facilitating glucose uptake. The 
rate of synthesis is dependent on several factors, including the availability of plasma 
glucose as a result of hepatic glucose production, the transportation of glucose into 
the cell via GLUT4, the intramuscular concentration of glucose-6-phosphate (G-6-P), 
and the activity of enzymes such as glycogen synthase, which is related to the level 
of glycogen depletion. Due to the changing activity of these enzymes and the 
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effectiveness of the glucose transportation, there are two different phases of glycogen-
synthesis post-exercise. The first phase, occurs independent of a rise in circulating 
insulin concentrations, and is therefore often referred to as the insulin-independent 
phase (Piehl, 1974). Glycogen synthase (the rate-limiting enzyme for glycogen 
synthesis) is present in an inactive or active form. When muscle glycogen is low, both 
glycogen synthase phosphatase is activated, which triggers the dephosphorylation of 
glycogen synthase, converting it to an active form and enhancing the rate of glycogen 
synthesis (Ivy & Kuo, 1998). Further to this, the availability of glucose, which is 
dependent on GLUT4 at the plasma membrane will affect this phase. For the first hour 
post-exercise, there is enhanced GLUT4 availability at the cell membrane, thereby 
facilitating glucose uptake. AMPK activity also elicits greater GLUT4 translocation, 
though this is partially mediated by muscle glycogen availability due to the glycogen 
binding domain in AMPK (McBride et al, 2009). As such, low glycogen availability has 
been demonstrated to enhance AMPK signalling responses and adaptations to 
exercise in rat (Wojtaszewski et al, 2002) and human skeletal muscle (Wojtaszewski 
et al, 2003). This phase has been suggested to only occur when post-exercise 
glycogen concentrations are less than ~ 120 – 150 mmol/kg dw (Price et al, 1994). 
 
The insulin-dependent phase which follows supports continued glycogen storage as a 
result of post-exercise CHO ingestion, and although this phase occurs at a much 
slower rate, it can last for up to 24 hours (Jenjens and Jeukendrup, 2003). This phase 
is characterised by an enhanced sensitivity of skeletal muscle to physiological 
increases in plasma insulin, which can last for several hours depending on the level of 
glycogen depletion and provision of CHO (Cartee et al, 1989). Why this occurs is yet 
to be elucidated, though it is likely to be due to an interaction between muscle glycogen 
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concentration, AMPK and insulin signalling molecules (Jensen and Richter, 2012). 
After glucose enters the cell, the majority will be directed toward glycogen storage 
rather than oxidation. This is regulated via enhanced glycogen synthase activity, which 
is activated through insulin, though may also be due to an increase in GLUT4 activity 
in the cell leading to greater glycogen synthesis rates (Ren et al, 1994).  
 
Research has also demonstrated that glycogen resynthesis can differ between the 
subcellular pools of glycogen. Nielsen et al, (2011) observed impaired INTRA 
glycogen resynthesis during the first 4 h of recovery from high intensity exercise when 
no CHO was consumed, whereas resynthesis of IMF and SS glycogen was less 
affected. When CHO is present during recovery, serum levels of insulin increase. 
Increases in glucose uptake after the initial 1-2 h recovery is only observed when 
insulin is present (Frosig & Richter, 2009). Interestingly, the T-system has been 
demonstrated to be a key site for insulin-mediated glucose uptake (Lauritzen et al, 
2006). The t-tubuli are extensions of the cell membrane that penetrate into the centre 
of skeletal muscle cells, thus providing direct access for the incoming glucose to the 
INTRA region of the cell. Therefore, when CHO is withheld during recovery, this will 
result in impaired insulin-dependent GLUT4 translocation to the T-system rather than 
to the sarcolemma. Furthermore, research by Nielsen et al, (2011) demonstrated that 
glycogen in the IMF and SS regions was fully resynthesized at 22 h post-exercise, 
whilst the INTRA glycogen levels had only reached 60% of the respective pre-exercise 
levels, regardless of CHO availability during the first 4 h post-exercise. This suggests 
a delay in the recovery of INTRA stores beyond 24 h following exercise, regardless of 
total post-exercise CHO intake. However, this is in contrast to data by Marchand et al, 
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(2007), who demonstrated a preferential resynthesis of INTRA glycogen following 
prolonged exercise.  
 
Early work from the late 1980’s suggested that consumption of 0.7g CHO/kg BW/h 
immediately post-exercise could elicit an increase of ~20 mmol/kg dw/h as the 
maximal rate attainable over 4 h (Ivy et al, 1987). However, further work demonstrated 
that consuming smaller amounts (30 min intervals) of CHO post-exercise, providing 
1.2g CHO/kg BW/h further augmented the rate of glycogen synthesis to 44.8 mmol/kg 
dw/h (Van Loon et al, 2000). The highest rate of glycogen resynthesis recorded is 85 
mmol/kg dw/h, though this was only attainable through a CHO infusion whilst being in 
a glycogen depleted state (Bergstrom & Hultman, 1967). The type of CHO and method 
of consumption should be considered carefully. High glycaemic index (GI) CHO has 
been demonstrated to produce 61% greater glycogen resynthesis than low GI CHO 
(Burke, 1993). The effect of GI is likely mediated through an increase in gastric 
emptying, therefore the concentration of blood glucose available for absorption by 
skeletal muscle.  Practically, a mixture of fluid and solid CHO is recommended to be 
consumed is recommended to facilitate rehydration and repletion of glycogen following 
exercise, respectively.  
 
2.7 Lipid metabolism  
 
2.7.1 Skeletal muscle lipid storage  
 
Triacylglycerol (TG) molecules consist of 1 glycerol molecule (backbone) with 3 FA 
molecules attached. The primary storage site for TG within the body, is within 
subcutaneous and visceral adipose tissue depots. Here the amount of TG will vary 
greatly between individuals due to factors such as training status and diet, but the 
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average healthy male of ~ 70kg will store 9 – 15 kg of TG within adipose tissue, 
equating to an energy store of ~ 80,000 – 140,000 kcal (Van Loon, 2004). As such, 
diet leading to caloric excess will result in adipose tissue stores expanding in size, 
whilst under conditions of caloric deficit will lead to reductions in adipose tissue TG as 
the hydrolysis of TG will result in FA mobilisation so the body’s energy requirements 
can be met. Therefore, making TG within adipose tissue a dynamic pool for FA storage 
and release as demand dictates. As introduced above, adipose tissue is the primary 
storage site for fat, though this means there are others. FA can also be stored as TG 
within intracellular lipid droplets (LD). In muscle, smaller quantities of TG are seen 
within muscle fibres, known as IMTG. The concentration of IMTG is generally within 
the range of 2 and 10 mmol.kg-1 wet weight, which equates to mixed muscle TG 
content of approximately 0.2kg, providing an energy store of ~ 1,850 kcal (Van Loon, 
2004; Watt et al, 2002; Wendling et al, 1996). The concentration of IMTG is heavily 
influenced by energy intake, diet and training status. Indeed, one of the most 
prominent adaptations to endurance training is enhanced IMTG storage (reviewed in 
Shaw et al, 2010). Electron microscopy analysis of skeletal muscle tissue has 
demonstrated IMTG-containing LD are located close to the mitochondria (Hoppeler, 
1999; Shaw et al, 2008), therefore providing a readily available fuel store of FA for 
oxidation during exercise. IMTG storage is known to be up to three-fold greater in type 
I muscle fibres in comparison to type II (Essen et al, 1975; Koopman et al, 2001; 
Malenfant et al, 2001; Van Loon et al, 2003a, 2003b), with exercise causing a 
preferential reduction in IMTG content of type I fibres (Van Loon et al, 2003; 
Stellingwerff et al, 2007). The subcellular distribution of IMTG has been demonstrated 
using TEM to be in two LD pools, 1) subsarcolemmal LDs, located just beneath the 
plasma membrane, and 2) intermyofibrillar LDs, located between the myofibrils 
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(Nielsen et al, 2010a). This is important as TEM investigations have demonstrated a 
reduction in intermyofibrillar, but not subsarcolemmal LDs following 1 h of moderate-
intensity exercise in lean, healthy individuals (Chee et al, 2016).   
 
 
2.7.2 Lipid droplets  
 
 
IMTG is referred to throughout this thesis as a description of the source of FA which 
contribute to fat oxidation during exercise. Although adipose tissue is the predominant 
site for TG storage, nearly all cell types can store FA as TG, and TG is typically housed 
within intracellular LD. For years, LD’s were considered to be inert storage depots.  
However, they are now recognised as functional organelles playing key roles in a 
number of biological processes (Walther & Farese, 2009). In adipose tissue, LD are 
unilocular and have one large LD per cell per se, whilst in skeletal muscle there are 
numerous smaller LD. The structure of LD’s is unique, consisting of a neutral lipid core 
primarily containing TG and cholesterol esters with a surrounding monolayer of 
phospholipids (Ohsaki et al, 2009) that is decorated with integral and peripheral 
proteins (Fujimoto et al, 2011). Proteomic analyses have revealed that there are over 
300 proteins either functionally associated with or embedded within the phospholipid 
monolayer of LD’s (Zhang et al, 2011). Of these proteins, the most well known are the 
PAT proteins, or more commonly known as the Perilipin (PLIN) proteins, as well as 
many other proteins that regulate LD formation, TG synthesis and hydrolysis. The 
proteome of LD subpopulations likely determines their role in cellular function, as well 
as their morphology and subcellular location. When considering morphology, the 
balance between synthesis and breakdown of TG will determine the number and size 
of LD. Currently though, it is yet to be elucidated whether an increase in LD synthesis 
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will lead to an increase in individual LD number and/or LD size, with the same also 
applying to our knowledge on the breakdown of LD during exercise. Nevertheless, 
what is clear is that although LD are relatively small, there is variation in size (0.20 – 
0.50 µm2, Daemen et al, 2018). 
 
 
2.7.3 IMTG utilisation during exercise   
 
 
As mentioned previously, whole-body fat oxidation is maximal during moderate-
intensity exercise, where fat oxidation rates are increased by ~ 10 fold in comparison 
to rest in trained individuals (Romijn et al, 1993; Van Loon et al, 2001). In order to 
investigate the contribution of IMTG to total fat oxidation during exercise, several 
studies have used indirect calorimetry measures alongside the infusion of a 13C-
labelled FA tracer (Romijn et al, 1993; Van Loon et al, 2001; Watt et al, 2002; Van 
Loon et al, 2003). Stable isotope tracers provide a powerful, unique tool for 
investigating substrate utilisation at a whole-body level by combining indirect 
calorimetry with the use of stable and/or radioactive isotope tracers (Rennie, 1999). 
Using this technique, it is possible to measure total fat and plasma free fatty acid (FFA) 
oxidation, and subsequently calculate the contribution of other fat sources (i.e. IMTG 
and lipoprotein-derived TG) to total fat oxidation. However, this method assumes 
lipoprotein-derived TG oxidation to make a small contribution to total fat oxidation (~5-
10%), which it does following an overnight fast under normal dietary conditions (Van 
Loon, 2004; Watt et al, 2002). Overall, it has been concluded that IMTG represents an 
important substrate during moderate-intensity exercise and the measurement of 
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plasma FFA oxidation using stable isotopes enables an indirect estimation of both 
muscle and/or lipoprotein-derived TG oxidation during exercise.  
 
While stable isotopes provide an indirect estimate of IMTG oxidation, directly 
measuring IMTG content before and after exercise enables net changes in IMTG to 
be calculated.  One such method to achieve this is the use of Proton magnetic 
resonance imaging 1H-MRS, which provides a non-invasive technique allowing 
quantification of both intramyocellular and extramyocellular lipid (EMCL) (Boesch et 
al, 1999; Boesch & Kreis, 2000). It enables quantification by measuring the 
resonances from methyl and methylene groups of muscle triglycerides appearing in 
multiple peaks on the proton spectrum, such peaks have been linked to either 
intramyocellular lipid (peak at 1.3 – 1.4 ppm) or EMCL (peak at 1.5 – 1.6 ppm) (Boesch 
et al, 1999; Szczepaniak et al, 2001). This was validated via a differentiation in 
readings of subjects with generalised lipodystrophy (characterised by the absence of 
interfascial adipose tissue), where no EMCL (peak at 1.5 – 1.6 ppm) was detected in 
comparison to a strong IMCL signal (peak at 1.3 – 1.4 ppm) (Szczepaniak et al, 2001). 
Using this technique, it has been consistently reported that IMTG concentration is 
significantly reduced by ~20–40% following moderate-intensity exercise (reviewed by 
Van Loon, 2004), and therefore provides evidence to support IMTG contributing to 
total fat oxidation in active individuals during exercise.  
 
Using 1H-MRS it has also been established that short-term, high-fat diets (48 h) 
enhance IMTG utilisation, which is likely due to the greater pre-exercise IMTG content 
(Johnson et al, 2003; Zderic et al, 2004). Further to this, validation for this method was 
provided by studies observing strong correlations between IMTG content determined 
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with 1H-MRS and electron microscopy (Howald et al, 2002) and immunofluorescence 
microscopy (Van Loon et al, 2003). In summary, 1H-MRS provides a non-invasive 
method enabling the quantification of IMTG content over time under different 
conditions i.e. nutritional or exercise, in vivo in humans. However, MRI is an expensive 
technique, and machines are not readily accessible or portable; factors which will 
preclude its accessibility and feasibility within a field-based sporting environment. 
 
While both stable isotope and 1H-MRS methods provide some evidence of the 
contribution of IMTG to total fat oxidation during moderate-intensity exercise in active 
individuals, direct quantification of IMTG concentrations through biochemical 
extraction in skeletal muscle tissue provide a less clear view. Using the biochemical 
extraction technique, exercise induces a significant decrease in the concentration of 
IMTG in skeletal muscle following exercise in numerous studies (Essen-Gustavsson 
& Tesch, 1990; Phillips et al, 1996; Sacchetti et al, 2002; Watt et al, 2002), whereas 
others did not observe any significant changes (Kiens et al, 1993; Kiens and Richter, 
1998; Wendling et al, 1996). It has been suggested that the equivocal findings using 
this method could be due to the heterogeneity of research protocols (i.e. duration 
and/or intensity, mode of exercise) as well as the selected population being examined 
(Van Loon, 2004). Such factors will likely contribute to some variability, but they do not 
fully explain such contradictory findings within the literature. Methodological difficulties 
with the TG extraction technique may also account for some of the variability (Watt et 
al, 2002). For example, the between-biopsy variability has a large coefficient of 
variation of 20-26% (Wendling et al, 1996), meaning that net reductions in IMTG 
content less than this will not reach statistical significance in such studies (Wendling 
et al, 1996). The source of the variability is likely linked to the presence of EMCL in 
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muscle samples (Guo, 2001; Watt et al, 2002; Wendling et al, 1996). Although the 
removal of EMCL is possible via microdissection (Guo, 2001), the presence of even a 
few adipocytes will cause a substantial overestimation in total IMTG content. To 
reduce the impact of EMCL on estimates of IMTG, using only well-trained endurance 
subjects, who typically have low EMCL, is suggested (Boesch et al, 2000; 
Szczepaniak et al, 2001; Wendling et al, 1996). Clearly though, this limits the 
application of this technique to investigate IMTG as a substrate during exercise in 
more unhealthy or diseased populations.  
 
Using the 1H-MRS or biochemical extraction technique only permits the quantification 
of mixed-muscle TG concentration, and therefore does not take fibre type or 
subcellular location of IMTG-containing LDs into account, as well as the subcellular 
distribution of IMTG. The development of immunofluorescence microscopy methods 
allowed the discrimination between IMTG content in type I and type II fibres using Oil 
red O (ORO) staining, thus allowing the quantification of IMTG content on a fibre type-
specific basis. This technique has revealed that IMTG content is ~2-3-fold greater in 
type I fibres compared to type II fibres (Essen et al, 1975; Howald et al, 1985). Further 
to this, immunofluorescence microscopy has shown that there are greater amounts of 
IMTG stored in the peripheral regions of muscle fibres (Van Loon et al, 2004; 
Stellingwerff et al, 2007; Shaw et al, 2008). On the other hand, it is important to note 
that immunofluorescence microscopy will only provide a semi-quantitative analysis, 
and the efficacy of the staining procedure and image acquisition settings will highly 
influence the area fraction stained. Therefore, controls should be used to minimise 
variability. When accurately controlled, this technique has been used to show 2 h of 
moderate-intensity exercise will reduce the intramuscular lipid pool in type I fibres by 
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>60% (Van Loon et al, 2003).  Moreover, the reduction in IMTG during exercise 
appears to be related to pre-exercise IMTG levels (Stellingwerff et al, 2007). 
Interestingly, mixed-muscle IMTG measured using immunofluorescence correlates 
with IMTG quantification using biochemical extraction techniques, though this 
relationship disappears when used to quantify utilisation during exercise (Stellingwerff 
et al, 2007). This is predominantly due to the rate of IMTG utilisation being greater in 
type I fibres than in type II.  
 
It is important to note that when staining for IMTG, ORO is not without experimental 
disadvantages. To use ORO the tissue requires fixing, thus preventing its use on live 
cells.  Furthermore, completely dissolving ORO into solution has proved difficult and 
once created, has a limited shelf life (Spangenburg et al, 2011). Moreover, there is a 
high level of background staining observed when using ORO, which due to the efficacy 
of the staining procedure and image-acquisition settings will highly influence the area 
fraction stained (outcome variable for quantifying IMTG content using 
immunofluorescence microscopy). An alternative dye to visualise LD in skeletal 
muscle is the fluorescent dye BODIPY (493/503), which emits a bright green 
fluorescence (Listenberger & Brown, 2007). BODIPY (493/503) can be coupled with 
fluorescence staining of other proteins whilst also not needing to be made “fresh” for 
each use (Spangenburg et al, 2011). When determining protein interactions with LD, 
immunofluorescence in combination with wide-field or confocal imaging has often 
been used (Daemen et al, 2016). Immunohistochemistry is an irreplaceable method 
to examine the distribution of LD as it provides a highly valuable research tool that 
enables the collection of (semi)-quantitative data alongside informative visual images 
exhibiting spatial distributions of cellular structures. We recently compared BODIPY to 
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ORO for visualising and quantifying IMTG content (Strauss et al, 2020), and showed 
that the detection and quantification of IMTG content was greater when using BODIPY 
due to the detection of a larger number of LD, when compared to ORO (Fig. 2.4, 































Figure 2.4. Fibre type specific lipid staining using BODIPY and ORO before and after exercise. For BODIPY panel of images, LD’s 
stained before and after exercise using BODIPY (green) and the cell membrane using Laminin (pink) can be seen in the large images 
for type I (top), type IIa (middle) and type IIx (bottom). The smaller images show the corresponding fibre type staining with MHCI 
denoting type I fibres (red) and MCHIIa (blue) and no stain showing type IIx fibres. For ORO panel of images, LD’s stained before 
and after exercise using ORO (greyscale for clarity) and cell membrane (pink) can be seen in the large images for type I (top), type 
IIa (middle) and type IIx (bottom). The smaller images show the corresponding fibre type staining with MHCI denoting type I fibres 



















Pre-exercise Post-exercise Pre-exercise Post-exercise 




Moreover, BODIPY was more photostable and had a lower within-sample coefficient 
of variation than ORO. In summary, there are important differences to consider when 
deciding which lipid stain to use for quantifying IMTG on a fibre type and subcellular-
specific basis. When comparing ORO and BODIPY it has been concluded that 
BODIPY (493/503), offers a respected alternative to ORO, when examining LD 
function in skeletal muscle (Spangenberg et al, 2011) due to its greater photo-stability 
and capability to specifically detect IMTG whilst avoiding quantification of membrane 
structures, compared to ORO (Strauss et al, 2020).  
 
Although immunofluorescence microscopy allows quantification on a fibre-specific and 
subcellular basis, another microscopy technique that can be used to examine IMTG 
utilisation is transmission electron microscopy (TEM).  This technique enables direct 
and detailed information to be gathered showing LD and their localisations in relation 
to the mitochondria and spatially within the muscle fibres (see Fig. 2.3). TEM can be 
used to determine exercise-induced changes in substrate utilisation. By virtue of the 
greater magnification capabilities and excellent resolution, TEM can be considered the 
most accurate method to measure changes in LD size and number.  Although TEM 
provides greater detail with regards to the subcellular localisation of LD distribution in 
muscle, this technique relies on morphological factors to identify fibre type, and 
analysis is only limited to a small number of fibres per sample (~4-8 fibres). A further 
disadvantage of TEM, is the ability to only be used on chemically-fixed, and thus 
material with restricted antigenicity. This complicates the ability to co-stain with 
specific antibodies in order to examine the interaction of proteins with LDs, for example 
(Daemen et al, 2016). The validity of TEM when examining IMTG has been 
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investigated by Howald et al, (1985), who found a strong correlation between TEM 
and 1H-MRS. Overall, both immunofluorescence microscopy and TEM provide 
methods to visualise and quantify IMTG utilisation and changes in LD morphology on 
a fibre-type and subcellular specific basis, though to date, no direct comparison 
between the two microscopy methods in quantifying IMTG utilisation has been made. 
 
2.8 Skeletal muscle lipid metabolism  
 
2.8.1 IMTG turnover    
 
IMTG turnover is reflective of the balance between the rate of lipolysis and lipid 
synthesis, both of which are highly influenced by mitochondrial fat oxidation capacity 
and plasma FFA availability. FA that are esterified in the IMTG pool are hydrolysed by 
TG lipases before oxidation, whilst they can be recycled back into the IMTG pool when 
not oxidised. In healthy individuals, the IMTG pool is in a constant state of flux (due to 
the regular use of IMTG as a fuel source during exercise) and the major proportion of 
FA entering the muscle at rest are shunted toward esterification into IMTG (Sacchetti 
et al, 2004). Overall, it is thought that in resting skeletal muscle, the turnover rate of 
the entire IMTG pool is approximately 29 h (Sacchetti et al, 2004).  It is thought that 
lipolysis is hypothetically well-matched to mitochondrial β-oxidation given the location 
of LD in close proximity to the mitochondria in trained individuals. A potential reduction 
in the capacity of mitochondrial fat oxidation due the presence of larger LD positioned 
away from (or without direct contact) to the mitochondria may lead to the promotion of 
a lower turnover rate of IMTG. Factors that mediate the rate of IMTG turnover include 
the oxidative capacity of the muscle, the rate of lipolysis i.e. IMTG breakdown, FFA 
availability and finally, esterification of fatty acids and intermediate products, such as 
diacylglycerol (DAG).  
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2.8.2 Lipolysis    
 
Lipolysis is the process of TG breakdown, where the three fatty acids are liberated 
from the glycerol backbone. Hormone sensitive lipase (HSL) was initially believed to 
be the the rate-limiting enzyme of lipolysis, with hydrolase activity of HSL at rest 
accounting for ~ 60% of total neutral hydrolase activity (Watt et al, 2004). By inhibiting 
HSL in rat skeletal muscle, contraction-induced increases in TG lipase activity were 
eradicated (Langfort et al, 2000). Similar to IMTG, the content of HSL is greater in type 
I fibres compared to type II fibres (Langfort et al, 1999). Under conditions that stimulate 
IMTG breakdown (such as exercise), circulating adrenaline levels are increased and 
will activate HSL via cAMP-dependent protein kinase (PKA) phosphorylation on HSL 
Ser563 and Ser660 (Watt et al, 2003; 2006). On the other hand, a postprandial rise in 
circulating insulin concentrations will inhibit skeletal muscle HSL activity by activating 
a phosphodiesterase which converts cAMP to inactive 5’-AMP, therefore meaning 
there is a reduction in the proportion of HSL that is positively phosphorylated 
(Enoksson et al, 1998). During exercise, muscle contraction also activates HSL 
through protein kinase C and extracellular signal-related kinase (Donsmark et al, 
2003), most probably via the phosphorylation at Ser600 (Greenberg et al, 2001). During 
higher intensity exercise, AMP-activated protein kinase (AMPK) will increase and 
subsequently cause the phosphorylation and inhibition of HSL on Ser565 which will 
result in an anti-lipolytic effect (Watt et al, 2004; 2006). Further to this, increases in 
long-chain fatty acyl-CoA, observed during high intensity exercise and also during 
prolonged steady state exercise (>2 h in duration), may allosterically inhibit HSL 
activity (Kiens et al, 1999; Watt et al, 2002). Thus, HSL is upregulated at low-to-
moderate exercise intensities, (i.e. 30 and 60% VO2peak) in comparison to higher 
exercise intensities (90% VO2peak) (Watt et al, 2003). In addition to post-
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transformational modifications regulating the activity of HSL, another key step is the 
translocation of HSL from its cytosolic store to the LD. In response to adrenaline or 
electrically-stimulated muscle contraction, HSL localises to LD in isolated rat skeletal 
muscle, and actually appears to penetrate the phospholipid monolayer of the LD, 
therefore gaining access to TG within the core of the LD (Prats et al, 2006). Further to 
this, Whytock et al, (2018) recently observed a similar redistribution of HSL to LD 
specifically within type I fibres of human skeletal muscle in response to 60 min of 
moderate intensity cycling exercise. 
 
Approximately 20 years ago, evidence began to emerge to suggest that other lipases 
were also present in adipose tissue and muscle.  For example, TG hydrolase activity 
was only reduced by 50% in adipose tissue of HSL-deficient mice in comparison to 
wild-type controls (Haemmerle et al, 2002b). Furthermore, in skeletal muscle 
homogenates prepared from resting biopsies and incubated with an antiserum against 
HSL, there was a decrease in TG hydrolase activity, though this was only reduced by 
~25% (Roepstorff et al, 2004). Moreover, research in rodent skeletal muscle 
demonstrated that under either HSL knockout or knockdown conditions contraction-
induced lipolysis of IMTG still occurred despite the lack of HSL (Alsted et al, 2013). 
This highlighted the idea that other lipases may be present and subsequently adipose 
triglyceride lipase (ATGL) was discovered, primarily in adipose tissue but also in 
skeletal muscle (Villena et al, 2004; Zimmermann et al, 2004). Overall, ATGL is a 
relatively new lipase, with research investigating the regulation within skeletal muscle 
remaining relatively limited. Similar to HSL, ATGL is greater within type I fibres (Jocken 
et al, 2008), with endurance training augmenting ATGL protein expression primarily in 
type I fibres (Turnbull et al, 2016). Overexpression of ATGL in human primary 
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myotubes initiates an increase in lipolysis and a reduction in TG content (Badin et al, 
2011). In contrast, under ATGL-knockout conditions, mice demonstrate accumulation 
of TG in skeletal muscle (Haemmerle et al, 2002a), suggesting that ATGL primarily 
acts on TG rather than DAG. ATGL activation appears to require the co-activator 
comparative gene-identification-58 (CGI-58) (Schweiger et al, 2006). Individuals with 
a mutation of CGI-58 are known to have greater IMTG content (Lass et al, 2006).  
Overall, when CGI-58 expression is normal it can augment an increase in lipase 
activity by ~ 20 fold in cultured kidney cells (Lass et al, 2006), therefore demonstrating 
the importance of CGI-58 in ATGL activity. The interaction between ATGL and CGI-
58 has also been shown to be increased in rat skeletal muscle through muscle 
contraction, alongside a decrease in IMTG content (MacPherson et al, 2012).  
 
In human adipose tissue, phosphorylation of ATGL on Ser404 on ATGL is enhanced 
through β-adrenergic stimulation and correlates with greater rates of lipolysis (Pagnon 
et al, 2012). However, in skeletal muscle 60 min of moderate-intensity exercise has 
no effect on ATGL phosphorylation (Mason et al, 2012), suggesting that 
phosphorylation is not vital for ATGL activation. Under basal conditions, the 
phosphorylation of the Thr372 residue on the hydrophobic region in the C-terminus of 
ATGL inhibits the colocalization with LDs and subsequently reduces ATGL-mediated 
TG hydrolysis (Xie et al, 2014).  Several other ATGL phosphorylation sites have been 
identified, although their function is yet to be elucidated (Xie et al, 2014). Opposite to 
HSL, ATGL is already localised with LD in skeletal muscle, in both resting conditions 
and following moderate-intensity exercise (Mason et al, 2014a). The general 
consensus is now that ATGL and HSL work in a sequential process, as such ATGL 
catalyses the initial step of TG lipolysis in human skeletal muscle by causing the 
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release of one FA molecule and creating DAG, before HSL then becomes crucial for 
DAG hydrolysis to generate a second FA and monoacylglycerol. Subsequently, final 
FA liberation from the glycerol backbone is mediated by MGL (Taschler et al, 2011). 
However, as HSL and ATGL equate for ~ 98% of contraction-induced TG lipase 
activity (Alsted et al, 2013), the relative importance of MGL in the process of lipolysis 
is much lower. 
 
2.8.3 IMTG synthesis  
 
 
FA uptake into skeletal muscle occurs through the process of facilitated diffusion, 
mediated by several FA transporter proteins. FAT/CD36 is the primary FA transporter, 
and at rest resides at the endosomal membrane, but at the onset of exercise it 
translocates to the plasma membrane (Bonen et al, 2000; Bradley et al, 2012). FA 
uptake in FAT/CD36 knockout mice is reduced considerably both at rest and during 
exercise in comparison to wild-type controls alongside a decrease in fat oxidation 
(McFarlan et al, 2012), thereby demonstrating fat oxidation rates are highly dependent 
on FA uptake into skeletal muscle. Once FA’s enter muscle, they are attached to a 
coenzyme to form fatty acyl-CoA, catalysed by fatty acyl-CoA synthetase.  The first 
step in TG synthesis is the attachment of a fatty acyl-CoA to glycerol 3-phosphate, 
resulting in the formation of lysophosphatidic acid (LPA), a reaction catalysed by 
glycerol-3-phosphate acyltransferase (GPAT). A second fatty acyl-CoA is then 
attached to LPA to form phosphatidic acid by the enzyme 1-acyl-glycerol-3-phosphate-
O-acyltransferase (AGPAT). A phosphate group is then removed from the 
phosphatidic acid to form DAG. Finally, a third fatty acyl-CoA unit is attached to the 
44 
 
DAG to form TG, a reaction catalysed by diacylglycerol acyltransferase (DGAT). The 


















Figure 2.5. IMTG synthesis and hydrolysis in skeletal muscle. 
APGAT: 1-aclyglycerol-3-phosphate acyltransferase, ATGL: adipose triglyceride 
lipase, ACS: acyl-CoA synthase, DAG: diacylglycerol, DGAT: diacylglycerol 
transferase, FA: fatty acid, FA-CoA: fatty acyl-CoA, CD36: cluster of differentiation 36, 
G-3-P: glycerol-3-phosphate, GPAT: glycerol-3-phosphate acyltransferase, HSL: 
hormone sensitive lipase, IMTG: intramuscular triglyceride, LPA: lysophosphatidic 






Four different isoforms of GPAT exist, differing in subcellular distribution. As such, 
GPAT1 and GPAT2 are found localised to mitochondria, whilst GPAT3 and GPAT4 
are found localised to the endoplasmic reticulum (Gimeno and Cao, 2008). GPAT is 
considered to be the rate-limiting enzyme in the IMTG synthesis pathway as it displays 
the lowest enzyme activity (Coleman & Lee, 2004), and of this activity, 90% of total 
GPAT activity in skeletal muscle is due to GPAT1 (Park et al, 2002). When GPAT1 is 
overexpressed, FA oxidation is suppressed (Linden et al, 2004), whilst in GPAT1 
knockout mice, FA oxidation is enhanced (Hammond et al, 2005). GPAT1 expression 
has been examined in human skeletal muscle using western blot methods (Schenk & 
Horowitz, 2007; Newsom et al, 2011), though an understanding of the regulation of 
GPAT1 in skeletal muscle is currently limited. If GPAT creates lysophosphatidic acid 
at the mitochondria during IMTG synthesis, it may require transportation to the 
endoplasmic reticulum where other IMTG-synthesising enzymes are located. In the 
liver this is facilitated via liver-FA binding protein (Gonzalez-Baro et al, 2007), though 
in skeletal muscle more research is warranted.  
 
DGAT is responsible for the final step of IMTG synthesis (Choi et al, 2007), catalyzing 
the addition of a FA to DAG leading to the formation of TG and subsequently 
increasing IMTG content. DGAT is known to exist in two isoforms, both expressed in 
skeletal muscle but localising at different subcellular locations, with DGAT1 localising 
to the endoplasmic reticulum and DGAT2 localising to the endoplasmic reticulum, 
mitochondria and LD (Bosma et al, 2012). DGAT1 is the primary isoform expressed in 
skeletal muscle (Cases et al, 1998; 2001), suggesting TG synthesis in skeletal muscle 
will primarily occur in the endoplasmic reticulum. DGAT1 overexpression in C2C12 
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myotubes leads to a three-to-four fold greater DGAT activity and therefore six-fold 
greater intracellular TG content and reduced DAG content (Liu et al, 2007). Similar to 
GPAT1, there is limited data available on the regulation of DGAT1 in human skeletal 
muscle. However, GPAT1 and DGAT1 have been demonstrated to increase following 
an overnight lipid-heparin infusion, the day after a bout of endurance exercise which 
consisted of 45 min treadmill running and 45 min cycle ergometer at 65% VO2peak 
(Schenk and Horowitz, 2007). Thus, GPAT1 and DGAT1 expression is sensitive to 
exercise, at least in the face of elevated FA availability.  
 
2.9 Perilipin proteins regulating IMTG turnover 
 
2.9.1 Overview  
 
 
LDs are coated with >300 different LD associated proteins (Zhang et al, 2011), of 
which, the most common and well-known proteins are the perilipin (originally termed 
the PAT proteins) family (Bickel et al, 2009). Of this family, there are five perilipin 
(PLIN) protein members with proposed roles in the regulation of TG storage and 
breakdown. PLIN1 was the first member of the family to be identified and is generally 
believed to be exclusively expressed in adipose tissue and steroidogenic cells (Londos 
et al, 1995), though there is some evidence to suggest that PLIN1 is also expressed 
in skeletal muscle (Gjelstad et al, 2012).  In adipose tissue, PLIN1 appears to play a 
key role in regulating both the storage and hydrolysis of TG stored in LD’s (Brasaemle, 
2007; Bickel et al, 2009; Morales et al, 2017).  Subsequently, four other members of 
the PLIN family were identified (their original nomenclature is in parentheses): PLIN2 
(adipose differentiation related protein/adipophin), PLIN3 (tail interacting protein of 
47kDA), PLIN4 (S3-12) and PLIN5 (OXPAT). PLIN2 and PLIN3 are ubiquitously 
47 
 
expressed, whilst PLIN4 and PLIN5 have a more limited tissue expression, but 
includes skeletal muscle (Sztalryd & Braseamle, 2017). A feature of many proteins 
that are associated with LD, including the PLIN proteins, is the similarity of the amino 
acid sequences predicted to form amphipathic alpha helices to support LD binding 
(Bussell et al, 2003; Krahmer et al, 2011). When comparing the amino acid sequences 
across the PLIN proteins, PLIN2 and PLIN3 have the greatest similarity (Brasaemle, 
2007; Miura et al, 2002; Kimmel et al, 2016), whereas PLIN4 has the most diverse 
amino acid sequence with very limited similarity to other PLIN proteins. For a summary 
of the tissues each PLIN is expressed in alongside proposed function see table 2.1. 
For the purpose of this thesis, there will only be a focus on PLIN’s 2, 3, 4 and 5, which 
are all expressed in skeletal muscle. The following section will focus on the role of 
each perilipin protein on IMTG turnover and LD regulation, first examining cell-based 








Table 2.1. Basic characteristics of PLIN proteins, adapted from Itabe et al, (2017) 
Protein  Major site of expression  Other sites of expression  Function  
PLIN1 White adipose tissue Brown adipose tissue, cardiac muscle 
liposarcoma 
Hormone-induced lipolysis 
Large LD stabilization 
 
PLIN2 Liver Premature adipocytes macrophages sebocytes 
mammary gland epithelia 




Small LD generation 
LD stabilization 
 
PLIN3 Ubiquitous  skeletal muscle 
neutrophils, mast cells 
retinal pigment epithelium 
sebocytes 
 





PLIN4 White adipose tissue  hMSC (induced during differentiation) 
skeletal muscle 
 
Human adipocyte differentiation 
PLIN5 Cardiac muscle, brown 
adipose tissue, skeletal 
muscle  
islet β-cells 
hepatic stellate cells 
 
LD stabilization 





2.9.2 PLIN2  
 
 
PLIN2 was originally identified to play a role in LD biosynthesis, due to its presence in 
3T3-L1 adipocytes and early differentiated adipocytes (Brasaemle et al, 1997).  
Cultured cells exposed to oleic acid show an increase in PLIN2 protein expression 
alongside an increase in TG stores in Chinese hamster ovary fibroblast cells (Xu et al, 
2005) and in J774 murine macrophages (Masuda et al, 2006). Further to this, oleate 
treatment in COS-7 cells leads to PLIN2 and DGAT2 colocalising at the LD surface 
(Stone et al, 2009), indicating a role for PLIN2 in TG synthesis. The downregulation of 
PLIN2 in cultured myotubes led to reduced formation of LD following oleate treatment 
suggesting a role of PLIN2 in LD stabilisation (Bosma et al 2012a). Overall, data from 
cell studies suggests that PLIN2 is important in the expansion of intracellular TG stores 
in response to lipid exposure.   
 
The mechanism by which PLIN2 supports IMTG storage is unknown, but one 
possibility is via suppression of lipolytic enzymes.  In support, PLIN2 co-
immunoprecipitates with ATGL in rat skeletal muscle under basal conditions, whereas 
following ex vivo electrically-stimulated muscle contraction, this association decreases 
by 21% (MacPherson et al, 2013a). This suggests that PLIN2 enhances lipid 
accumulation by sequestering ATGL and supressing lipolysis under basal conditions, 
but releases ATGL enabling it to interact with its co-activator CGI-58 under conditions 
of lipolytic stimulation (MacPherson et al, 2013a). The post-transformational changes 
that lead to PLIN2 activation though are not known, since work from the same lab was 
unsuccessful in determining changes in global serine phosphorylation of PLIN2 
following adrenaline exposure or electrically-stimulated muscle contraction 
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(MacPherson et al, 2013b).  Data from studies in humans does indicate a role for 
PLIN2 in the expansion of IMTG stores.  In human skeletal muscle, IMTG content and 
PLIN2 protein expression are well-matched (Shaw et al, 2009; Peters et al, 2012; 
Shepherd et al, 2013), and endurance training enhances IMTG content concomitant 
with elevated PLIN2 protein expression (Shaw et al, 2013; Shepherd et al, 2013). 
Immunohistochemical analysis has shown ~60% of LD are associated with PLIN2 
(Shaw et al, 2009; Shepherd et al, 2013), indicating LD heterogeneity. Thus, using this 
method it can be inferred that two specific LD pools exist; those associated with PLIN2 
(PLIN2+ LD) and those not associated with PLIN2 (PLIN2- LD).  When IMTG content 
is increased via 6 h lipid infusion, the amount of PLIN2+ LD increases significantly 
without any changes to overall PLIN2 content (Shepherd et al, 2017) therefore 
providing evidence of a subcellular redistribution of PLIN upon expansion of the LD 
pool.    
 
There is also evidence that PLIN2 may support IMTG breakdown during exercise, 
since it has been reported that PLIN2+LD are preferentially utilised during 1 h of 
moderate-intensity exercise in untrained men (Shepherd et al, 2012; 2013). However, 
there was no preferential utilisation of PLIN2+ LD after 6 weeks of endurance or sprint 
interval training, since both PLIN2+LD or PLIN2-LD utilisation decreasing during 1 h 
of moderate-intensity exercise (Shepherd et al, 2013). Nevertheless, PLIN2 may also 
interact with HSL, since the cytosolic pool of HSL becomes localised to PLIN2 
following adrenaline exposure or electrically-stimulated muscle contraction in rat 
skeletal muscle (Prats et al, 2006).  In human skeletal muscle though, Whytock et al, 
(2018) demonstrated no increase in PLIN2 and HSL localisation during 1 h of 
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moderate intensity exercise.  Further research is required to clarify a role of PLIN2 in 
regulating IMTG breakdown, and whether this involves the regulation of HSL.  
 
2.9.3 PLIN3  
 
 
The third PLIN to be discovered, PLIN3, was first suggested to play a role in TG 
synthesis.  In non-skeletal muscle cell work, Bulankina et al, (2009) observed a 
reduction in LD maturation and decreased incorporation of TG into LD in HeLa cells 
when PLIN3 expression was suppressed. Furthermore, in adipocytes incubation with 
oleic acid, glucose and insulin leads to the localisation of PLIN3 to small LD (Wolins 
et al, 2005).  Interestingly though, continued incubation leading to an increase in LD 
size results in replacement of PLIN3 by PLIN2 (Wolins et al, 2005), suggesting a 
temporal relationship exists between the PLIN protein coat of LDs and the stage of LD 
growth and expansion. Further to this, knock out models of both PLIN2 and PLIN3 
causes reductions in TG storage and the residual LD are fewer but larger in size (Bell 
et al, 2008). Overall, these cell-based studies indicate PLIN3 being of importance in 
the formation and maturation of LD.  
 
Although it is not known if PLIN3 will display a similar role within skeletal muscle, 
Kleinert et al, (2016) demonstrated that pharmacological activation of AMPK in mice 
increases PLIN3 gene expression leading to an increase in IMTG content, therefore it 
has been suggested that PLIN3 may be a factor in IMTG storage. Subcellular 
localisation may also play a role in the function of PLIN3 as it has been demonstrated 
that endurance exercise, not short electrically induced contractions, augments PLIN3 
expression and its association with mitochondria in rat muscle (Ramos et al, 2015). 
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Whether this is species-specific or due to intracellular localisation is still unknown. 
There has however, been confirmation that PLIN3 interacts with both ATGL and HSL 
in rat skeletal muscle, although this is unaffected by lipolytic stimulation (Macpherson 
et al, 2013b). Therefore, the current body of evidence from cell and rodent work 
suggests PLIN3 may support expansion of TG stores, but the data to support PLIN3 
role in IMTG lipolysis is less clear.  
 
In human skeletal muscle, type I fibres are known to display greater PLIN3 protein 
expression (Shepherd et al, 2017b) and there is also evidence of greater PLIN3 
expression in females (Peters et al, 2012) when overall IMTG content is increased. 
Prolonged acute exercise at 50% VO2max leads to enhanced PLIN3 expression in 
human skeletal muscle (Covington et al, 2014), though how this is related to IMTG 
lipolysis is yet to be elucidated. Currently, whether PLIN3 expression is enhanced 
following endurance exercise training is under debate. PLIN3 expression did not 
increase after 12 weeks of endurance exercise in neither lean or obese subjects 
(Peters et al, 2012) or after 12 weeks of endurance training combined with strength 
training in type 2 diabetics (Daemen et al, 2018). Conversely when examining fibre-
specific changes after 4 weeks of endurance exercise, PLIN3 expression is enhanced 
in sedentary obese males (Shepherd et al, 2017a). Furthermore, after 6 h of lipid 
infusion, PLIN3+ LD increases alongside increases in IMTG content without changes 
in overall PLIN3 content (Shepherd et al, 2017). There is also an increase in PLIN3 
protein expression following 7 days on a high fat, high calorie diet (Whytock et al, 
2020). Taken together, the current evidence from human studies suggests PLIN3 
could exhibit a role in augmenting IMTG stores, but the exact role warrants further 




2.9.4 PLIN4  
 
 
PLIN4 is expressed in skeletal muscle, heart and also adipose tissue and is 
preferentially situated in LD with cholesterol esters (Hsieh et al, 2012). To date, little 
is known about PLIN4 in skeletal muscle, though of all the PLIN proteins it is 
apparently the most highly expressed (Pourteymour et al, 2015). The lack of 
information on PLIN4 is in part, due to the importance of PLIN4 in regulating TG being 
questioned by Chen et al, (2013), who demonstrated that PLIN4 knockout mice had 
no major alterations in skeletal muscle lipid content. In addition to this, PLIN4 mRNA 
expression and overall protein content remains unaltered or even reduced following 
endurance training (Peters et al, 2012; Pourteymour et al, 2015). However, in more 
recent years greater PLIN4 protein expressed has been reported in trained compared 
to sedentary individuals (Shepherd et al, 2017b). Like PLIN3, subcellular localisation 
may be important in defining the role of PLIN4’s role, as it was shown that LD located 
at the periphery of 3T3-L1 adipocytes following oleate treatment were coated with 
PLIN4 (Wolins et al, 2005). In addition, incubation of cultured myotubes with oleic acid 
enhances PLIN4 mRNA expression (Gjelstad et al, 2012), whereas in vivo a low-fat 
diet reduces PLIN4 mRNA expression in human skeletal muscle (Gjelstad et al, 2012). 
Overall, although PLIN4 is expressed in skeletal muscle, there is currently limited and 
conflicting data on the importance of PLIN4 in IMTG regulation. 
 
 





Unlike PLIN4, there is much more research concerning PLIN5, which is highly 
expressed in oxidative tissues such as cardiac tissue and skeletal muscle (Laurens et 
al, 2016). PLIN5 was the final PLIN protein to be discovered with its high expression 
in tissues that exhibit high rates of lipolysis and β-oxidation (Wolins et al, 2006; Peters 
et al, 2012; Shepherd et al, 2013). It is found on the LD surface, within the cytosol and 
at the mitochondria (Bosma et al, 2012b; Shepherd et al, 2013). Overexpression of 
PLIN5 in Chinese hamster ovary cells (Dalen et al, 2007), in rat skeletal muscle 
(Bosma et al, 2013) and in COS-7 cells (Wolins et al, 2006) leads to an increase in 
TG concentration. PLIN5 overexpression also results in greater interaction between 
LD and mitochondria (Bosma et al, 2012b) and a greater rate of FA oxidation (Wolins 
et al, 2006; Bosma et al, 2012b). This interaction may assist in trafficking TG-derived 
FA to the mitochondria to undergo the process of β-oxidation. However, under PLIN5 
knock out conditions, there is a decrease in whole-body FA oxidation observed in mice 
without any change in the interaction between PLIN5 and mitochondria (Mason et al, 
2014b). Therefore, the role of PLIN5 in augmenting greater IMTG-derived FA oxidation 
requires further investigation. 
 
PLIN5 could also provide a functional role as a scaffold protein mediating lipolysis 
rather than regulating IMTG synthesis. PLIN5 has a conserved N-terminus sequence 
enabling binding to HSL (Anthonsen et al, 1998) and a C-terminus region enabling 
binding to ATGL or CGI-58 (Granneman et al, 2011; Wang et al, 2011). CGI-58 is a 
known co-activator of ATGL, as demonstrated by greater rates of TG hydrolysis when 
there is an increased interaction between ATGL and CGI-58 (Wang et al, 2011). 
Binding of PLIN5 to ATGL or CGI-58 in Chinese hamster ovary cells suppresses TG 
hydrolysis under basal conditions (Wang et al, 2011). Furthermore, when PKA is 
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activated under conditions of PLIN5 and ATGL overexpression, there is an increased 
rate of lipolysis (Wang et al, 2011). From these data, it can be suggested that PLIN5 
limits lipolysis under basal conditions via inhibition of ATGL and CGI-58, but enhances 
lipolysis by allowing the interaction between ATGL and CGI-58 subsequent to lipolytic 
stimuli.  
 
Data from human skeletal muscle also supports a role of PLIN5 in IMTG lipolysis. 
Exercise training has been demonstrated to increase PLIN5 expression alongside 
increases in IMTG content (Shepherd et al, 2013), this increase in PLIN5 expression 
indicates a role of PLIN5 in supporting greater IMTG utilisation during exercise. In 
untrained individuals, before training and following endurance training, there is a 
preferential utilisation of PLIN5+ LD before and after 1 h of moderate-intensity exercise 
in human skeletal muscle in comparison to PLIN5- LD (Shepherd et al, 2013). Despite 
this proposed role, there is a lack of research into the interaction between HSL, ATGL 
and PLIN5. Recently though, Whytock et al, (2018) demonstrated that HSL relocated 
to PLIN5+ LD in response to 1 h of moderate-intensity exercise.  Moreover, PLIN5 
protein expression also correlates positively with IMTG stores in type I fibres 
(Shepherd et al, 2013; Shepherd et al, 2017b), in endurance trained subjects (Daemen 
et al, 2018) or after endurance training (Peters et al, 2012; Shepherd et al, 2013). In 
this way, it is possible that PLIN5 also supports IMTG storage. For example, in human 
skeletal muscle, 6 h lipid infusion causes an increase in IMTG with an increase in 
PLIN5+ LD in type I fibres (Shepherd et al, 2017b). Further to this, a prolonged 
exposure to increased lipids via a 5-day high fat diet, will result in greater PLIN5 protein 
expression (Gemmink et al, 2017a). Whereas, increased IMTG following greater FFA 
availability as a consequence of prolonged fasting is entirely attributable to an increase 
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in PLIN5+ LD (Gemmink et al, 2016). Taken together, this data suggests PLIN5 protein 
expression is often upregulated through enhanced FA availability, and PLIN5 
colocalization to LD is enhanced in situations of increased IMTG content, and this may 
support IMTG storage as well as breakdown when metabolic demands increase. 
Furthermore, although PLIN5 increases in response to increased FA availability, which 
is linked to increases in PLIN5+ LD, time-course studies are required to determine 
whether the increase in PLIN5 labelled LD leads to, or is as a result of, the increase 
in IMTG.  
 
2.10 Lipid droplet formation 
 
The exact process of LD formation in skeletal muscle is still under debate, and this 
topic has been extensively reviewed in several recent articles (Pol et al, 2014; Henne 
et al, 2018; Goodman et al, 2020). For the purposes of this thesis, it is pertinent to 
provide a brief overview of this process.  Currently, the most prevalent hypothesis is 
that lipid accumulates between two leaflets of the endoplasmic reticulum membrane 
until this lens of neutral lipid reaches a critical size and is budded into the cytoplasm 
as a newly formed LD (known as primordial LDs) (Murphy & Vance, 1999). Cultured 
human macrophages analyzed using freeze-fracture high resolution electron 
microscopy have provided evidence for this by demonstrating endoplasmic reticulum 
membranes lie external to and follow the contour of LD, similar to an egg held by an 
egg cup (Robenek et al, 2006). Immunogold labelling has demonstrated PLIN2-
enriched domains of the cytoplasmic leaflet of the endoplasmic reticulum are where 
the LD are located, therefore suggesting a role of PLIN2 in LD biogenesis (Robenek 




Several mechanisms have been proposed to explain how LD increase in size, 
including; 1) the fusion of two LD via pores in the phospholipid monolayer, 2) ripening 
of one LD through the transfer of lipids and proteins from a LD decreasing in size, and 
3) the expansion of pre-existing LD due to increased synthesis of TG from FA 
(Gemmink et al, 2017). Investigations in NIH 3T3 adipocyte cells showed LD growth 
via fusion to be independent of TG synthesis, but required the presence of 
microtubules and the motor protein, dynein (Bostrom et al, 2005). Microtubules 
provide a pathway within cells for LD to move to other LD or different organelles 
altogether (Welte, 2009). Freeze-fracture electron microscopy investigations in 
macrophages demonstrate close contact between LD and smaller (possibly newly-
formed) LD, supporting the concepts of fusion and/or ripening (Robenek et al, 2006). 
The family of SNARE proteins may also play a role in LD fusion, since knockdown of 
SNAP23, syntaxin-5 and VAMP4 in NIH-3T3 adipocytes reduced the rate of LD fusion 
leading to an overall decrease in LD size (Bostrom et al, 2007). LD can also decrease 
in size via the processes of fission or fragmentation. The ADP ribosylation factor 
(ARF)- COPI machinery is known to coat endosomal membranes and Golgi vesicles 
and is thought to be involved in this process. TG lipolysis in the core of LD by ATGL 
and HSL is also expected to reduce LD size, though whether fission of LD and TG 
lipolysis occur together or independently is yet to be elucidated. With regard to LD size 
and number, it is generally accepted that having a greater number of smaller LD is 
metabolically advantageous as this provides a greater surface area for regulatory 
proteins to bind to. This hypothesis stems from the fact that endurance-trained 
individuals display greater numbers of smaller LD compared to obese individuals and 




2.11 Manipulating IMTG content through diet 
 
 
IMTG content has been demonstrated to be strongly associated with dietary fat intake, 
with increases of 50-100% following consumption of high-fat diets which provide 40-
65% of total energy intake as fat (Hoppeler et al, 1999; Helge et al, 1998, 2001; 
Johnson et al, 2003; Vogt et al, 2003; Zderic et al, 2004). Moreover, high fat diets can 
lead to a shift in fat metabolism. Chronic consumption (4-7 weeks) of a high fat diet 
increases the capacity for whole-body fat oxidation (Spriet, 2014; Volek et al, 2015).  
Adaptations occurring to support this include enhanced carnitine palmitoyl transferase 
I activity (Fisher et al, 1983) and reductions in hexokinase activity (Fisher et al, 1983). 
When combining exercise training with either a low-fat (20%) or high-fat (62%) diet 
over a 7-week period, whole-body fat oxidation increased by ~80% during exercise 
after consuming a high-fat diet (Helge et al, 2001). This increase during exercise was 
accounted for via increases in both plasma FFA (~50%) and muscle and/or lipoprotein-
derived TG (~100%), though they suggested that IMTG utilisation was of only minor 
quantitative importance, since they failed to report a significant exercise-induced 
decrease in IMTG content. There is, however, convincing evidence that a short-term 
high-fat diet will lead to greater IMTG utilisation during exercise (Johnson et al, 2003; 
Zderic et al, 2004). Johnson et al, (2003) used 1H-MRS to demonstrate an ~50% 
increase in resting IMTG content in the vastus lateralis following 2 days of a high-fat 
compared to a low-fat diet, with an exercise-induced reduction of 64% and 57% 
following each diet, respectively. Zderic et al, (2004) also provided evidence to suggest 
that enhanced fat oxidation following a high-fat diet was largely due to increases in the 




Further to this, there has been great recognition as to the importance of pre-exercise 
muscle glycogen concentrations being an important factor in mediating endurance 
performance capacity (Bergstrom et al, 1967). Thus, leading to focus on high-CHO 
dietary recommendations and less focus on the fat component of the diet. High CHO 
diets, with fat intake varying from 2 – 25% can markedly decrease IMTG storage 
(Starling et al, 1997; Coyle et al, 2001; Johnson et al, 2003). Furthermore, 1H-MRS 
studies have observed significant impairments in post-exercise IMTG repletion 
following consumption of a low-fat, high-CHO diet (Decombaz et al, 2000; Decombaz 
et al, 2001; Larson-Meyer et al, 2002; Van Loon et al, 2003). However, fat intake in 
these studies was as low as 10–15% total energy intake, which is markedly less than 
typical fat intake in elite endurance athletes (Van Loon et al, 2004). When examining 
post-exercise IMTG repletion after 3 h of moderate-intensity cycling in well-trained 
individuals, there was no repletion for at least 48 h when consuming a high-CHO diet 
containing only 24% of energy from fat (Van Loon et al, 2003). In contrast, a moderate-
fat diet of ~39% lead to IMTG stores returning to baseline by 24–48 h of recovery. 
Taken together, it is evident that post-exercise macronutrient intake has an effect on 
intramuscular substrate replenishment and more research is needed to assess the 
optimal strategy to support glycogen resynthesis alongside IMTG repletion.   
 
2.12 Demands of field-based training and competition  
 
 
Despite decades of research examining glycogen utilisation during exercise and 
resynthesis post-exercise, it is still difficult to provide guidelines for CHO consumption 
in relation to fuelling exact training sessions due to varying metabolic demands of 
training and competition. As far back as 2003, recommendations from the international 
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Olympic committee expert panel acknowledged that fuel demands vary largely based 
on the type of event, exercise intensity and duration (Burke, 2004). Even among elite 
endurance athletes, training loads can vary from 10-12 hours per week with key 
sessions being 60 – 120 min (e.g. track runner), up to 25-30 hours per week with 
sessions lasting 4-6 hours (e.g. triathletes/cyclists) (Burke et al, 2018). This led to a 
‘sliding’ scale of CHO intake targets rather than a universal recommendation for CHO 
fuelling strategies (Burke et al, 2018). The timing and amount of CHO intake should 
be considered in relation to fuel cost for that days specific training or competition load, 
with this concept now being referred to as ‘fuel for the work required’ (Impey et al, 
2018). Given the variability in training loads discussed above, any given amount of 
CHO and timing of intake may equal ‘high CHO availability’ on one specific day or in 
one specific athlete, whilst in another context e.g. different athlete or different training 
focus, it may be considered ‘low’.  
 
However, Burke et al, (2018) highlighted that key CHO guidelines being used by 
athletic populations are not underpinned by data from field-based environments, but 
rather strict laboratory-based conditions. Subsequently, the majority of studies 
currently influencing sports nutrition guidelines, to date, are largely based on 
laboratory-based protocols (Burke et al, 2011). Thus, although the concept of different 
and/or changing CHO requirements for different training and individuals is now being 
considered, there is an overall lack of understanding of the fuel costs of these habitual 
training and field-based competitive environments. This restriction in our knowledge 
also applies to the utilisation of IMTG during exercise with our understanding being 




The primary issue that arises from the laboratory-based protocols (e.g. fasted exercise 
at a fixed relative intensity for a given duration, such as 1 h at 70% VO2max), is the 
rigorous control measures put in place to ensure reproducibility and reliability such as 
set workloads, intensities and durations. This does not consider factors such as 
exogenous CHO availability, changes in terrain and incline, and environmental 
influences such as wind speed and rain, all of which will influence pace, power, speed, 
the athlete’s rating of perceived exertion, heart rate and the intensity of the training. 
Although an athlete may be prescribed a specific training session, external factors 
such as those listed will alter the metabolic demand of a training session considerably. 
Further to this, exercise mode indoors may cause differences in muscle activation and 
therefore muscle substrate utilisation, in comparison to the same exercise mode 
outdoors. A review by Hooren et al, (2020) demonstrated increased knee flexion at 
footstrike and contact time, alongside decreases in knee flexion range of motion and 
foot-ground angle at footstrike when running on a motorised treadmill in comparison 
to overground running. Such biomechanical differences on a motorised treadmill used 
in laboratory-based research provide further emphasis as to why more field-based 
research should be undertaken. Moreover, the physiological demands of treadmill 
running vs overground running have been demonstrated to differ, with treadmill 
running requiring a lower rate of oxygen uptake than overground running (Aubry et al, 
2018), and when running at the same intensity on an outdoor running track, there is 
greater energy expenditure than a motorised treadmill (Bidder et al, 2017). Overall, 
whilst the laboratory-based studies on which the CHO guidelines are based provide 
complete control, they are not representative of training or competition in a field-based 
environment. It has now been highlighted as a key question for future research, that 
the fuel costs, and particularly glycogen utilisation, are fully understood, in order to 
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inform CHO requirements of various training sessions commonly undertaken by 
athletes (Burke et al, 2018).  
 
2.13 General Overview 
 
As well as providing an overview of CHO and fat metabolism during exercise, Chapter 
2 serves to identify a number of gaps in our knowledge which require further 
investigation, some of which will be tackled in this thesis.  Chapter 3 provides a 
detailed account of the common methodologies used in each of the experimental 
chapters, including information on sample collection and detailed protocols for sample 
staining for both TEM (Chapter 4) and immunofluorescence microscopy (Chapter 5 & 
6).  
 
In chapter 4, muscle substrate utilization during two different habitual field-based 
training sessions in recreationally-active males were investigated using TEM 
methodology. Specifically, this chapter focused on quantifying fibre type and 
subcellular-specific glycogen and IMTG utilization in both the vastus lateralis and the 
gastrocnemius in response to a 10 mile steady state run and a track interval session 
(8x800m).  Ultimately, the aim of this study was to understand substrate use during 
field-based training sessions.  In chapter 5, we continue to investigate IMTG utilization 
under field-based conditions, but this time during a cross-country skiing race. This 
study, aimed to evaluate immunofluorescence microscopy as a suitable method to 
measure IMTG utilisation and changes in LD morphology on a fibre and subcellular-
specific basis during a field-based competitive scenario. It is also important to consider 
which microscopy method is best suited for our investigations, leading to a secondary 
aim of chapter 5 to establish the level of agreement between transmission electron 
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microscopy and immunofluorescence microscopy.  This will aid to understanding of 
whether subcellular-specific data could be generated using immunofluorescence 
microscopy. Finally, chapter 6 examines IMTG utilisation and also considers the lack 
of data of post-exercise IMTG resynthesis in comparison to glycogen. Thus, chapter 
6 examined the impact of post-exercise CHO availability and the molecular 
mechanisms underpinning IMTG resynthesis using immunofluorescence microscopy, 
following on from our findings in chapter 5. As the study aimed to explore potential 
regulatory mechanisms it was conducted in a more controlled laboratory-based setting 
than the previous two studies described. In chapter 7 the findings of each of the 
experimental chapters are discussed and placed within the context of general 
literature, making proposals for future research directions in light of the findings from 









































































3.1 Overview of chapter 
 
This chapter primarily serves to describe in detail the muscle biopsy procedure, and 
the theoretical basis and protocols used for the immunofluorescence microscopy and 
transmission electron microscopy work undertaken across the experimental chapters 
of the thesis (Chapters 4-6).  These methods are cited, where appropriate, within each 
experimental chapter.  Participant characteristics, the study design and experimental 
protocol is included in each experimental chapter. 
 
3.2 Muscle samples  
 
Percutaneous skeletal muscle biopsies were collected from either the vastus lateralis, 
the lateral head of the gastrocnemius, or triceps brachii under local anaesthesia (~ 5 
ml 1% lidocaine). Following local anaesthesia of the selected site, a small incision was 
made (~ 1 cm) in the skin and the fascia before the biopsy needle was inserted. 
Biopsies were collected using either the Bergstrom (Bergstrom et al, 1967) needle 
biopsy technique (Chapters 5 and 6) or the micro-biopsy technique (Bard Monopty 
Disposable Core Biopsy Instrument 12 guage x 10cm length, Bard Biopsy Systems, 
Tempre, AZ, USA) (Chapter 4). Under a micro-dissection microscope, muscle 
samples were blotted of excess blood and any visible fat tissue was removed and 
discarded. For immunohistochemical analysis, muscle tissue was embedded in 
Tissue-tek OCT compound (Sakura Finetek Europe, The Netherlands) on a cork board 
which was subsequently frozen in liquid nitrogen-cooled isopentane (Sigma-Aldrich, 
Dorset, UK) and stored in cryotubes at – 80C. The protocol used to preserve muscle 
samples for subsequent analysis using transmission electron microscopy (TEM) is 




3.3 Immunohistochemical analysis of skeletal muscle sample  
 
3.3.1 Sample preparation and protocol  
 
Immunofluorescence microscopy analyses were used in experimental chapters 5 and 
6 of this thesis.  Serial 5 μm cryosections were cut at -25C and mounted onto 
uncoated, ethanol-cleaned glass slides. Muscle sections from each time-point for the 
same participant were mounted on to the same slide in order to minimise any 
difference in the staining process within each subject.  Sections were initially fixed to 
maintain the structural integrity and antigenicity of the muscle samples in 3.7% 
formaldehyde solution for 1 h followed by three rinses (each for 30 s in doubly-distilled 
water (dd H2O)).  General membrane permeabilization is then achieved through 
incubating the slides in 0.5% Triton X-100 for 5 min so that the fluorescent probe can 
reach the target antigen.  Triton-X 100 is a detergent, and aids in partially solvating 
the cellular membranes without disturbing interactions between proteins, thus 
improving the penetration of the antibody through the tissue.  
 
Following three 5 min washes in phosphate buffered saline (PBS, 137mM sodium 
chloride, 3mM potassium chloride, 8 mM disodium hydrogen phosphate and 3 mM 
potassium dihydrogen phosphate, pH of 7.4), slides were incubated for 60 min with 
appropriate primary antibodies. Following this incubation period, a further three 5 min 
PBS washes were completed before the slides were incubated with appropriately-
targeted fluorescently-labelled secondary antibodies for 30 min. Three more 5 min 
washes in PBS preceded a 20 min incubation with BODIPY 493/503 (Invitrogen, 
Paisley, UK) on occasions when lipid staining was required.  Due to the light sensitive 
nature of BODIPY 493/503, all procedures from this point forward were undertaken in 
a dark room. Following a final 5 min wash in PBS solution, coverslips were mounted 
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using Vectashield (H-1000 Vector Laboratories, Burlingame, CA, USA) and sealed 
with nail varnish before being left to dry overnight. 
3.3.2 Antibodies and lipid dye 
 
Primary antibodies were obtained for both experimental chapters 5 and 6 from 
commercially available sources and diluted in PBS. Details of both primary and 
secondary antibodies used in chapters 5 and 6 are detailed in Table 3.1. The working 
dilutions for each of the primary antibodies used are displayed in table 3.1 and were 
based on previous studies from the laboratory (Shepherd et al, 2017; Whytock et al, 
2018). Alexa Fluor conjugated secondary antibodies were also obtained from 
commercially available sources and were diluted in PBS at 1:200 unless stated 
otherwise. To visualise intramuscular triglycerides, a cell permeable lipophilic 
fluorescence dye Difluoro{2-[1-(3,5-dimethyl-2H -pyrrol-2-ylidene-N )ethyl]- 
3,5-dimethyl-1H -pyrrolato-N }boron 493/503 (BODIPY (493/503) was used, which 








Target    Primary antibodies  Dilution Commercial source 
Myosin slow twitch fibres  MHCI, host species: mouse 1:100 DSHB, University of Iowa, USA (Cat no. A4.840c) 
Myosin fast twitch IIa fibres MHCIIa, host species: mouse  1:100 DSHB, University of Iowa, USA (Cat no. N2.261c) 
Cell membrane Laminin, host species: rabbit 1:50  
 Secondary antibodies 
Visualization of MHCI Goat Anti-Mouse IgM 546 1:200 Thermofisher Scientific, Paisley, UK (Cat no. A-21045) 
Visualization of MHCIIa Goat Anti-Mouse IgG 405 1:200 Thermofisher Scientific, Paisley, UK (Cat no. A-31553) 
Visualization of the plasma membrane  Goat Anti-Rabbit IgG 633 1:200 Thermofisher Scientific, Paisley, UK (Cat no. A-21070) 
  Post staining – also used in chapter 6  
IMTG Bodipy 493/503 1:100 Invitrogen, Paisley, UK (Cat no. D3922) 
Chapter 6 
Target  Primary antibodies  
Myosin slow twitch fibres MHCI, host species: mouse  1:100 DSHB, University of Iowa, USA (Cat no. A4.840c) 
Myosin fast twitch IIa fibres MHCIIa, host species: mouse  1:100 DSHB, University of Iowa, USA (Cat no. N2.261c) 
PLIN2  Mouse monoclonal anti-adipophilin 
 
1:50 American Research Products, Waltham MA, USA (Cat 
no. E-AB-1073) 
PLIN3 Rabbit polyclonal anti-perilipin 3/TIP-47 
 
1:50 Novus Biologicals, Cambridge, UK (Cat no. NB110-
40764) 
PLIN5 Guinea pig polyclonal anti-OXPAT 
 
1:50 Progen Biotechnik, Heidelberg, Germany (Cat 
no.GP31S) 
 Secondary antibodies 
Visualization of PLIN2 Goat anti-Mouse IgG1 633 1:200 Thermofisher Scientific, Paisley, UK (Cat no. A-21126) 
Visualization of PLIN3 Goat anti-rabbit IgG 633 1:200 Thermofisher Scientific, Paisley, UK (Cat no. A-21072) 
Visualization of PLIN5 Goat anti-guinea pig IgG 633 1:200 Thermofisher Scientific, Paisley, UK (Cat no. A-21105) 
Cell membrane  Wheat Germ agglutinin (WGA) Alexa Fluor 
633 
1:100 Invitrogen, Paisley, UK (Cat no. W21404) 
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3.3.3 Image capture using confocal microscopy  
 
Images of cross-sectionally orientated muscle fibres were captured using an inverted 
confocal microscope (Zeiss LSM710; Carl Zeiss AG, Oberkochen, Germany) with a 
63x 1.4 NA oil immersion objective with a 1.1x digital zoom. An argon laser was used 
to excite the Alexa Fluor 488 fluorophore and BODIPY 493/503, a helium-neon laser 
excited the Alexa Fluor 546 and 633 fluorophores, and a diode laser excited the Alexa 
Fluor 405 fluorophore. To assess fibre-specific IMTG content, fibres that were 
positively stained for myosin heavy chain type I were classified as type I fibres, while 
those that were stained positively for myosin heavy chain type IIa were classified as 
type IIa fibres. ~20 images were captured per time point aiming for an even split across 
type I and type IIa fibres. All other fibres were assumed to be type IIx fibres, and though 
some images were captured, there was an insufficient number of type IIx fibres to 
perform statistical analysis and therefore the results are not included in chapter 5 or 
6.  Information on the number of fibres analysed for each fibre type are detailed in the 
individual experimental chapters.  
 
In chapter 6, to investigate co-localisation between LD and PLIN proteins the same 
microscope and magnification were utilised to obtain the digital images, but with a 4x 
digital zoom applied on the straightest edge of an identified cell. This first allowed an 
image to be taken at the peripheral region of the cell and subsequently the field of view 
was manually moved to the centre of the cell identified using the cell membrane, to 







3.3.4 Immunofluorescence controls 
 
Before imaging took place, several controls were put in place when staining the muscle 
samples.  First, PBS was used instead of the primary antibody in order to check for 
non-specific binding of the secondary antibody. For example, using the same fixation 
and permeabilization method as described in 3.2.1 above, the primary antibody was 
replaced with PBS, followed by the secondary antibody. The result was extremely low 
levels of staining (intensity was < 10 AU) in images without the primary antibody. When 
using the primary antibody, the intensity was considerably more with the typical 
fluorescence intensity being > 80 AU. Control samples were also generated to check 
for bleed-through of signal into different colour channels of the microscope.  Moreover, 
the staining procedure was conducted in the absence of any antibodies to check for 
any autofluorescence of the samples alone that could potentially impact imaging.  
Further to this, controls where PLIN2 was blocked using a recombinant peptide 
incubated with the primary antibody, resulting in the fluorescence signal of PLIN2 
being removed (Shepherd et al, 2012). The concentration of the blocking peptide was 
titrated to saturating concentrations that would completely block the binding sites for 
the secondary antibody. This has also been completed for PLIN3 (Shepherd et al, 
2017) and PLIN5 (Shepherd et al, 2013). 
 
3.3.5 Image analysis  
 
Image processing and analysis was completed on a fibre type-specific basis using 
Image-Pro Plus 5.1 software (Media Cybernetics, Rockville, MD, USA). An intensity 
threshold was uniformly selected to represent a positive signal for IMTG and/or each 
PLIN protein. The content of IMTG or PLIN content was expressed as the positively 
stained area relative to the total area of the peripheral or central region of each muscle 
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fibre. Using the Image-Pro Plus software the cells were split into two subcellular 
regions, the peripheral and central regions of the cell. This was completed by using a 
2 μm band around the edge of the cell border, identified via the immunofluorescence 
staining with the appropriate antibody as described in table 3.1, to create the 
peripheral region to measure subsarcolemmal LD (first 2 μm from the cell border) and 
the central region to measure intermyofibrillar LD (remainder of the cell). This 
approach of using a fixed 2 μm distance from the membrane to represent the 
subsarcolemmal region has been utilised previously to examine IMTG content in 
differing populations (Van Loon, 2004).  LD density was expressed as the number of 
LD’s relative to the area of the peripheral or central region. LD size reflects the average 
size of all LD’s detected in a single image of both the peripheral and central region 
separately. 
3.4 Transmission electron microscopy sample preparation 
 
Fresh muscle samples were fixed with 2.5% glutaraldehyde in 0.1M sodium 
cacodylate buffer (pH 7.3) for 24 h before being rinsed four times in 0.1M sodium 
cacodylate buffer. Subsequently, the samples were post-fixed with 1% osmium 
tetroxide and 1.5% potassium ferrocyanide in 0.1M sodium cacodylate buffer for 90 
min at 4C. Reduced osmium tetroxide containing potassium ferrocyanide was used 
due to its preference for a high electron density of glycogen particles (De Bruijin, 
1973). After post-fixation, the muscle samples were rinsed twice in 0.1M sodium 
cacodylate buffer at 4C, and then underwent a graded dehydration using ethanol (30, 
50, 70, 90 and 100% concentration).  Following two washes with 100% propylene 
oxide, samples were penetrated with graded mixtures of propylene oxide and epoxy 
resin (Agar 100 Medium, Agar Scientific, Essex, UK) at 20C (2:1, 1:1, and 1:2 ratios 
of propylene oxide to epoxy resin, for 1-2 h each concentration), and finally embedded 
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in 100% epoxy resin for 12 h at 60C. Longitudinal orientated ultra-thin (~60 nm) 
sections were obtained using a ultramicrotome (Reichert Jung Ultracut, Vienna, 
Austria) fitted with a diamond blade and collected on to formvar coated grids (200 
copper mesh size).  To obtain as many fibres as possible, sections were collected at 
three different depths into the tissue block separated by ~150 nm. 
3.4.1 Post-staining procedures 
 
Post-staining is advised on samples for TEM to increase the contrast of subcellular 
structures. Prior to use, stock solutions of both the Reynold’s lead citrate and uranyl 
acetate (UA) (3% by weight in ddH2O) were aliquoted and microcentrifuged for 5 min. 
Samples were then incubated in UA for 14 min, after which excess UA was removed 
by manual washing of the sample in ddH2O (only moving the sample in an up and 
down motion). Subsequently, the sample was incubated in Reynold’s lead citrate for 
5 min in a dark room at room temperature, followed by washing in ddH2O. Samples 
were air dried at room temperature for at least 30 min prior to imaging. 
3.4.2 Transmission electron microscopy measures of mitochondria and 
glycogen. 
 
Each muscle sample contained both transverse and longitudinal fibres, but only  
longitudinally orientated fibres were imaged using a TEM (FEI Morgagni, Field 
Electron and Ion Company, Oregon, USA), coupled with an Olympus Megaview III 
camera, which provided an average of 10 fibres per biopsy (range: 6-12 fibres).  Each 
fibre was initially viewed at x1,000 magnification in order to locate the plasma 
membranes and visually assess the available myofibrillar area (Figure 3.1). For 
mitochondria and glycogen analysis, images were collected at x36,000 magnification 
(Figure 3.2), where a total of 24 images were obtained per fibre in a randomized 
systematic order (Figure 3.1). Of these 24 images collected per fibre, 12 images were 
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obtained of the subsarcolemmal region (SS), 6 images of the superficial region of the 
myofibrillar space (superficial myofibrillar) and 6 images of the central region of the 












































Figure 3.1. Representative location of TEM image locations for glycogen. 
Representing the subsarcolemmal region (SS), the superficial myofibrillar region (SM) 



































































Figure 3.2. Representative TEM images, top image taken at 36,000x scale bar = scale 
bar = 0.5µm, bottom image taken at 22,000x scale bar = 1µm. 







3.4.3 Overview of stereology    
 
At a practical level, the use of stereological methods enables quantitative information 
to be gathered on microscopic, 3-D structures, permitting reliable data to be collected 
from sections (Gundersen et al, 1988). Morphometric measurements using 
stereological methods are often required in muscle-based research with measures 
such as muscle area, fibre area and number of muscle fibres (Zacharova & Kubinova, 
1995). Manual methods or methods that require manual tracing are very time-
consuming, whilst automated methods come into difficulty identifying individual fibres. 
When using such methods, important considerations include any manipulation of the 
microscope which will alter measurement conditions should be avoided if possible, 
and when counting, the classification rules must not change throughout. The images 
collected using transmission electron microscopy were analysed using such methods 
in order to identify fibre type and subsequently quantify glycogen and lipids.  
3.4.4 Fibre type determination  
 
Fibre type differences were assessed through classification of the fibres as either type 
I or type II by combining measures of IMF mitochondria volume and Z-line width 
(Sjostrom et al, 1982) First, a 135 nm grid was applied to the image (see Figure 3.3 
for grid size referencing) before all points of the grid with mitochondria underneath 
were counted and recorded. The Z-line of each image was then measured twice and 
recorded. The IMF mitochondria volume fraction was subsequently plotted against the 
Z-line width for each fibre obtained from each biopsy (Figure 3.4), and the fibres with 
the greatest IMF mitochondria volume fraction and the thickest Z-line width were 
classified as type I fibres, with the opposite being true for type II fibres (i.e. lowest IMF 
mitochondria volume fraction and narrowest Z-line width). Only the 2 most distinct type 































Figure 3.3. The grid sizes used during the quantification of mitochondria, glycogen and lipid. 1. 300nm grid, 2. 180nm grid, 3. 


















Figure 3.4. Example plot to determine fibre type using Z-line measurement and IMF 


















































3.4.5 Image analysis  
 
For each type I and type II fibre, three spatial localizations of glycogen were defined 
in the following: 1) the subsarcolemmal (SS) space, 2) the intermyofibrillar (IMF) 
space, and 3) the intramyofibrillar (Intra) space, defined as being inside the myofibrils, 
between the contractile elements of the fibre.  Subsarcolemmal images were used to 
determine SS glycogen, whereas the combination of superficial and central myofibrillar 
images were used to determine IMF and Intra glycogen pools. 
3.4.6 Glycogen counting  
To determine SS glycogen, the length of the subsarcolemmal region was first 
measured and recorded, and then an 180nm grid (Figure 3.3) was applied to the image 
for point counting to take place. Point counting refers to the counting of the 
intersections of the grid with the target, i.e. mitochondria, glycogen, lipid or interspace, 
directly underneath of the respective grid size. To determine both the IMF and intra 
glycogen, first the interspace points were counted and recorded using a 300nm grid 
(Figure 3.3), this measure refers to any part of the image that is myofibrillar space. 
Glycogen points in the IMF region were then counted using a 180nm grid, whilst the 
intra glycogen was counted under a 60nm grid (Figure 3.3). These grid sizes have 
been extensively used in research conducted by our collaborators in experimental 
Chapter 5 (Nielsen et al, 2010, 2013, 2017; Ørtenblad et al, 2013, 2018; Koh et al, 
2017; 2018), and we subsequently adopted these grid sizes for use in Chapter 4. ~ 8 
glycogen particles per image were randomly selected and measured to gather particle 





3.4.7 TEM data calculations – glycogen  
 
In relation to experimental chapter 3 and the TEM comparisons made in chapter 4, the 
following calculations explain how the absolute and relative distributions of 
mitochondria, glycogen and lipid in the IMF, intramyofibrillar (intra) and SS locations 
were calculated.  
 
Absolute and relative glycogen  
The glycogen volume fraction (Vv) in each of the three locations was estimated as 
proposed by Weibel (eq. 4.20, Weibel, 1980), where the effect of section thickness 
has been taken into account: 
 
 
Where 𝐴𝐴 is glycogen area fraction, 𝑡 is section thickness, 𝐵𝐴  is the glycogen boundary 
length density, 𝑁𝐴 is the number of particles per area and 𝐻 is the average profile 
diameter.  
 
It was assumed that the particles were spherical (Melendez-Hevia et al, 1993) and the 
fibres were cylindrical with a diameter of 80 μm (Saltin & Gollnick, 1983). Since IMF 
and intra volume fractions are expressed as densities and SS as volume per surface 
area, total glycogen values were obtained by recalculating IMF and intra data to 
volume per fibre surface area. Assuming fibres are of a cylindrical shape, the volume 
beneath the surface area of the fibre (Vb) is: 
 
 
Where 𝑅  is fibre radius and 𝐴 is the fibre surface area. Therefore, when the radius is 
assumed to be 40 μm and the fibre surface area is 1 μm2, the volume beneath the 
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surface area of fibre is 20 μm3. Therefore, the VV of IMF and intra regions are multiplied 
with a factor of 20 when relative comparison with SS region is conducted and total 
values are calculated (Neilsen et al, 2010). 
 
The relative contribution of glycogen in each subcellular location to total glycogen per 






Absolute mitochondria in the intermyofibrillar region 
IMF mitochondrial volume fraction was calculated using point counting. The sum of 
IMF mitochondria is then divided by this to give us the area fraction of IMF 
mitochondria in the superficial region.  As the superficial region of a cylinder occupies 
3 times more volume than the central region, volume estimates from the superficial 
region were weighted 3 times more than those from the central region. Thus, to 




Absolute Mitochondria in the subsarcolemmal region 
In the SS region, mitochondria is not expressed as volume fraction, but is instead 
expressed as volume per surface area of the fibre. The volume of the image is 
multiplied by the volume fraction to obtain an absolute volume. The absolute volume 
(3 ∗ 𝐼𝑀𝐹 𝑚𝑖𝑡𝑜𝑐ℎ𝑜𝑛𝑑𝑟𝑖𝑎 𝑖𝑛 𝑡ℎ𝑒 𝑠𝑢𝑝𝑒𝑟𝑓𝑖𝑐𝑖𝑎𝑙 + 𝑐𝑒𝑛𝑡𝑟𝑎𝑙 𝑟𝑒𝑔𝑖𝑜𝑛 𝑒𝑞𝑢𝑖𝑣𝑎𝑙𝑒𝑛𝑡)/4 
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per length of fibre is divided by the thickness of the section to obtain an estimate per 
surface area of the fibre. The SS mitochondria count is then divided by the grid 
reference space for mitochondria divided by the length of the fibre available to give 
the area fraction of SS mitochondria.  This then is divided by the image volume which, 
then gives us the absolute volume to be divided by the thickness of the section. The 




3.5 Transmission electron microscopy measures of lipid. 
 
3.5.1 Imaging   
 
For lipid analysis, the magnification was X11,000 and ~16 (10 – 18) images were 
collected of the SS and superficial IMF locations, with ~24 (20 – 28) images being 
taken of the central IMF location. This magnification allowed three specific locations 
to be defined and analysed: SS, central IMF and superficial IMF. IMF lipid was 
expressed relative to the myofibrillar space whilst, the SS lipid was relative to the 
surface area of the fibre through calculating the available length.  Within these images, 
two pools of lipid droplets were identified: IMF LD and SS LD. The fibre typing was 
undertaken as described in section 3.3.4.  
 
3.5.2 Image analysis for lipid 
 
Our criteria for identifying LD included having a circular white/greyish appearance, 
lacking a distinct membrane as seen with mitochondria. In agreement with previous 
research, LD also needed to have a minimum diameter of 200 μm, if smaller than this, 
they were excluded from the analysis (Koh et al, 2017). To count SS lipid, the image 
𝐼𝑀𝐹 𝑚𝑖𝑡𝑜𝑐ℎ𝑜𝑛𝑑𝑟𝑖𝑎 𝑣𝑜𝑙𝑢𝑚𝑒 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 + (𝑆𝑆 𝑚𝑖𝑡𝑜𝑐ℎ𝑜𝑛𝑑𝑟𝑖𝑎 𝑣𝑜𝑙𝑢𝑚𝑒 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 / 20) 
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was zoomed in to 200% to ensure accuracy in the counts and measurements, then 
the available length of the subsarcolemmal region was measured before applying the 
180nm grid (Figure 3.2). The LD were measured, both in width and height of the 
maximum points to generate an average LD diameter. To calculate the myofibrillar 
lipid, a 200% zoom was applied on the superficial myofibrillar region and the central 
myofibrillar region separately before point counting occurred. 
 
3.5.3 TEM data calculations – Lipid 
 
 
Absolute and relative lipid 
 
The same calculations for absolute and relative glycogen were applied to the absolute 
and relative lipid data. However, the reference grid points were adapted accordingly, 
using the 180nm grid to count lipid and mitochondria (Figure 3.3). There was no intra 
data collected meaning no interspace counts were required.  
 
Lipid droplet size and number estimations  
 
LD size was calculated by measuring and averaging the major and minor diameters 
of each individual LD recorded. The aspect ratio of the LD reflects the “length-to-width 
ratio” (calculated as major diameter/minor diameter). LD number was calculated by 
dividing the subcellular LD volume fraction by the mean individual LD volume of the 
respective subcellular region. The LD were assumed to be spherical in shape and the 








3.5.4 Precision estimates 
 
The precision of stereological estimates, represented by the estimated coefficient of 
error (CEest), for mitochondria, glycogen and lipid was calculated as proposed by 




For each estimate, n = the number of micrographs, x is the total points per micrograph 
and y is the points crossing the objects of interest. The CEest value examines the 
variation in the parameters between images and allows the quality of quantitative 
estimates gathered from stereological methods such as point counting used in this 
TEM analysis to be estimated. By definition the CE is the standard error of the mean 
of repeated estimates divided by the mean. The CEest values are reported within 
experimental chapter 4. Inter-investigator and intra-investigator correlation coefficients 
for all analyses were > 0.96. Inter-investigator correlation coefficient was calculated 
through each researcher analysing the same muscle fibre, then values from each 
researcher were compared. Intra-investigator correlation coefficients were calculated 




















Chapter 4 - A microscopy-based investigation into 
subcellular substrate utilisation during field-based 








































To date, comparisons of exercise intensity on muscle substrate utilisation at both a 
fibre type and subcellular-specific level, have not yet been simultaneously examined 
within the same study in a field-based training environment. This study aimed to 
quantify glycogen and lipid utilisation on a fibre type and subcellular-specific basis 
during two field-based training sessions using TEM. In a randomised, repeated 
measures cross-over design, 11 male runners (age 25  3 years, body mass 76.2  
7.6 kg, height 178.5  5.4 cm) completed a 10-mile road run performed at lactate 
threshold or an 8x800m high-intensity interval track session at VO2peak under 
standardised nutritional conditions, with muscle biopsies obtained from the vastus 
lateralis and gastrocnemius before and after exercise. Overall, glycogen was reduced 
regardless of fibre type across all subcellular locations following exercise with a 
preferential use of intramyofibrillar glycogen. In the vastus lateralis, INTRA glycogen 
utilisation was greater following the 8x800 trial (P = 0.002) in comparison to the 10 
mile trial (P = 0.061). Lipid utilisation, however, occurred primarily in the IMF region of 
type I fibres, particularly during the 10-mile trial (P = 0.001). Furthermore, there was a 
tendency for LD number to be reduced during the 8x800m trial (P = 0.071), whereas 
there was a tendency for LD size to be reduced during the 10-mile trial (P = 0.067). 
These data highlight the interaction between muscle fibre recruitment, relative 
exercise intensity and training duration in modulating subcellular-specific glycogen 
and lipid utilisation within specific exercise protocols. Being the first to investigate on 
a subcellular-basis using TEM in running and allowing us to identify a preferential use 
of INTRA glycogen during exercise, independent of intensity. Furthermore, lipid 
utilisation occurs primarily in the IMF region of type I fibres, but changes in LD 
morphology maybe related to exercise intensity and duration.  The pattern of glycogen 
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and lipid utilisation here, specific to the training status of the participants and exercise 
intensities compared, may aid practical guidelines in relation to fuelling strategies to 
promote training intensity and metabolic adaptations by providing field-based data to 

























As outlined in Chapter 2, despite the emphasis on the importance of understanding 
nutrition to optimise performance in endurance events, there is a considerable lack of 
data that has been collected in a field-based training or competitive environment. 
Indeed, the majority of studies influencing sports nutrition guidelines have used  
laboratory-based protocols (e.g. fasted exercise at a fixed relative intensity for a given 
duration, such as 1 h at 70% VO2max), which although have the benefits of being able 
to implement strict control measures, may not always be representative of field-based 
training due to the lack of physiological responses to changes in changing weather 
and terrain. Moreover, laboratory-based research often uses motorised treadmills or 
cycle ergometers. The physiological demands of treadmill running have been 
demonstrated to require a lower rate of oxygen uptake than overground running (Aubry 
et al, 2018), and when running at the same intensity on an outdoor running track, there 
is greater energy expenditure than a motorised treadmill (Bidder et al, 2017). In 
addition to this, differences between specific muscles (Koh et al, 2017) and specific 
muscle fibre types (Pendergast et al, 2000) are also likely to affect both CHO and lipid 
utilisation during field-based training sessions at different intensities and durations. To 
address this, Impey et al, (2020) recently undertook a comprehensive study that aimed 
to assess sex and muscle differences in glycogen utilisation in the vastus lateralis and 
gastrocnemius during different typical run training sessions completed in a field-based 
training environment. Overall, by assessing glycogen concentration using the 
biochemical extraction technique, they reported a greater utilisation of glycogen in the 
gastrocnemius in comparison to the vastus lateralis, and a greater glycogen 
requirement during a prolonged moderate-intensity run compared to a shorter, interval 
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running session.  Within muscle though, glycogen content varies depending on fibre 
(type I, type IIa and type IIx fibres) and subcellular region (subsarcolemmal (SS), 
intermyofibrillar (IMF) and intramyofibrillar regions (INTRA)). Whilst IMF glycogen 
stores are the largest, it is the INTRA glycogen stores (Marchand et al, 2007, Nielsen 
et al, 2011), and the SS glycogen stores that are preferentially utilised during exercise 
(Jensen et al, 2020).  This is important, because it has been shown that glycogen and 
muscular fatigue likely originates via a connection between INTRA glycogen and 
sarcoplasmic reticulum (SR) Ca2+ release (Ørtenblad et al, 2011). Thus, when 
examining muscle substrate utilisation, it would be preferable to use a method that 
allows assessment on both a fibre type and subcellular-specific basis. Currently, such 
comparisons of exercise intensity, muscle and substrate utilisation at both a fibre and 
subcellular region-specific basis, have not yet been simultaneously examined within 
the same study in a field-based training environment. 
 
Similar to glycogen, intramuscular triglyceride (IMTG)-containing lipid droplets (LD) 
are also distributed on a fibre and subcellular specific basis (Nielsen et al, 2010; Koh 
et al, 2017; 2018).  Importantly, transmission electron microscopy (TEM) allows the 
identifiation and quantification of exercise-induced changes in LD content and 
morphology (number and size).  It is now well known that moderate-intensity exercise 
leads to a decrease in IMTG content specifically in type I fibres (reviewed by Van Loon, 
2004), and there is some evidence that IMF LDs are specifically reduced (Chee et al, 
2016; Koh et al, 2017).  However, the effect of exercise intensity on fibre and 
subcellular-specific changes in both LD content and morphology are yet to be 




Consequently, the aim of the present study was to quantify glycogen and lipid 
utilisation of the vastus lateralis and gastrocnemius muscle of recreationally active 
male runners during either steady state endurance training or high intensity interval 
training in a field-based training environment. This was achieved using TEM, which by 
virtue of its high magnification and resolution capabilities, is considered the gold-
standard method for investigating changes in the quantity and morphology of 
substrates at the subcellular level. Therefore, we quantified glycogen and lipid 
utilisation on a fibre and subcellular-specific basis during both a 10-mile road run at 
lactate threshold or an 8x800m track interval session at VO2peak. We hypothesised 
glycogen utilisation would be preferential to the INTRA glycogen stores, whilst lipid 
utiisation would be specific to the IMF region and that overall, substrate utilisation 
would differ between exercise trials, with greater glycogen utilisation following the 
















Participants and ethics 
 
Eleven male competitive and recreational runners were recruited as part of a larger 
study (Impey et al, 2020). Participant’s anthropometric and physiological profiles are 
presented in Table 4.1. All participants had at least 5 years of competitive running 
experience and were training routinely ≥3 times a week, with a best 10km race time of 
≤45 min. Following a detailed explanation of the nature of the study, all participants 
provided written informed consent. All procedures conformed to the standards set by 
the Declaration of Helsinki and the study was approved by the NHS Research 


















Table 4.1. Anthropometric profile, training history and physiological profile.  
 
 Participants (n = 11) 
Anthropometric profile  
Age (years) 25  3 
Body mass (kg) 76.2  7.6 
Height (cm) 178.5  5.4 
Fat Free Mass (kg) 59.0  6.1 
  
Training profile  
Weekly distance (km) 34.9  21.2 
Weekly duration (hours) 4.6  2.0 
  
Physiological profile  
VO2peak (L/min) 4.2  0.4 
VO2peak (mL.kg-1.min-1) 53.9  4.7 
VO2peak (mL.kg-1 FFM.min-1) 69.7  6.1 
vVO2peak (km.h-1) 16.5  0.7 
Lactate Threshold (%VO2peak) 68.6  6.3 
Lactate Threshold (km.h-1) 12.5  0.7 
Lactate Turnpoint (%VO2peak) 76.4  6.1 
Lactate Turnpoint (km.h-1) 13.6  0.7 
  
















In a randomised, repeated measures cross-over design participants took part in two 
different training sessions at different exercise intensities which are representative of 
those used to prepare for a 10km race (Spillsbury, personal communication, English 
Institute of Sport). These sessions consisted of 1) a steady state trial of 10 miles 
performed at lactate threshold, or 2) a high-intensity intermittent training session of 8 
x 800m performed at maximal oxygen uptake (VO2peak). Muscle biopsies were taken 
from the vastus lateralis and the lateral head of the gastrocnemius immediately before 
(pre) and after (post) exercise. The corresponding running speeds for each trial were 
individual to each participant, and determined on a separate occasion through 
completion of a graded exercise test to establish VO2peak lactate threshold and lactate 
turn-point. 48 hours prior to the main experimental trials, participants completed a 
glycogen-depletion protocol before subsequently receiving a standardised diet in an 
attempt to normalise pre-exercise muscle glycogen values between participants prior 




All participants reported to the exercise physiology laboratories at Liverpool John 
Moores University in an overnight fasted state between 07:00h – 08:00h. Participants 
were given a standardised breakfast (CHO 2 g.kg-1 body mass, protein 25g, fat 10g) 
3 hours before starting the graded exercise test in the form of incremental running on 
a treadmill (HP Cosmos, Germany). A resting finger-tip blood sample was collected 
(Lactate Plus, Nova Biomedical USA) before completing a self-selected warm up. 
During the graded exercise test, oxygen uptake was measured during exercise via 
breath-by-breath measurements using a CPX Ultima series online gas analysis 
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system (Medgraphics, Minnesota, USA). This was calibrated with internal standard of 
known gases and volumetric syringe.  
 
The graded exercise test commenced with the treadmill at a speed of 10 km.h-1 and 
1% incline, and the speed increased by 1 km.h-1every 3 min. At the end of each stage 
blood lactate was assessed via finger-prick capillary blood sampling (Lactate Plus, 
Nova Biomedical, USA). Participants continued to run until both lactate threshold and 
lactate turn-point had been achieved. Lactate threshold was expressed as an increase 
in blood lactate above the resting value by 0.4mmol.L-1, and lactate turn-point was 
expressed as an increase in blood lactate of ≥ 1.0 mmol.L-1 above resting (Winter et 
al, 2007). Part 2 of the test began at a speed 2 km.h-1 below the speed reached at 
lactate turn-point, and the speed was then increased by 1 km.h-1 every minute until 
volitional fatigue or until 16 km.h-1 was reached, where the incline was then increase 
by 1% every minute until volitional fatigue. VO2peak was determined as the greatest 
VO2 value obtained in any 10 sec period if meeting two of the following criteria: heart 
rate within 10 beats per min of age-predicted maximum, respiratory exchange ration 
(RER) > 1.1 or plateau of oxygen consumption despite greater workload. Thus, to 
calculate the speed at VO2peak the final treadmill speed was used if this was ≤16 kph.  
For those participants who had reached the incline stages of the test the following 
equation was used to calculate velocity at VO2max: 
 
Speed at V̇O2peak = (V̇O2max x 60) / Running economy 
⇒  Kph = (ml.kg-1.min-1 x 60) / ml.kg-1.km-1 
⇒  Running economy = V̇O2 / (16 / 60) 





Days 1 and 2: Participants arrived at the laboratory on the evening of the first 
experimental day after avoiding alcohol and vigorous physical activity for 24 h prior. A 
heart rate (HR) monitor (Polar FT1, Finland) was fitted and body mass (BM) was 
recorded before participants commenced an intermittent glycogen-depleting running 
protocol on a manually operated treadmill (HP, Cosmos, Germany). Particpants 
performed 90-min of high-intensity interval running (or to exhaustion if this occurred 
first). First they completed a self-selected 5 min warm up, and then commenced 
running for 2 min bouts at 100% VO2max, interspersed with 2 min recovery at 60% 
VO2max. When participants could no longer complete the 2 min bouts at 100% VO2max, 
the work-rest ratio was reduced to 1.5 min – 2 min and then finally, reduced to 1 min 
– 2 min. Once unable to complete 1 min bouts at 100% VO2max the intensity was 
reduced to 90% VO2max and completed in the same pattern of work-rest ratio as 
described above. The protocol was chosen to maximally diminish muscle glycogen in 
both type I and type II muscle fibres. This protocol has been successfully used 
previously in our laboratory (Bartlett et al, 2013; Impey et al, 2016; Taylor et al, 2013). 
For both experimental trials, water was consumed ad libitum throughout exercise and 
total time to exhaustion. Subsequent to completing the glycogen depletion, 
participants were given 1.2 g CHO.kg-1 BM through a sports drink and bar (Lucozade, 
UK) and 25g whey protein (Science in Sport, UK) to be consumed within the first hour 
post-depletion. The evening meal provided to the participants included 2 g CHO.kg-1 
BM, 15g fat and 40 g protein. For the next 36 h participants were provided with food 
and drink containing 6 g CHO.kg-1 BM per 24 h, 2 g protein.kg-1 BM per 24 h, and 1 g 
fat.kg-1 BM per 24 h. All food was prepared by a SENr registered sport nutritionist and 
was in line with dietary preferences of the participants. During this 36 h period, 
96 
 
participants were also advised to avoid caffeine and alcohol as well as strenuous 
physical exertion. 
 
Day 3: On the afternoon of day 3, participants either arrived at the Tom Reilly building 
at Liverpool John Moores University to complete the 10-mile trial, or at an outdoor 
running track (Wavertree Athletics Centre, Liverpool, UK) to complete the 8x800m 
trial. Trials were separated by a minimum of 7 days and were completed in a 
randomised order. Skeletal muscle biopsies of the vastus lateralis and gastrocnemius 
were collected at rest and preserved for TEM analysis, described in more detail below. 
Participants were fitted with a GPS watch (Garmin Forerunner 620) before 
commencing each exercise trial. The 10-mile trial was a supervised road run from and 
returning to Liverpool John Moores University at a speed corresponding to lactate 
threshold. Heart rate (HR) and rating of perceived exertion (RPE) were recorded at 
rest and at the end of every mile. During the 8x800m trial, participants completed 8 
repetitions of 800m with 2 min recovery between repetitions at a speed corresponding 
to VO2peak. HR and RPE were recorded at rest and at the end of each interval. Muscle 
biopsies were collected after each trial 2 cm distal to the pre-exercise biopsy, and a 




Skeletal muscle biopsies were collected from the vastus lateralis and the lateral head 
of the gastrocnemius before and after exercise. Muscle biopsies were collected under 
local anaesthesia (0.5% Marcaine) from separate incision sites approximately 2 – 3 
cm apart using a Bard Monopty Disposable Core Biopsy Instrument (Bard Biopsy 
Systems, Tempe, AZ, USA). The muscle samples were prepared for TEM according 
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to the protocol described in section 3.5 and 3.5.1. They were then imaged according 
to the description in section 3.6.1, and fibre type was determined as described in 
section 3.6.2, see figure 4.1 (glycogen) and 4.2 (lipid) for examples of micrographs,. 
Representative images of glycogen and lipid can be seen in figure 4.1 and 4.2, 
respectively. Finally, mitochondria, glycogen and lipid analysis were then undertaken 
as described in section 3.6.3. Approximately 14,000 electron micrographs were 
analysed from 58 muscle biopsies (30 pre-exercise, 28 post-exercise) for glycogen 
and mitochondria. For lipid, ~ 18,000 electron micrographs were analysed from 45 
biopsies (23 pre-exercise, 22 post-exercise). The coefficient of error (CEest), calculated 
as explained in section 3.4.4 for mitochondria was 0.119  0.028 and 0.176  0.055 in 
the IMF and SS regions, respectively. Glycogen and lipid CEest values are displayed 





















Table 4.2. The precision of stereological estimates represented as coefficient of error 
(CEest).  
 
CEest for volume fraction  Pre-exercise Post-exercise 
Glycogen IMF 0.070  0.019 0.078  0.036 
INTRA 0.101  0.045 0.139  0.133 
SS 0.101  0.032 0.125  0.082 
Lipid 
 
IMF 0.153  0.046 0.159  0.035 
SS 0.329  0.079 0.315  0.055 
 
Values are presented as mean  SD including data from both exercise trials, both 
























































Figure 4.1. Transmission Electron Micrographs for glycogen analysis 
 
Images taken at x 36,000, scale bar = 0.5µm showing 1. Intermyofibrillar, 2. 
Intramyofibrillar and 3. Subsarcolemmal pools of glycogen. Full description can be 




































Figure 4.2. Transmission Electron Micrographs for lipid analysis 
 
Images taken at x 11,000 showing, scale bar = 2µm 1. Central myofibrillar, 2. 
Superficial myofibrillar 3. Subsarcolemmal area of the cell. Full description can be 












Statistical analyses were performed using SPSS (SPSS; version 23, IBM, USA). 
Linear mixed modelling was used to examine all dependent variables (glycogen, 
mitochondria and lipid) pre and post-exercise for both the 10-mile and 8x800m trial, 
with data separated into the two different muscles, vastus lateralis and gastrocnemius. 
All main effects and interactions were tested using a linear mixed-effects model, with 
random intercepts to account for repeated measurements within subjects to examine 
differences between exercise trial, muscle, fibre type and subcellular region. 
Subsequent Bonferroni adjustment post-hoc analysis was used to examine main 
effects and interactions. Data is presented as mean ± SD. Significance was accepted 

















Fibre-type dependent distribution of mitochondria, glycogen and lipid pre-exercise.  
 
Total mitochondria volume fraction was 51% and 61% greater in type I compared to 
type II fibres in the vastus lateralis and gastrocnemius, respectively (P < 0.05). There 
was no difference between muscles in the total mitochondria volume fraction (P = 
0.241). When considering subcellular region, mitochondria volume fraction was fibre 
type dependent in both the IMF (P < 0.05) and SS subcellular locations of the vastus 
lateralis (P = 0.017), with type I fibres containing 51% and 47% more mitochondria in 
each subcellular location, respectively, compared to type II fibres (Table 4.3). 
However, in the gastrocnemius this fibre-type dependent distribution was only evident 
in the IMF location (P < 0.05), with type I fibres containing 64% more mitochondria 
than type II fibres. In contrast, the SS mitochondria volume fraction was not different 
in the gastrocnemius between type I and II fibres.  The relative distribution of total 
mitochondria between the IMF and the SS locations was not different when comparing 
the vastus lateralis to the gastrocnemius (P > 0.05). In type I fibres, 89  2% of 
mitochondria was located in the IMF region, whilst 11  2% was located in the SS 
region. In type II fibres, 85  1% of mitochondria was located in the IMF, whilst 15  


























 Vastus Lateralis Gastrocnemius 
 Type I Type II Type I Type II 
Mitochondria      
IMF m3·m-3 myofibrillar space·103  0.117  0.049 0.057  0.018* 0.154  0.026 0.055  0.008* 
SS m3·m-2 fibre surface area·103 
Total m3·m-3 myofibrillar space·103 
0.336  0.191 
0.134  0.056 
0.179  0.119* 
0.066  0.023* 
0.322  0.146 
0.170  0.031 
0.219  0.143 
0.066  0.012* 
 





Pre-exercise, in the vastus lateralis, there were no fibre-specific differences in 
glycogen in the IMF or INTRA locations, however there was a trend for SS 
glycogen to be greater in type I fibres compared to type II fibres (P = 0.094, 
Figure 4.3c). The relative distribution of glycogen across subcellular locations 
was not different between fibre types, with IMF, INTRA and SS glycogen 
contributing 84%, 5% and 11% of total glycogen in type I fibres, respectively, 
and 83%, 5% and 12% of total glycogen in type II fibres, respectively (Figure 
4.4).  However, the location of glycogen in the gastrocnemius was found to be 
highly dependent on fibre type.  IMF glycogen was 16% greater in type I fibres 
compared to type II fibres (P = 0.011, Figure 4.3a), whereas INTRA glycogen 
was 80% higher in type II fibres compared to type I fibres (P = 0.049, Figure 
4.3b). No fibre type differences were observed for SS glycogen (P = 0.382, 
Figure 4.3c).  Thus, IMF glycogen contributed 85% of total glycogen in type I 
fibres, but only 82% of total glycogen in type II fibres (P = 0.018, Figure 4.4). In 
contrast, INTRA glycogen contributed only 3% of total glycogen in type I fibres, 
which increased to 5% in type II fibres (P = 0.019).  SS glycogen contributed 
12% and 13% of total glycogen in type I and type II fibres, respectively (P = 
0.149). When comparing the two muscles, INTRA glycogen was greater in the 
vastus lateralis compared to the gastrocnemius, which was true across both 































Figure 4.3. Glycogen content in the IMF, INTRA and SS locations before 
exercise. 
 
Glycogen content in the vastus lateralis and gastrocnemius in a) 
intermyofibrillar, b) intramyofibrillar and c) subsarcolemmal locations. Values 
are means  SD. * P < 0.05 significant fibre type differences, ~ P < 0.094 trend 
for significant fibre type differences. 













































































































Figure 4.4. Relative distribution of glycogen and lipid across subcellular 
locations.  
 
Values are mean %  SD * P < 0.05 vs type I fibres of the respective muscle. 
** P < 0.01 vs type II fibres irrespective of muscle, *** vs type I fibres 
irrespective of muscle.  
11 ± 2 SS
84 ± 3 IMF
5 ± 2  INTRA
12 ± 5 SS
83 ± 6 IMF
5 ± 2 INTRA
12 ± 4 SS
85 ± 4 IMF
3 ± 2 INTRA
13 ± 9 SS
82 ± 8 IMF*
5 ± 3 INTRA*
89 ± 2 IMF **
11 ± 2 SS
90 ± 4 IMF
10 ± 4 SS ***
87 ± 5 IMF **
13 ± 5 SS
83 ± 8 IMF








































































At rest, LD volume fraction was not different between muscles in either the IMF 
(P = 0.752, Figure 4.5a) or SS region (P = 0.241 Figure 4.5b). Overall though 
(i.e. across muscles), LD volume fraction in the IMF region was 26% greater in 
type I fibres compared to type II fibres (P = 0.012). In the SS region there were 
no fibre-specific differences (P = 0.889). Similarly, the relative distribution of 
lipid was not different between muscles in either the IMF (P = 0.131, Figure 4.4) 
or SS region (P = 0.131, Figure 4.4). There was, however, a tendency for IMF 
lipid to be greater in type I compared to type II fibres (P = 0.074), whereas SS 
lipid tended to be greater in type II when compared to type I fibres (P = 0.059). 
When considering LD morphology, IMF and SS LD number was also unaffected 
by muscle  or fibre type (P > 0.05, Figure 4.5c and d) Further to this, IMF and 
SS LD size did not differ by muscle or fibre type (P > 0.05, Figure 4.5e and f). 
It is important to note, however, that although differences in LD size and number 
were not significantly different between fibre types, the overall fibre difference 
in IMF LD volume fraction is likely due to a combination of small non-significant 
differences between fibre types for both LD size (LDs in type I fibres being 4% 
greater than LDs in type II fibres) and LD number (29% more LDs in type I 
compared to type II fibres).  
 
In summary, the pre-exercise data showed mitochondria to be greater in type I 
fibres with no differences between muscles. Fibre type differences in the IMF 
region of both muscles, but only in the vastus lateralis for the SS region. In 
regard to glycogen, in the vastus lateralis, no fibre differences were seen within 
the IMF or INTRA regions, but there was a trend for SS glycogen to be greater 
in type I fibres. In the gastrocnemius, glycogen was highly dependent on fibre 
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type in the IMF and INTRA region, with no differences within the SS region. LD 
volume fraction was unaffected by muscle, with type I fibres having greater IMF 
LD. LD size and number unaffected by muscle, fibre or region though the overall 
fibre difference in IMF LD volume fraction is likely due to a combination of small 













































































Figure 4.5. LD volume fraction, number and LD size before exercise. 
 
Lipid pre-exercise in the vastus lateralis and gastrocnemius. LD volume fraction 
a) IMF and b) SS. LD number c) IMF and d) SS, LD size e) IMF and f) SS. 






















































































































































































































































Localisation and fibre-type dependent glycogen utilisation following exercise 
 
In the vastus lateralis, INTRA glycogen decreased by 30% and 31% in type I 
and type II fibres, respectively following the 8x800m trial (P = 0.002, Figure 
4.6d). There was also a tendency for INTRA glycogen to be reduced following 
the 10-mile trial (P = 0.061, Figure 4.6c). Consequently, the utilisation of INTRA 
glycogen in the vastus lateralis was greater in the 8x800m trial in comparison 
to the 10-mile trial (P = 0.041). In the gastrocnemius, INTRA glycogen 
decreased by 38% and 26% in type I and II fibres, respectively, following the 
8x800m trial (P = 0.005, Figure 4.7d).  Although pre-exercise INTRA glycogen 
was greater in the 10-mile trial compared with the 8x800m trial, similar 
reductions were also observed in the 10-mile trial, with INTRA glycogen 
decreasing by 31% and 44% in type I and II fibres, respectively (P < 0.001), 
with no difference between fibres.  
 
Overall, exercise reduced SS glycogen in both type I (-27%) and type II fibres 
(-20%, main effect of time; P < 0.05, Figure 4.6e/f and 4.7e/f) but there were no 
differences between trials (P = 0.596) or between muscles (P = 0.651). The 
overall reduction in IMF glycogen (main effect of time; P = 0.014) was also not 
specific to either muscle (P = 0.254) or trial (P = 0.573), but the reduction in 
IMF glycogen tended to be greater in type I (-17%) compared to type II fibres (-
7%, P = 0.054, Figure 4.6a/b and 4.7a/b). When examining the reduction in 
total glycogen there were no significant differences between muscles, with total 
glycogen being reduced by 16% in the vastus lateralis and 20% in the 
gastrocnemius (P = 0.606). Equally, there was no difference in total glycogen 
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utilisation between trials (P = 0.260).  When considering fibre-specific 
responses, there was a trend for total glycogen utilisation to be greater in type 











































































Figure 4.6. Glycogen content before and after each exercise trial in the 
vastus lateralis  
 
The effect of the 10 mile trial on the a) IMF, c) INTRA and e) SS. The effect of 
the 8x800m trial on the b) IMF, d) INTRA and f) SS. Values are means  SD. * 
P < 0.05 significant difference to pre exercise, ** P < 0.054 trend for type I 
reductions (-17%) to be greater than type II reductions (-7%). 
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Figure 4.7. The effect of exercise on absolute glycogen values in the 
gastrocnemius. 
 
The effect of the 10 mile trial on the a) IMF, c) INTRA and e) SS. The effect of 
the 8x800m trial on the b) IMF, d) INTRA and f) SS. Values are means  SD. * 
P < 0.05 significant difference to pre exercise, ** P = 0.054 trend for type I 
reductions (-17%) to be greater than type II reductions (-7%). 






































































































































































Given the differences in INTRA glycogen in the gastrocnemius between trials 
(described above), there was a greater proportion of total glycogen was located 
in the INTRA location both pre and post-exercise in the 10-mile trial when 
compared to the 8x800m trial (P = 0.007, Table 4.4).  Importantly though, the 
contribution of INTRA glycogen to total glycogen content in the 8x800m trial 
was decreased in both the gastrocnemius (P = 0.004) and the vastus lateralis 
(P = 0.023) in both type I and type II fibres. In contrast, there only tended to be 
a reduction in the contribution of INTRA glycogen to total glycogen content in 
response to the 10-mile trial in both the gastrocnemius (P = 0.052) and the 
vastus lateralis (P = 0.068). There was no change in the contribution of SS 
glycogen to total glycogen content in either muscle (P = 0.651) across both 
trials (P = 0.549).  Consequently, the relative contribution of IMF glycogen to 
total glycogen content increased in both the gastrocnemius (P = 0.033) and the 
vastus lateralis (P = 0.019) across both trials. Taken together, this suggests 
that overall in both muscles and trials there was a preferential utilisation of the 












Table 4.4. Relative distribution (%) of glycogen in human skeletal muscle 
before and after each exercise trial. 
 
Glycogen   
Gastrocnemius IMF INTRA # SS 
Fibre type  Pre Post Pre Post Pre Post 
10 Mile       
Type I 82  4 85  6 4  2 4  3 13  5 11  5 
Type II 83  5 84  3 6  2 5  3 11  4 11  4 
8x800m       
Type I 88  3 86  2 2  1 † 2  2 † 10  2 12  3 
Type II 81  
10 
86  4 3  2 † 2  2 † 16  
11 
12  4 
   
Vastus 
Lateralis 
IMF INTRA # SS 
Fibre type  Pre Post Pre Post Pre Post 
10 Mile       
Type I 84  3 84  6 5  2 4   1* 10  2 11  5 
Type II 86  5 86  4 5  2 4  2* 9  3 10  3 
8x800m       
Type I 84  2 87  6* 6  2 4  2* 11  2 15  4* 
Type II 79  6 85  6* 6  2 4  2* 15  5 11  5* 
 
 
IMF, intermyofibrillar glycogen; INTRA, intramyofibrillar glycogen; SS, 
Subsarcolemmal glycogen. Values are expressed as %, and represent mean  
SD. * P < 0.05 vs pre exercise. † P < 0.05 differences between exercise trial. # 














Localisation and fibre-type dependent lipid droplet utilisation following exercise 
 
Exercise caused a 51% reduction in IMF LD volume fraction in type I fibres 
during the 10-mile trial (P = 0.001), and IMF LD volume fraction also tended to 
decrease in type II fibres (-34%, P = 0.084, Figure 4.8). There also tended to 
be a small reduction in IMF LD volume fraction following the 8x800m trial of 
22% across both type I and type II fibres (P = 0.093, Figure 4.8), and regardless 
of muscle (P = 0.471). In contrast, SS LD volume fraction was not reduced in 
response to exercise (P = 0.645, Figure 4.8), regardless of muscle (P = 0.931) 
or fibre type (P = 0.877). Overall though, there was a significant difference 
between exercise trials, with post-exercise LD volume fraction being 66% lower 
in the 10-mile trial compared to the 8x800m trial (P = 0.019). Thus, overall lipid 
utilisation was greater in the 10-mile trial compared to the 8x800m trial.  With 
regards to the relative distribution of lipid, exercise caused the distribution of 
lipid in the vastus lateralis to decrease in the IMF region (P = 0.006), 
consequently causing an increase in the SS region (P = 0.028, Table 4.5). In 
the gastrocnemius, the relative distribution of lipid in both the IMF and SS 



















































Figure 4.8. The effect of exercise on LD volume fraction in the vastus lateralis 
and gastrocnemius. 
 
The effect of the 10 mile trial on a/e) IMF and c/g) SS. The effect of the 8x800 
trial on b/e) IMF and d/h) SS. Values are means  SD. * P < 0.05 significant 
difference to pre exercise, # P = 0.019 significant difference to 10 mile trial. ~ P 
= 0.084 and P = 0.093 for 10 mile and 8x800 trial, respectively, trend of 
reductions from pre exercise. 
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Gastrocnemius Pre exercise Post exercise 
Fibre type  IMF SS IMF SS 
10 Mile     
Type I 91  3   9  3 86  13 14  13 
Type II 85  9 13  9 86  7 14  7 
8x800m     
Type I 86  6 14  6 83  8 17  8 
Type II 85  8 15  8 81  9 19  9 
Vastus 
Lateralis 
Pre exercise Post exercise 
Fibre type  IMF SS IMF SS 
10 Mile     
Type I 92  3 8  3 86  3* 14  3* 
Type II 88  4 12  4 85  5* 15  5* 
8x800m     
Type I 86  6 14  6 82  12* 18  12* 
Type II 88  7 12  7 80  9* 20  7* 
 
 
IMF, intermyofibrillar glycogen; SS, Subsarcolemmal glycogen. Values are 
























In terms of LD morphology, there was a tendency for IMF LD size to decrease 
by 12% following the 10-mile trial (P = 0.067, Figure 4.9), although this was not 
specific to fibre type or muscle. SS LD size was unaffected by exercise, trial, 
muscle or fibre (P > 0.05). When examining LD number, there was a tendency 
for IMF LD number to be reduced following the 8x800m trial (-5%; P = 0.071, 
Figure 4.10), although this was not specific to fibre type or muscle. SS LD 
number decreased by 38% in type I fibres in the gastrocnemius following 
exercise (P = 0.030, Figure 4.10), with similar, but not quite significant 
decreases in the type I fibres of the vastus lateralis (-32%, P = 0.068, Figure 
4.10). Trial alone did not significantly effect LD number in response to exercise 





























































Figure 4.9. The effect of exercise on LD size in the vastus lateralis and 
gastrocnemius. 
 
The effect of the 10 mile trial on a/e) IMF and c/g) SS. The effect of the 8x800m 
trial on b/f) IMF and d/h) SS. Values are means  SD. ~ P = 0.067 trend of 
reductions from pre exercise. 
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Figure 4.10. The effect of exercise on LD number in the vastus lateralis and 
gastrocnemius. 
. 
The effect of the 10 mile trial on a/e) IMF and c/g) SS. The effect of the 8x800 
trial on b/f) IMF and d/h) SS. Values are means  SD. # P = 0.068 reduction 
from pre exercise, ~ P = 0.071 trend of reductions from pre exercise. 
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4.5 Discussion  
 
The aim of the present study was to quantify glycogen and lipid utilisation on a 
fibre and subcellular level in the vastus lateralis and gastrocnemius muscle of 
recreationally active male runners during either steady state endurance running 
(10-mile trial) or high intensity interval exercise (8x800m trial) in a field-based 
training environment. The key findings of this study were that 1) INTRA 
glycogen was preferentially utilised in both type I and type II fibres from both 
muscles during both exercise trials, 2) IMF lipid droplets in both muscles were 
preferentially reduced in type I fibres in comparison to type II fibres during the 
10-mile trial, and 3) changes in LD morphology were dependent on trial, with 
LD size being reduced following the 10-mile trial, whereas LD number was 
reduced following 8x800m trial.  
 
Pre exercise mitochondria, glycogen and lipid  
 
 
In the present study, total mitochondrial volume fraction was greater in type I 
compared to type II fibres, irrespective of the muscle studied.  More specifically, 
in the vastus lateralis, both the IMF and SS mitochondria pool was greater in 
type I fibres compared type II fibres, which is in agreement with a previous study 
in highly-trained cross country skiers (Ørtenblad et al, 2018). In contrast, in the 
gastrocnemius, only the IMF mitochondria pool, and not the SS mitochondria 
pool, was greater in type I compared to type II fibres. However, when examining 
the relative distribution of mitochondria between the IMF and SS regions, there 
was no differences between muscles with 87% in the IMF and 13% in the SS 
region, similar to that reported by Ørtenblad et al. (2018) who stated 83–86%  
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and 11-14% of mitochondria were present in the IMF and SS pools, 
respectively.  
 
Before exercise, the relative proportion of glycogen in each of the subcellular 
locations was similar across muscles and fibre types, with IMF glycogen 
contributing ~83%, SS glycogen contributing ~12% and INTRA glycogen 
contributing ~4%.  When considering the volume fraction of glycogen, both IMF 
and INTRA glycogen were similar in type I and type II fibres within the vastus 
lateralis; that is, there was no fibre-specific distribution of either the IMF or 
INTRA glycogen pools. This is in agreement with previous research in 
sedentary obese subjects (Nielsen et al, 2010a) and recreationally active young 
and elderly males (Nielsen et al, 2010b). However, in the present study SS 
glycogen tended to be greater in type I compared to type II fibres in the vastus 
lateralis. It has been suggested that fibre type differences in each of the 
subcellular glycogen pools emerge as a training adaptation (Nielsen & 
Ørtenblad, 2013), since in highly-trained individuals SS and INTRA glycogen 
pools are both greatest in type I fibres, whereas IMF glycogen is greatest in 
type II fibres (Nielsen et al, 2011).  If this is true, the data from the present study 
in moderately-trained individuals would suggest that this fibre type adaptation 
first occurs in the SS region.  The reason for this is unknown, but could be 
related to the higher Na+-K+ pump energy requirements of trained muscle fibres 
(Nielsen & Ørtenblad, 2013), and the fact that Na+-K+ pump activity is greater in 
type I compared to type II fibres during repetitive contractions (Everts & 
Clausen, 1992). This adaptation would support the classical adaptation of 
enhanced endurance capacity following endurance training.  The present data 
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also provides novel insight into the subcellular distribution of glycogen in the 
gastrocnemius.  In this muscle, fibre type-specific differences in glycogen 
appear to be dependent on the specific glycogen pool; that is, IMF glycogen 
was greater in type I compared to type II fibres, whereas INTRA glycogen was 
greater in type II compared to type I fibres.  When compared to the vastus 
lateralis, these differences could simply be due to the muscle being studied. 
However, previous qualitative data has reported glycogen particles in the 
vastus lateralis to be more frequently observed in the INTRA space of type II 
fibres (Sjostrom et al, 1982b; Friden et al, 1989).  Finally, in the gastrocnemius, 
SS glycogen was not different between fibre types.  Building on the hypothesis 
outlined above regarding the adaptation of specific glycogen pools along the 
aerobic training continuum, it could be that the adaptation is not only fibre-
specific, but also muscle-specific too.  This hypothesis requires investigation 
though in a separate study employing a longitudinal training programme.  In 
addition to this, when comparing the two muscles, INTRA glycogen in general 
was greater in the vastus lateralis compared to the gastrocnemius.  This could 
be due to the size of individual muscle fibres being larger in the vastus lateralis, 
compared to the gastrocnemius, therefore providing ‘more room’ to store 
INTRA glycogen (Edstrom & Nystrom, 1969).  
 
With regards to muscle lipid, we observed a fibre type dependency for IMF LD 
volume fraction, with type I fibres containing 26% more IMF LDs than type II 
fibres, an observation consistent across both muscles. This is in agreement 
with previous research by Koh et al, (2017), who at rest, also saw fibre-specific 
differences (albeit larger than those reported in the present study), with IMF LD 
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volume fraction being 3-fold greater in type I compared to type II fibres. In the 
present study, the fibre type difference in IMF LD volume fraction is likely due 
to a combination of small, non-significant differences in IMF LD number and 
size (i.e. more and larger LDs in type I compared to type II fibres).  In contrast, 
SS LD volume fraction was not different between type I and type II fibres, which 
is in line with previous work in highly-trained athletes (Koh et al, 2017).  Thus, 
it is possible that SS LDs are less dependent on the oxidative properties of 
muscle fibres. Moreover, it appears that unlike the muscle-specific differences 
in subcellular glycogen distribution between type I and type II fibres, the 
distribution of subcellular LD is more consistent across muscles.  
 
Subcellular glycogen utilisation during exercise. 
 
Overall, our results displayed a tendency for greater glycogen utilisation in type 
I compared to type II fibres during the 10-mile trial. This is in line with 
Henneman’s size principle (Henneman and Olson, 1965), i.e. smaller motor 
units that are often associated with type I fibres are recruited at lower 
intensities, whilst larger motor units, are often associated with type II fibres and 
higher intensities. Indeed, previous research has also reported greater 
glycogen utilisation in type I compared to type II fibres during exercise (Gollnick 
et al, 1973; 1974; Stellingwerff et al, 2007; Branth et al, 2009; Jensen et al, 
2020).  A key observation of the present study was that INTRA glycogen was 
preferentially used during both the 8x800m and 10-mile trials, compared to IMF 
and SS glycogen. This is evidenced by the decrease in the relative contribution 
of INTRA glycogen to total glycogen following exercise.  Moreover, this 
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observation is is line with previous research in moderately or well-trained 
subjects during either prolonged cycling or cross-country ski racing (Marchand 
et al, 2007; Nielsen et al, 2011).  Due to the design of the current study, whereby 
participants undertook exercise trials of two different intensities, and two 
muscles were sampled, we can now extend previous observations regarding 
INTRA glycogen utilisation; that is, we show that INTRA glycogen utilisation in 
the gastrocnemius was similar between exercise trials, whereas INTRA 
glycogen utilisation in the vastus lateralis was greater in the 8x800m trial 
compared to the 10-mile trial.  Interestingly, mechanistic investigations have 
identified a link between INTRA glycogen content and SR Ca2+ release in 
skinned rat muscle fibres (Nielsen et al, 2009), isolated human SR vesicles 
(Ørtenblad et al, 2011) and intact mouse muscle fibres (Nielsen et al, 2014).  
Therefore, INTRA glycogen likely plays a key role in energy provision for 
muscle contraction. The proposed relationship between INTRA glycogen and 
SR Ca2+ release may help explain why INTRA glycogen use was greatest in 
the vastus lateralis during the 8x800m trial.  This is because the high intensity 
nature of the 8x800m trial (compared to the 10-mile trial) requires recruitment 
of a greater total muscle mass in the legs, which would in-turn require greater 
rates of SR Ca2+ release to support the high frequency of muscle contraction. 
Together with previous literature, these results suggest that the preferential 
utilisation of INTRA glycogen could be key to understanding the glycogen-
dependent influence on muscle fatigue and performance.  
 
 
IMF and SS glycogen were also decreased in response to exercise, although 
this wasn’t fibre type or muscle-specific and was similar between the exercise 
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trials. Specifically, exercise reduced SS glycogen in both type I (-27%) and type 
II fibres (-20%), and although exercise also reduced IMF glycogen, this tended 
to be greater in type I (-17%) compared to type II fibres (-7%). Previous 
research has also observed utilisation of SS and IMF glycogen in response to 
30km cross-country running (Sjostrom et al, 1982a). The reduction in IMF, and 
particularly SS glycogen, might be related to the concept of glycogen sparing, 
such that utilisation of these two pools of glycogen increases endurance 
capacity potentially by sparing INTRA glycogen in order to maintain muscle 
contraction capabilities, due to the proposed relationship between INTRA 
glycogen and SR Ca2+ release (Nielsen et al, 2009; Ørtenblad et al, 2011; 
Nielsen et al, 2014). In support, Jensen et al, (2020) recently showed that that 
INTRA glycogen is the best predictor of time to exhaustion, but that SS 
glycogen was also reduced during exercise. As noted earlier, SS glycogen may 
contribute energy to support Na+-K+ pump activity at the sarcolemma (Nielsen 
& Ørtenblad, 2013), and in this way spare the utilisation of INTRA glycogen 
which is also proposed to provide energy for the activity of the Na+-K+ pump 
(Ørtenblad et al, 2015). Furthermore, the IMF glycogen pool may act as a 
reserve that can be utilised as fuel for Ca2+ re-uptake into the sarcoplasmic 
reticulum, thereby allowing muscle contraction to continue.  Identifying the role 
of the IMF glycogen pool should be a focus of future work.  Taken together with 
our results, these observations suggest that INTRA glycogen is preferentially 








Subcellular lipid utilisation during exercise 
 
 
Overall, lipid utilisation was apparent in both exercise trials, with a 51% 
reduction in LD volume fraction following the 10-mile trial and a smaller 
reduction of 22% following the 8x800m trial. In the 10-mile trial, this was 
specifically from the IMF region in type I fibres, although there also tended to 
be a reduction in IMF LD volume fraction in type II fibres. In the SS region, there 
was no significant reductions in LD volume fraction in response to exercise. 
This supports the concept of there being a compartmentalised energy demand 
for lipid utilisation in skeletal muscle.  Given the spatial arrangement of LD in 
close proximity to the mitochondria (Hoppeler et al, 1985), and that IMF 
mitochondria supports ATP production for the contracting myofibrils (Hood, 
2001), this would explain the preferential use of IMF lipid during exercise. Our 
results are in agreement with data in elite cross country skiers who completed 
a field-based competitive time trial and showed reductions in IMF lipid (Koh et 
al, 2017), and also results from young subjects who completed a 1 h moderate-
intensity cycling bout, which augmented a 40% reduction in IMF lipid with no 
change in SS lipid (Chee et al, 2016). Thus, it would seem that regardless of 
training status, there is a preferential utilisation of IMF lipid during exercise. 
Though, Chee et al, (2016) also found that older lean active and older 
overweight inactive individuals did not display any change in IMF lipid with 
exercise. Therefore, in populations that would elicit a decrease in IMTG content 
during exercise (Van Loon & Goodpaster, 2006), it is typically due to reductions 




The utilisation of IMF lipid in type I fibres during the 10-mile trial can be 
attributed to reductions in LD size. This finding opposes earlier research 
attributing reductions in IMF lipid to reductions in LD number in elite cross-
country skiers completing a 1 h high-intensity time trial (Koh et al, 2017). We 
did, however, observe a tendency for IMF LD number to be reduced in the 
8x800m trial. Taken together, these data suggest that exercise that is of a 
higher intensity (8x800m trial in the present study, and 1 h cross-country skiing 
time trial in Koh et al, 2017) may specifically result in a reduction in LD number, 
whereas moderate-intensity exercise (10-mile trial) may induce reductions in 
LD size. During the 10 mile trial, which was longer in duration, the continuous 
state of LD turnover as FA entering the muscle alongside FA utilisation may 
explain why LD number was not decreased in response to exercise, as the 
utilised LD are replaced with newly-formed LD. However, when considering the 
reduction in LD number that is present following the 8x800m trial, it is well-
established that exercise training augments protein content of PLIN2, PLIN3 
and PLIN5 (Shaw et al, 2012; Shepherd et al, 2013), and LD with PLIN2 or 
PLIN5 associated are preferentially utilised during exercise (Shepherd et al, 
2012; 2013). PLIN are able to relocate from the cytosol to the LD (Gemmink et 
al, 2016), and potentially between LDs (Shepherd et al, 2017).  During higher 
intensity exercise (i.e. 8x800m trial) when metabolic demand is high, it could be 
speculated that from an efficiency perspective the movement of PLIN3 and 
PLIN5 would be limited; that is, these proteins may locate to a LD and remain 
in situ at that LD until all IMTG contained within that LD has been broken down. 
If this is true, this would explain the decrease in LD number observed during 
the 8x800m trial.   
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When specifically examining LD volume fraction in the SS region, there were 
no significant reductions in response to exercise. However, we did observe a 
decrease in SS LD number. Whilst changes in LD size were not apparent, there 
were small (albeit non-significant) increases in LD size in both type I (6%) and 
type II (3%) fibres. These opposing changes in SS LD size and number may 
explain why there was no reduction in overall SS LD volume fraction.  It was 
notable though that the reduction in SS LD number was observed in both 
muscles and during both trials, and in fact, Koh et al. (2017) also reported a 
decrease in SS LD number in the absence of a reduction in SS LD volume 
fraction.  Thus, exercise-induced decreases in LD number appear to be a 
consistent finding, although the importance of this is yet to be determined.  It is 
possible that the close proximity of SS LD to nuclei means that this pool of LDs 
supports nuclear processes.  For example, it is known that IMTG-derived fatty 
acids can act as ligands to support transcriptional processes, thereby 
supporting the adaptive response to exercise (Seibert et al, 2020).  To reconcile 
the lack of a change in overall SS LD volume fraction, it could be speculated 
that FA coming into the muscle during exercise may subsequently be directed 
to pre-existing SS LD, thereby resulting in small increases in LD size.  Future 
work should aim to identify the roles that each LD pool play in cell function.  
 
 
Implications for lipid and glycogen use during exercise 
 
 
We previously reported that whole muscle glycogen utilisation, as assessed by 
biochemical assay, was greater during the 10-mile trial compared to the 
8x800m trial, and that glycogen utilisation was greater in the gastrocnemius 
compared to the vastus lateralis (Impey et al, 2020).  In contrast to these 
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observations, using TEM the present study found that glycogen utilisation 
during exercise was not different between the two trials or the two muscles. The 
advantage of TEM though is the ability to investigate glycogen at the fibre type 
and subcellular specific level. Consequently, we found that glycogen utilisation 
tended to be greater in type I compared to type II fibres during the 10-mile trial, 
whereas glycogen utilisation was similar in type I and type II fibres in the 
8x800m trial.  Further to this, we now provide unique insight into how the 
different subcellular pools of glycogen are used depending on exercise 
intensity.  Both IMF and SS glycogen were similarly reduced in the 
gastrocnemius and vastus lateralis following both trials.  Furthermore, INTRA 
glycogen was reduced to a similar degree following both trials in the 
gastrocnemius, but the reduction in INTRA glycogen was greater in the 8x800m 
trial compared to the 10-mile trial in the vastus lateralis.  Thus, greater use of 
the INTRA glycogen pool appears to be required to meet the elevated metabolic 
demand during high intensity exercise. 
 
Total LD volume fraction was similar before exercise between trials and across 
both muscles.  However, post-exercise LD volume fraction was lower following 
the 10-mile trial when compared to the 8x800m trial. This suggests that the 
oxidation of FA derived from IMTG stored in LD made a larger contribution to 
overall energy expenditure in the 10-mile trial, which is is in line with the 
classical literature demonstrating that IMTG utilisation is greatest during 
moderate-intensity exercise (Van Loon et al, 2001; Romijn et al, 1993). 
Furthermore, the decrease in lipid was entirely due to a reduction in the IMF LD 
pool, which occurred predominantly in type I fibres during the 10-mile trial.  
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There was a tendency for IMF LD volume fraction to be reduced following the 
8x800m trial, suggesting that IMTG may also partly contribute to energy 
provision during higher intensity exercise (although the magnitude of the 
decrease was smaller than that for the 10-mile trial). Taken together, it appears 
that INTRA glycogen was a key substrate during the 8x800m trial, which aligns 
with previous research demonstrating INTRA glycogen to be the best predictor 
of time to exhaustion (Jensen et al, 2020).  In contrast, the lower exercise 
intensity of the 10-mile trial means that more energy can be derived from IMTG 
located in IMF LDs.   
 
When comparing muscles, we did not see any differences in total glycogen or 
lipid utilisation between muscles in either the 10-mile or 8x800m trial. Nielsen 
et al. (2011) and Koh et al. (2017) did observe differences in the utilisation of 
glycogen and lipid, respectively, between muscles from different limbs (triceps 
brachii vs. vastus lateralis) during a cross-country skiing time trial.  Glycogen 
utilisation occurred in type I and type II fibres in the triceps brachii, but only in 
type I fibres in the vastus lateralis (Nielsen et al, 2011).  Lipid utilisation was 
specific to the triceps brachii, with no reduction in LD volume fraction observed 
in the vastus lateralis (Koh et al, 2017). We examined two muscles from the 
same limb, both of which are highly activated in running regardless of exercise 
intensity, and despite differences in the overall size of the muscles we were 
investigating, there is evidence demonstrating that both muscles have a 
relatively similar distribution of fast and slow twitch muscle fibres (Johnson et 
al, 1973; Staron et al, 2000). Thus, similarities in fibre type distribution and 
overall activation when running could provide an explanation for why we did not 
133 
 
observe any differences in total muscle glycogen or lipid utilisation between 
muscles.  
 
The present study provides a unique insight into substrate utilisation under 
field-based conditions using TEM.  Importantly, the CEest values (as seen in 
Table 4.2) are similar to those reported in other studies (Nielsen et al, 2010; 
2011; Koh et al, 2017; 2018), thereby demonstrating the validity of the data in 
the present study and the conclusions drawn herein. However, field-based data 
collection does have its limitations, i.e. not being able to control variables such 
as weather conditions altering pace and RPE. Further to this, individual 
differences in running style i.e. forefoot vs. heel-strike runners and muscle 
length may be factors to consider in future research, in order to assess if these 
factors may alter the activation of the vastus lateralis and gastrocnemius, and 
therefore influence muscle-specific substrate utilisation.  
 
In conclusion, the present study highlights the interaction between muscle fibre 
type, relative exercise intensity and training duration in modulating the 
subcellular specific-glycogen and lipid requirement with specific exercise 
protocols. This research provides a unique insight into subcellular substrate 
utilisation in field-based habitual training sessions, being the first to investigate 
on a subcellular-basis using TEM in running and allowing us to identify a 
preferential use of INTRA glycogen during exercise, independent of intensity. 
Furthermore, lipid utilisation occurs primarily in the IMF region of type I fibres, 
but changes in LD morphology maybe related to exercise intensity and 
duration. The pattern of glycogen and lipid utilisation here, specific to the 
training status of the participants and exercise intensities compared, may aid 
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practical guidelines in relation to fuelling strategies to promote training intensity 
and metabolic adaptations by providing field-based data to add to the 





















































Chapter 5 – Quantification of exercise-induced 
changes in IMTG content and lipid droplet 
morphology on a fibre type and subcellular 



























5.1 Abstract  
 
Until recently, the role of intramuscular triglyceride (IMTG) as a substrate during 
exercise was controversial due to discrepancies in the literature stemming from 
methodological differences. Now, Transmission Electron Microscopy (TEM) 
has shown that exercise reduces IMTG content and alters lipid droplet (LD) 
morphology in a fibre type and subcellular-specific manner.  
Immunofluorescence microscopy may provide an alternative, more cost-
effective method to measure exercise-induced changes in IMTG content. The 
aim of this study was to evaluate immunofluorescence microscopy as a suitable 
method to measure IMTG utilisation and changes in LD morphology on a fibre 
and subcellular-specific basis during a field-based competitive scenario, and 
evaluate the agreement with TEM. Ten elite male cross-country skiers 
completed a ~20km (~1h) cross-country skiing time trial with muscle biopsies 
collected pre and post-exercise from both the arm (triceps brachii) and leg 
(vastus lateralis). Across both muscles, IMTG content tended to reduce in both 
type I (-28%) and type IIa (-50%, P = 0.071). In both fibre types there was a 
tendency for IMTG content to be reduced more in the peripheral region (-40%) 
compared to the central region (-36%; P = 0.080). This was due to both 
reductions in LD size (P = 0.004) and number (P = 0.064); specifically, 
reductions in the number of moderately size LD, 400 and 600 nm2 (P < 0.05).  
There were significant correlations between immunofluorescence microscopy 
and TEM methods when examining IMTG content, but not LD size or number, 
likely due to greater magnification and resolution capabilities of TEM. In 
conclusion, ~1 hour of cross-country skiing in a real-world environment reduced 
IMTG content in both type I and type IIa fibres, and in both subcellular regions, 
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which was due to a reduction in both LD size and number. In the first 
comparison between TEM and immunofluorescence, we demonstrated 
immunofluorescence provides an alternative method to quantify IMTG content 
but not LD size and LD number. Therefore, these data have important 
implications for future studies aiming to understand the mechanisms regulating 
LD pools. As such, immunofluorescence microscopy analysis should be 
considered when the aim is to understand the mechanisms regulating the 
utilisation of specific subcellular LD pools, such as investigations examining the 


















5.2 Introduction  
 
Fat is predominantly stored as triacylglycerol (TG) in white adipose tissue, and 
to a lesser extent in skeletal muscle as intramuscular triglycerides (IMTG). 
During moderate-intensity exercise in healthy individuals, the rate of whole-
body fat oxidation is increased ~10-fold (Van Loon et al, 2001), and stable 
isotope tracer studies estimate that ~50% of oxidised fatty acids are derived 
from IMTG (Havel et al, 1967; Oscai et al, 1990; Frayn et al, 1996; Helge et al, 
2001). However, studies that have sampled skeletal muscle tissue before and 
after exercise to investigate net changes in IMTG have produced equivocal 
findings with some reported a decrease (Bergstrom, Hultman & Saltin, 1973; 
Carlson, Ekelund & Froberg, 1971; Cleroux et al, 1989; Essen-Gustavsson & 
Tesch, 1990; Froberg et al 1971; Hurley et al, 1986; Phillips et al, 1996), and 
other reporting no change in IMTG (Bergman et al, 1999; Guo et al, 2000; Kiens 
et al, 1993; Kiens et al, 1998; Starling et al, 1997; Wendling et al, 1996).  
Measuring IMTG concentrations through biochemical extraction of TG is 
problematic, since any extramyocellular lipid that is present in a sample will 
interfere with the measurement of IMTG (Guo, 2001; Watt et al, 2002; Wendling 
et al, 1996).  To address this, studies employed immunohistochemical staining 
of muscle cross-sections with a lipid dye (e.g. oil red O), which permits 
exclusion of extramyocellular lipids from IMTG in the quantification process. 
Combining oil red O staining with an antibody targeting slow myosin heavy 
chain type I, led to the finding that IMTG content was reduced specifically in 
type I compared to type II fibres following 2 h of moderate-intensity exercise 
(Van Loon et al, 2003).  Although a number of studies have since replicated 
this observation (Van Proeyen et al, 2011; Shepherd et al, 2013), to the best of 
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our knowledge, none have made the distinction between type IIa and IIx fibres.  
This is important, because type IIa fibres are reported to have a similar oxidative 
capacity to type I fibres, at least in highly-trained individuals (Boushel et al, 
2014; Ørtenblad et al, 2018).  
 
Transmission electron microscopy (TEM) can also be used to examine IMTG-
containing LD, and this method has revealed that two pools of LDs exist in 
muscle: 1) subsarcolemmal (SS) LDs, located just beneath the plasma 
membrane, and 2) intermyofibrillar (IMF) LDs, located between the myofibrils 
(Nielsen et al, 2010a).  This finding was made possible by virtue of the greater 
magnification capabilities of TEM, which also permits the most accurate 
measures of LD morphology (size and number).  Using TEM, it has been shown 
that IMF, but not SS LDs were reduced following 1 h of moderate-intensity 
exercise in lean, healthy individuals (Chee et al, 2016).  Thus, TEM could be 
considered the gold standard method to investigate subcellular-specific 
changes in LD content and morphology in response to exercise. However, TEM 
relies on morphological factors such as mitochondria and Z-line band width 
within the skeletal muscle fibre to identify fibre type, cannot distinguish between 
type IIa and type IIx fibres, and analysis is only limited to a small number of 
fibres (~2-3 fibres per sample). Given these limitations, coupled with the 
relatively slow and technical nature of sample processing and imaging for TEM, 
it is important to determine whether immunofluorescence microscopy is also 
capable of detecting exercise-induced changes in LD content and LD 
morphology at the subcellular level, due to its ability to overcome such issues 




Cross-country skiing is considered one of the most challenging endurance 
sports due to the combined metabolic requirements of upper and lower body 
muscles. Events often also include varied terrain at moderate altitudes over 
different durations. The energy supply for cross-country skiing is primarily 
through the aerobic catabolism of CHO stores, thus resulting in an emphasised 
depletion of intracellular glycogen stores (Ørtenblad et al, 2011). However, 
using TEM it was recently shown that the IMF LD pool is preferentially used in 
the triceps brachii muscle during a ~1h cross-country skiing time trial in 
comparison to the vastus lateralis, which was attributed to a decrease in LD 
number rather than size (Koh et al, 2017).  Thus, IMTG also contributes to 
energy expenditure in highly trained athletes during relatively high intensity 
exercise (competitive time trial). Using immunofluorescence microscopy to also 
assess IMTG utilization in the same muscle samples as used by Koh et al. 
(2017) would enable a comparison to be made between the two methods.    
 
The primary aim of this study was to investigate IMTG utilisation on a fibre type 
and subcellular-specific basis during a field-based competitive scenario in elite 
cross-country skiers using immunofluorescence microscopy. The secondary 
aim was to evaluate the association and agreement between the two 
microscopy techniques; TEM and immunofluorescence microscopy, to 
compare, for the first time, the two methods for the investigation of fibre and 
region specific IMTG use during exercise. We hypothesise that a good level of 
agreement exisits between the two methods. If this hypothesis is true, 
immunofluorescence microscopy may be the preferred technique to investigate 
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Participants and ethical approval 
The muscle samples used for this study were part of a larger study to 
investigate subcellular-specific glycogen utilisation during exercise and the 
effect of carbohydrate availability on glycogen resynthesis (Nielsen et al, 2011) 
and the link to sarcoplasmic reticulum calcium handling (Ørtenblad et al. 2011). 
The original project was approved by the Regional Ethical Review Board in 
Umea ,̊ Sweden (no.07-076M). All participants gave informed consent to 
participate after being fully informed about the risks involved and any possible 
discomfort that could be caused. They could withdraw from the study at any 
time and the study conformed to the standards set out by the Declaration of 
Helsinki. 
 
Ten Norwegian elite male cross-country skiers volunteered to participate in the 
study, with a mean (± SD) age, weight, height and maximal oxygen uptake 
(VO2max) of 22 ± 1 years, 80 ± 9 kg, 182 ± 8 cm and 68 ± 5 ml.kg−1. min-1, 
respectively. Participants trained approximately 700 hours per year and had an 
average of 11 years experience competing and training in cross country skiing.  
 
Experimental procedures 
Prior to the day of the performance test, maximal heart rate (HR max) and VO2max 
were examined through an incremental exercise test using diagonal stride 
techniques on a modified treadmill allowing skiing uphill with roller skis (Calbet 
et al, 2005). On the day of the performance test skiers performed an 
individualised warm-up and ski preparation. The snow conditions on the day 
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favoured the diagonal stride technique and a high degree of double poling, i.e. 
upper body exercise. For the performance test, skiers were required to perform 
a ~20km cross-country skiing time trial. It took on average 57 min to complete 
(range 52-63 min). Muscle biopsies were obtained pre and post-exercise from 
both the arm (triceps brachii) and leg (vastus lateralis). The biopsies were taken 
by the same person to minimise variations in location and depth before (pre) 
and immediately (1-2 min) after exercise (post) when the skier had crossed the 
finish line. These muscles were selected as data has shown that they are highly 
active during cross-country skiing (Holmberg et al, 2005). One specimen of the 
muscle samples was fixed in glutaraldehyde for transmission electron 
microscopy (TEM) analysis, whereas another specimen was frozen directly in 
isopentane and stored for immunofluorescence microscopy (as outlined in 3.3).  
 
Image capture using immunofluorescence microscopy, image processing and 
data analysis  
 
Full details of the immunofluorescence staining procedures (3.2), including the 
antibody information (3.3.1), and the image capture process (3.4.2) are detailed 
in Chapter 3. A representative image including individual channels can be seen 
in Figure 5.1. 
Image processing was completed using Image-Pro Plus 5.1 software (Media 
Cybernetics, Rockville, MD, USA). IMTG content and LD morphology was 
investigated on a fibre type-specific basis. Fibres stained positive for MHC I 
were classified as type I fibres, and those stained positive for MHC IIa were 
classified as type IIa fibres. Any fibres with no staining were classified as type 
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IIx fibres. An intensity threshold was uniformly selected to represent a positive 
signal for IMTG and IMTG content expressed as the positively stained area 
fraction relative to the total area of each muscle fibre. The cell membrane 
staining enabled the calculation of individual cell areas. LD density was 
expressed as the number of LDs relative to area. Data on the area (size; μm2) 
of each individual LD were collected per image and used to calculate the 
frequency of LD’s over a range of sizes (100 nm) groups. The mean area of 
individual LD’s in an area of interest, such as the peripheral or central region, 
was also calculated. At pre-exercise 8  1 type I and 6  1 type IIa fibres were 
analysed per participant from n=5 arm and n=8 leg samples and at post 
exercise, 7  2 type I and 5  1 type IIa fibres were analysed per participant 
from n=4 arm and n=4 leg samples giving an overall total of ~ 300 fibres. Using 
the Image-Pro Plus software LD were identified as objects and their number 
and size was then measured. Using Image-Pro, the cells were split into two 
subcellular regions; the peripheral and central regions of the cell. 
Representative images of this process can be seen in Figure 5.2 and detailed 






















Figure 5.1. Immunofluorescence Confocal microscopy images.  
Images taken using an inverted confocal microscope (Zeiss LSM710; Carl Zeiss AG, Oberkochen, Germany) with a 63x 1.4 NA oil 
immersion objective with a 1.1x digital zoom. 
 
(a) Full image displaying all staining channels, (b) Cell membrane stained with Laminin displaying in pink, (c) BODIPY lipid stain in 
green, (d) MHCI staining in red and (e) MHCII staining in blue. Scale bar = 30 μm



















Figure 5.2. Image processing in order to measure IMTG content and LD 
morphology in the two subcellular regions. 
 
Region-specific image analysis. A grey scale image was created of both 
BODIPY staining (a) and the cell membrane stained using Laminin (b). A 2 μm 
region was identified within the inside of the membrane and used to visualise 
the LDs in the peripheral region (c) and central region was identified as the 
















Transmission Electron Microscopy 
Our collaborators at the University of Southern Denmark (Odense, Denmark) 
completed TEM analysis of the muscle samples as described in Koh et al. 
(2017). The raw data obtained through TEM was shared by the authors, thus 
enabling a direct comparison with the data generated through 
immunofluorescence microscopy. The TEM method is described in detail in 
Koh et al. (2017) and in chapter 3.6. Briefly, electron micrographs of 8-9 
longitudinally orientated muscle fibres were imaged per biopsy. Overall 80 
electron micrographs were obtained in a systematic random order per fibre at 
a magnification of x10,000. Based on the minimal electron micrographs 
required, the 80 micrographs collected were made up of 40 from the 
subsarcolemmal region, 20 from the superficial region and 20 from the central 
region of the myofibrillar space. Exercise-induced changes in subcellular-
specific LD volume fraction, LD size and LD number were calculated as 
described in chapter 3.6.3. 
 
Statistics 
Statistical analyses were performed using SPSS (SPSS; version 26, IBM, 
USA). A three-factor within-subjects repeated measures ANOVA was used to 
examine IMTG content, LD number and LD size in relation to the effect of time, 
fibre type and subcellular region. Linear mixed modelling was used to examine 
the frequency and changes of LD’s of specific sizes ranging from 100 to 1000 
nm2. Significant main effects and interactions were assessed using Bonferroni 
adjustment post hoc analysis.  Pearson correlation coefficients were calculated 
to investigate the correlation between the two methods in terms of the absolute 
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values.  Alongside this, Lin’s concordance coefficient test (LCC; Lin, 1989) was 
performed, which defines the level of agreement between two variables relative 
to a line through the origin at an angle of 45 degrees (slope = 1). Thus, this 
analysis was performed using relative data; individual values were related to 
one particular subject who had the median values for IMTG content in type I 
fibres using immunofluorescence microscopy.  LCC (Rc) has a scale between 
0 and 1 where 0.21 – 0.40 denotes fair concordance, 0.41 – 0.60 moderate 
concordance, 0.61 – 0.80 substantial concordance and finally 0.81 – 1.00 would 
show almost perfect concordance (Lin 1989). Data is presented as mean ± SD. 


































Following the immunofluorescence staining and imaging procedures it became 
apparent that there was a limited number of viable samples due to frost damage 
which could be included for analysis.  Thus, the viable arm and leg samples 
were pooled, and as a result the pre-exercise dataset sample size was n=13 
(n=5 arm, n=8 leg), whereas the post-exercise dataset had a sample size of 
n=8 (n=4 arm, n=4 leg). 
 
 
Using immunofluorescence microscopy to investigate resting IMTG content, 
distribution and LD morphology  
   
IMTG content (expressed as % area stained, Table 5.1) was 19% greater pre-
exercise in type I fibres in comparison to type IIa fibres (P = 0.049). However, 
there was no difference in IMTG content in the central region of the cell in 
comparison to the peripheral region (P = 0.144). Fibre had no significant effect 
on the relative distribution of IMTG content at rest in the peripheral region and 
central region, with ~12% and ~88% of total IMTG content, respectively (P = 
0.173).  Only one or two type IIx fibres were observed per muscle section for 
each participant, and therefore were not included in the analysis for IMTG 
content and LD morphology.  
 
With regards to LD morphology, LD number pre-exercise the peripheral region 
contained 13% more LDs than the central region (Table 5.1, P = 0.003) 
regardless of fibre type. On average, LD in the peripheral region were smaller 
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than those in the central region (P = 0.027). However, mean LD size was not 
different between type I and type IIa fibres (Table 5.1, P = 0.156).  Thus, the 
greater IMTG content in type I fibres was predominantly attributed to a higher 
number of LDs.  We further investigated the difference in LD size between 
subcellular regions across both type I and type IIa fibres by assessing the 
frequency of LD detected over a range of LD sizes from 100 – 1400 nm2. Across 
both fibre types, there was a greater frequency of LD ≤100 nm2 in the central 
compared to the peripheral region (P < 0.01), but conversely there was a 
greater frequency of LD 200 nm2 in size in the peripheral region compared to 


















Table 5.1. IMTG content, LD number and size before exercise.  
 
 
 Type I Type IIa 
IMTG content (% area stained)   
Peripheral 0.434  0.252 * 0.347  0.242 
Central 3.774  2.082 * 2.974  2.206 
LD number (LD.µm-2)   
Peripheral 0.014  0.006 † 0.011  0.006 † 
Central 0.010  0.045 0.093  0.057 
LD size (µm2)   
Peripheral 0.281  0.072 † 0.269  0.064 † 
Central 0.313  0.079 0.285  0.069 
 
 
Values reported as mean ± SD. *P = 0.049 Significantly different from type IIa 



















































Figure 5.3. LD frequency in type I and type II fibres before exercise.  
 
Difference in LD size and number between the two regions by determining the 
frequency of LDs detected in each region over a range of LD sizes in type I (a) 
and type IIa fibres (b). * P < 0.01 LD in the central region to be greater than in 
the peripheral, ** P < 0.05 LD in the peripheral region greater than in the central. 
































































































Using immunofluorescence microscopy to investigate exercise-induced 
changes in IMTG content, distribution and LD morphology  
 
Exercise tended to reduce IMTG content (Figure 5.4a, P = 0.071), although this 
was not fibre type-specific, with IMTG content being reduced by 28% and 50% 
in type I and type IIa fibres, respectively. Moreover, across both fibres there 
was a tendency for IMTG content to be reduced more in the peripheral region 
(-40%) compared to the central region (-36%; P = 0.080). Across both fibre 
types, the relative distribution of IMTG content was not significantly affected by 
exercise, with ~12% and ~88% of total IMTG content in the peripheral region 
and central region, respectively (Table 5.2, P = 0.576). 
 
Exercise also tended to reduce LD number (Figure 5.4b, P = 0.064), regardless 
of fibre-type, with reductions of ~35% in both type I and type IIa fibres (P = 
0.004). Further to this, across both fibre types there was a greater reduction in 
the number of LD from the peripheral region where there are a greater number 
of smaller LD < 200 µm2 (- 35%, P = 0.028), than in the central region, where 
there is a tendency of a greater number of larger LD > 200 µm2 (- 33%, P = 
0.070, Figure 5.5).  
 
When considering LD size, there was a significant reduction in response to 
exercise, with LD’s shrinking by 14% from pre to post exercise (Figure 5.4c, P 
= 0.019). Although this was not fibre-specific, with reductions in LD size of 
~14% in both type I and type IIa fibres, respectively (P = 0.031). Exercise had 
no effect on LD size in relation to subcellular region (P = 0.112). When 
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examining the frequency of LD over a range of LD sizes we found that exercise 
caused a significant decrease in the number of LD sized 400 and 600 nm2 

























Table 5.2. Relative distribution of lipid across the peripheral and central 
regions.  
 
 Type I Type II 
Pre-exercise (%)   
Peripheral 11  2 12  4 
Central 89  2 88  4 
Post-exercise (%)   
Peripheral 13  7 13  9 
Central 87  7 87  9  
 
 
Values reported as mean ± SD. No significant differences observed following 






























































Figure 5.4. Exercise-induced changes in IMTG content, LD number and LD 
size. 
 
~ P < 0.1 tendency for IMTG content and LD number to reduce in response to 
exercise in both fibre types. # P < 0.05 greater reduction in IMTG content from 
the peripheral region. * P < 0.05 greater reduction in LD number from the 
peripheral region. ** P = 0.019 reduction in LD size across both fibre types and 
regions. Values are mean ± S.D. 
































































































Figure 5.5. Effect of exercise on LD frequency. 
 
The effect of exercise on the difference in LD size and number by determining 
the frequency of LDs detected at each time point (pre and post) over a range 
of LD sizes in both fibre types and regions. * P < 0.05 reductions in the number 



































































































































































































Correlations between immunofluorescence microscopy and transmission 
electron microscopy (TEM) data 
 
Because TEM and immunofluorescence microscopy can be considered as the 
gold standard for assessing subcellular LD pools (TEM) and fibre type-specific 
IMTG content (immunofluorescence microscopy), the two methods were 
compared across these factors.  Thus, for each variable (LD/IMTG content, LD 
size and number), the data generated using immunofluorescence microscopy 
was compared to that generated using TEM (as reported in Koh et al, 2017) 
using both Pearson’s correlation coefficients and LCC.  The Pearson 
correlation coefficients (r values), P values and LCC (Rc) are presented in Table 
5.3.  There was a significant correlation between methods for assessing 
subcellular-specific LD/IMTG content in both the peripheral/subsarcolemmal (P 
= 0.008, Figure 5.6a) and central/intermyofibrillar regions (P = 0.013, Figure 
5.6b). Interestingly though, there was only a substantial agreement between 
methods for LD/IMTG content in the peripheral/subsarcolemmal region when 
examined using LCC (Rc = 0.660).  When comparing fibre types, the correlation 
between the two datasets for LD/IMTG content was significant for type I fibres 
(P < 0.05, Figure 5.7a), though there was only a trend for a correlation when 
examining type IIa fibres (P = 0.085, Figure 5.7b). Consequently, there was a 
moderate level of agreement between the two methods for investigating 
LD/IMTG content in type I fibres when examined using LCC (Rc = 0.542).   
 
With regards to LD morphology, there was significant correlations between the 
two methods for investigating LD size in both the peripheral/subsarcolemmal 
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(P = 0.002, Figure 5.6e) and central/intermyofibrillar regions (P = 0.039, Figure 
5.6f). However, the level of agreement between methods for investigating LD 
size in both the peripheral/subsarcolemmal and central/intermyofibrillar region 
was poor (Table 5.3).  Regarding fibre type, there were significant correlations 
for LD size in both type I (P = 0.009, Figure 5.7e) and type IIa fibres (P = 0.015, 
Figure 5.7f). Although again, the LCC showed a poor level of agreement 
between methods for investigating LD size in both fibres (Table 5.3). LD number 
only tended to be correlated when examined in both the 
peripheral/subsarcolemmal (P = 0.078, Figure 5.6c) and central regions (P = 
0.075, Figure 5.6d). However, there was no correlation between methods for 
investigating LD number in either fibre type (Figure 5.7 c/d).  Moreover, the 
corresponding LCC values were very low for LD number, overall suggesting 
that the agreement between the two methods for examining LD size and 









Table 5.3. Correlation matrix comparing the agreement between TEM and immunofluorescence microscopy for determining IMTG 
content, LD number and size. 
 
Correlations are between corresponding variables generated through TEM and immunofluorescence microscopy for IMTG content, 
LD number and LD size. Significant correlations are denoted as * (P < 0.05).  
 
The Lin’s concordance coefficient (Rc) is also included. Lin’s scale is defined as: 0.21 – 0.40 fair concordance, 0.41 – 0.60 moderate 
concordance, 0.61 – 0.80 substantial concordance and finally 0.81 – 1.00 would show almost perfect concordance.  
 IMTG content LD number LD size 
 r P RC r P RC r P RC 
Muscle fibre          
Type I 0.710 <0.001* 0.542 - 0.058 0.751 0.237 0.610 0.009* 0.094 
Type II 0.320 0.085 0.236 - 0.225 0.251 0.019 0.536 0.015* 0.103 
Region          
Peripheral/Subsarcolemmal 0.474 0.008* 0.660 0.327 0.078 0.271 0.466 0.002* 0.105 






























Figure 5.6. Correlations between TEM and immunofluorescence microscopy by 
subcellular region for IMTG content (a/b), LD number (c/d) and LD size (e/f). 
 



































Figure 5.7. Correlations between TEM and immunofluorescence microscopy by 
fibre type for IMTG content (a/b), LD number (c/d) and LD size (e/f). 
 





5.5 Discussion  
 
The present study aimed to investigate fibre type and subcellular-specific IMTG 
utilisation during cross-country skiing using immunofluorescence microscopy, 
then to evaluate the agreement with TEM.  By making a direct comparison with 
TEM (the gold standard for assessing subcellular LD pools), the study also aimed 
to determine the suitability of immunofluorescence microscopy for investigating 
subcellular-specific IMTG utilisation during exercise. The first novel finding was 
that ~1 hour of cross-country skiing reduced IMTG content in both type I and type 
IIa fibres, and in both the peripheral and central region of the cell, due to a 
reduction in both LD size and number. Second, there was agreement between 
TEM and immunofluorescence microscopy when examining LD/IMTG content, 
particularly in type I fibres, although there was little agreement when examining 
LD size and number. 
 
At rest, IMTG content was greater in type I compared to type IIa fibres, which is 
in agreement with previous literature demonstrating greater IMTG content in type 
I muscle fibres than in type II fibres (Essen et al, 1975; Malenfant et al, 2001; Van 
Loon et al, 2003a, Van Loon et al, 2003b). IMTG content itself reflects the 
combination of measures of LD number and size, and therefore these LD 
characteristics can be examined in order to understand the differences in IMTG 
content, distribution and morphology.  To this end, LD number tended to be 
greater in type I compared to type IIa fibres, whereas there were no fibre type 
specific differences in LD size.  Therefore, the higher IMTG content in type I fibres 
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was mainly due to a greater number of LDs, which is consistent with previous 
observations (Devries et al, 2007; Prats et al, 2013; Koh et al, 2017).  
 
Despite the differences in IMTG content between type I and type IIa fibres, there 
was no difference in the relative IMTG content when comparing the peripheral 
and central regions of the cell.  This is in agreement with other work using TEM 
to investigate subcellular-specific LD content in highly-trained individuals (Koh et 
al., 2017).  When considering LD morphology though, we found that there was a 
greater number of LDs present in the peripheral compared to the central region, 
whereas LDs in the central region were, on average, larger than those in the 
peripheral region.  The observed region-specific differences in LD morphology 
are one of few reported in the literature (Strauss et al, 2020). Large 
subsarcolemmal LDs are associated with insulin resistance (Nielsen et al, 2017), 
and therefore maintaining a greater number of small LDs in the peripheral region 
is likely an adaptation enabling well-trained individuals to possess high IMTG 
stores while remaining highly insulin sensitive.  Although centrally-located LDs 
had a larger average size than those located in the peripheral region, we also 
found that the frequency of LDs 100 nm2 in size was greater in the central 
compared to the peripheral region.  Conversely, there was a greater frequency of 
LDs 200 nm2 in size in the peripheral compared to the central region.  Together, 
this suggests that considering the size of individual LDs is more informative than 
simply measuring average LD size. The general belief is that small LDs have a 
greater surface area for the interaction of lipolytic enzymes with the IMTG 
substrate and regulatory proteins located on the LD surface (Bickel et al, 2009; 
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Morales et al, 2017).  Consequently, the frequency of very small LDs we observed 
in the central region may be an adaptation underpinning the greater utilisation of 
IMF LDs during exercise reported in previous studies (Koh et al, 2017).  Taken 
together, the novel observations from the current study demonstrate that 
differences in LD morphology (number and size) can occur independent of 
differences in IMTG content.  
 
Approximately 1 h of cross-country skiing tended to reduce IMTG content in both 
type I and type IIa fibres. IMTG utilisation during exercise is most apparent during 
moderate-intensity exercise (Van Loon, 2004).  However, the intensity of the 
cross-country skiing time trial here was >75% VO2max (Ørtenblad et al, 2011), 
which characteristically relies more heavily on muscle glycogen as a substrate, 
with less reliance on IMTG (Van Loon et al, 2001). Further to this, it is important 
to note that in the companion study detailing the TEM findings, Koh et al (2017) 
only observed reductions in LD content in the triceps brachii, not the vastus 
lateralis. Since in the present study we used a combination of both arm and leg 
muscle samples, this may also explain why we only observed a trend for a 
reduction in IMTG content.  Typically, exercise-induced reductions in IMTG 
content are specific to type I fibres (Van Loon et al, 2003), but here we report a 
decrease in both type I and type IIa fibres. Whilst it has been reported that 
mitochondrial content of type II fibres is lower than type I fibres in highly-trained 
cross country skiers (Ørtenblad et al, 2018), when comparing between arm and 
leg muscles, there was greater mitochondria reported in the type II fibres of arm 
muscle than leg (Ørtenblad et al, 2018). Furthermore, the mitochondrial content 
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of those type II fibres is still greater than that reported in healthy untrained 
individuals (Nielsen et al, 2010).  Therefore, the high mitochondrial content of the 
type IIa fibres, in these individuals could explain the reduction in IMTG content in 
these fibres. On a subcellular level, the decrease in IMTG content occurred in 
both the peripheral and central regions of the fibres (both type I and type IIa), and 
on closer inspection there was a tendency for IMTG utilisation to be greater in the 
peripheral region. In highly-trained cross country skiers mitochondrial content in 
the arm and leg muscles in type I and type II fibres is similar between the SS and 
IMF regions (Ørtenblad et al, 2018), suggesting the capacity for FA oxidation is 
similar across both subcellular locations.  Combined with the smaller size of LDs 
in the peripheral region (and therefore a potentially greater surface area for 
enzyme and protein binding), this could explain the tendency towards greater use 
of IMTG from the peripheral region.  
 
The exercise-induced decrease in IMTG content can be attributed to reductions 
in both LD number and size. This is in agreement with previous research in 
trained individuals (Van Loon et al, 2003) and untrained individuals (Shepherd et 
al, 2012), whilst others only observe a decrease in LD number (Koh et al, 2017; 
Devries et al, 2007; Shepherd et al, 2013). Differences are likely due to different 
populations studied, duration and intensity of exercise protocol or a combination 
of both. In the present study, LD number was reduced in both fibre types following 
1 h of exhaustive exercise, predominantly in the peripheral region. Li et al, (2014), 
demonstrated the more dominant LD store; IMF (i.e. central region) is not as 
sensitive to training as the other regions. Koh et al, (2017), also reported 
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reductions in LD number in the SS region of the legs. This is in line with previous 
data from Devries et al, (2007) who demonstrated moderate intensity cycling 
decreased intramuscular lipid content alongside reductions in LD number.  An 
increase in IMTG content is a consequence of endurance training and can be 
attributed, in part, to an increase in LD number. This has been found in type I and 
type II fibres after an acute bout of moderate-intensity exercise following either a 
period of endurance or sprint interval training by Shepherd et al, (2013), though 
their data showed no reduction in LD size after either exercise protocol. Whereas, 
when we examined LD size, a decrease was observed in both type I and type IIa 
fibres within both peripheral and central regions. However, the research from 
Shepherd et al, (2013) was from sedentary males. Therefore, a potential 
explanation for these differences in results could be the subject population as 
lipid metabolism is considerably different between sedentary individuals and elite 
athletes (Bergman et al, 1985).  In brief, some differences caused by training 
status include enhanced endogenous substrate concentrations (Shaw et al, 
2010; Moro et al, 2007). As such, endurance training will increase IMTG content 
in type I fibres as much as three-fold compared with type II fibres. Further to this, 
regular endurance training will augment the ability to oxidise fat at higher 
workloads and overall, enhance maximal fat oxidation (Lima-Silva et al, 2010; 
Scharhag-Rosenberger et al, 2010). 
 
Further to our observations of overall reductions in LD size, we would speculate 
that the smaller LD’s would be targeted for utilisation first, as they are highly 
abundant in both the central and peripheral regions of the cell (Figure 5.5). 
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However, by examining differences in the frequency of specific LDs (based on 
size), it seems that more moderately sized LD of 400 and 600 nm2 were reduced 
from pre to post-exercise. A possible explanation for the smaller LDs not being 
preferentially targeted for breakdown could be that they are newly-formed or 
nascent LDs, and are therefore not yet labelled with the appropriate LD-
associated PLIN protein isoforms. Alternatively, it could be that the smaller LD 
(e.g. 100 and 200 nm2) were in fact targeted for breakdown during exercise, but 
that at the same time the moderately-sized LD of 400 and 600 nm2 were also 
reduced in size, and became LDs of 100 and 200 nm2 in size.  This would then 
explain why no reduction in smaller sized LD was observed. Irrespective of the 
pool of LDs that is used, it has been demonstrated that LD with PLIN2 or PLIN5 
attached appear to be preferentially utilised during exercise over those LD without 
these proteins (Shepherd et al, 2012; 2013).  Further studies are required to 
explore which particular-sized LDs have PLIN2 and/or PLIN5 located within their 
phospholipid monolayer meaning that they are targeted for breakdown during 
exercise. 
 
The data obtained using immunofluorescence microscopy was compared to LD-
related data obtained by Koh et al, (2017) using TEM in order to determine how 
appropriate immunofluorescence microscopy may be for measuring IMTG 
content and LD morphology on subcellular-specific basis.  Whilst there was 
correlation between methods for assessing LD/IMTG content in both subcellular 
regions, there was only a substantial agreement between methods for examining 
LD/IMTG content in the peripheral region.  The positive aspect of this finding is 
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that it supports the use of a 2 μm band to represent the peripheral region when 
using immunofluorescence microscopy. Of course, using this approach does not 
take into account natural variations in the width of the SS region which are visible 
when using TEM.  However, the relative proportion of IMTG found in the 
peripheral and central region of the cell as determined through 
immunofluorescence microscopy is similar to the relative distribution of LD 
reported in the SS and IMF regions using TEM (Koh et al, 2017).  TEM is 
considered the gold standard for examining LD morphology due to the greater 
magnification and resolution capabilities.  When examining LD size in both 
regions there was significant correlation between methods, however, there was 
only a trend for a correlation when examining LD number, and the LCC analysis 
revealed little agreement between methods for examining LD size and number. 
This likely due to differences in magnification capacity.  
 
Conclusions 
In conclusion, ~1 hour of cross-country skiing in a real-world environment 
reduced IMTG content in both type I and type IIa fibres, across both the peripheral 
and central regions of the muscle fibres due to a reduction in both LD size and 
number. Compared to TEM, immunofluorescence microscopy apparently 
provides a good approach to assess IMTG content, but not LD size and number.  
Moreover, agreement between methods was good for measuring IMTG content 
and LD size in the 2 μm peripheral region of the cell, thereby supporting the use 
of this approach to distinguish subcellular regions using immunofluorescence 
microscopy. Overall, immunofluorescence provides an alternative method to 
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quantify IMTG content, but not LD size and number. Therefore, these data have 
important implications for future studies aiming to understand the mechanisms 
regulating LD pools. As such, immunofluorescence microscopy analysis should 
be considered when the aim is to understand the mechanisms regulating the 
utilisation of specific subcellular LD pools, such as investigations examining the 
























Chapter 6 - Skeletal muscle lipid droplets are 
resynthesized before being coated with perilipin 
























The full version of this chapter is published in the American Journal of Physiology, 
Endocrinology & Metabolism, as stated below. 
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‘Skeletal muscle lipid droplets are resynthesized before being coated with 
perilipin proteins following prolonged exercise in elite male triathletes’, AJP 





Intramuscular triglycerides (IMTG) are a key substrate during prolonged exercise, 
but little is known about the rate of IMTG resynthesis in the post-exercise period. 
We investigated the hypothesis that the distribution of the lipid droplet (LD)-
associated perilipin (PLIN) proteins is linked to IMTG storage following exercise.  
14 elite male triathletes (271 y, 66.51.3 mL.kg-1.min-1) completed 4 h of 
moderate-intensity cycling.  During the first 4 h of recovery, subjects received 
either CHO or H2O, after which both groups received CHO.  Muscle biopsies 
collected pre and post-exercise, and 4 h and 24 h post-exercise were analysed 
using confocal immunofluorescence microscopy for fibre type-specific IMTG 
content and PLIN distribution with LDs.  Exercise reduced IMTG content in type 
I fibres (-53%, P=0.002), with no change in type IIa fibres. During the first 4 h of 
recovery, IMTG content increased in type I fibres (P=0.014), but was not 
increased further after 24 h where it was similar to baseline levels in both 
conditions. During recovery the number of LDs labelled with PLIN2 (70%), PLIN3 
(63%) and PLIN5 (62%; all P<0.05) all increased in type I fibres.  Importantly, the 
increase in LDs labelled with PLIN proteins only occurred at 24 h post-exercise. 
In conclusion, IMTG resynthesis occurs rapidly in type I fibres following prolonged 
exercise in highly-trained individuals. Further, increases in IMTG content 
following exercise preceded an increase in the number of LDs labelled with PLIN 
proteins. These data, therefore, suggest that the PLIN proteins do not play a key 




6.2 Introduction  
 
The location of intramuscular triglyceride (IMTG)-containing lipid droplets (LD) in 
close proximity to mitochondria underpins the importance of IMTG as a fuel 
source during prolonged moderate-intensity exercise in trained individuals, 
particularly in type I muscle fibres (Van Loon et al, 2003). Indeed, many studies 
report a decrease in IMTG content during exercise (Van Loon, 2004; Kiens, 
2006), but to date there has been much less focus on post-exercise IMTG 
resynthesis. This is in contrast to the large body of research that has focused on 
glycogen use during exercise and dietary strategies to optimise glycogen 
repletion following exercise (Burke et al, 2011).  High carbohydrate (CHO) diets, 
however, are reciprocally low in fat (typically 2-25% of total energy intake) and 
markedly reduce IMTG storage (Starling et al, 1997; Coyle et al, 2001; Johnson 
et al, 2003).  Indeed, post-exercise IMTG resynthesis is suppressed up to 48 h 
following 3 h moderate-intensity cycling when consuming a high CHO diet 
(containing 24% fat) (Van Loon et al, 2003).  More recently though, post-exercise 
nutritional strategies have shifted towards CHO- or calorie-restriction in an 
attempt to augment specific training adaptations in human skeletal muscle. In this 
respect, limiting CHO or energy intake following glycogen-depleting exercise has 
been shown to enhance the activation of intracellular signalling pathways 
compatible with mitochondrial biogenesis (reviewed by Impey et al, 2018). 
Typically, in these studies CHO or energy provision is limited throughout exercise 
as well as during the first few hours following exercise, after which habitual energy 
and macronutrient intake are resumed.  As mentioned above, high CHO diet’s 
can suppress IMTG resynthesis for up to 48 h (Van Loon et al, 2003), but whether 
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nutritional strategies restricting CHO or energy provision post-exercise, designed 
to augment skeletal muscle training adaptations, can enhance post-exercise 
IMTG resynthesis, is yet to be investigated. 
 
Given the paucity of studies investigating post-exercise IMTG resynthesis, it is 
unsurprising that the mechanisms governing the synthetic response are poorly 
understood.  In skeletal muscle, cytosolic LDs provide a storage depot for IMTG, 
and given their large proteome (>300 proteins) (Zhang et al, 2011) these LDs are 
now considered a highly active organelle.  The perilipin (PLIN) proteins are the 
most abundant of the LD proteins in skeletal muscle, and are more highly 
expressed in type I compared to type II muscle fibres thereby mirroring the fibre-
specific distribution of IMTG (Shaw et al, 2009, 2012; Shepherd et al, 2012, 
2013).  Moreover, exercise training typically augments both the protein levels of 
PLIN2, PLIN3 and PLIN5 alongside elevations in IMTG content (Shaw et al, 2012; 
Shepherd et al, 2013), implying that the increase in PLIN protein content is 
mechanistically important to facilitate growth of the IMTG pool.  This assertion is 
supported by the observation that muscle-specific PLIN2 (Bosma et al, 2012) or 
PLIN5 overexpression (Bosma et al, 2013) in rodents fed a high-fat diet promotes 
IMTG storage, which may be linked to an ability of the PLIN proteins to restrict 
basal lipolytic rates (Laurens et al, 2016).  Recently, Gemmink et al. (2016) 
reported that IMTG storage augmented by prolonged fasting in healthy 
individuals coincided with an increase in the size and number of LDs containing 
PLIN5.  Because no changes occurred in the protein level of PLIN5, these data 
suggest that a redistribution of the pre-existing PLIN5 pool occurs when the LD 
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pool expands.  We recently corroborated this finding using an acute lipid infusion 
to stimulate IMTG accretion, and demonstrated that a redistribution of PLIN3, as 
well as PLIN5, also occurs across a growing LD pool (Shepherd et al, 2017).  
Whilst the use of both prolonged fasting and lipid infusion has provided insight 
into the potential role of the PLIN proteins in supporting IMTG storage, these 
experimental models do not represent the normal physiological milieu; that is, 
they expose the muscle to excess free fatty acid concentrations and stimulate 
IMTG accretion starting from a ‘resting’ level.  This physiological state, therefore, 
is distinct from one in which trained individuals regularly use (and reduce the size 
of) the IMTG pool during exercise and subsequently resynthesize IMTG in the 
post-exercise period.  Investigating the PLIN proteins under more physiologically 
dynamic conditions may therefore provide additional insight into their role in 
skeletal muscle. 
 
In addition to the possible mediation of IMTG storage, the PLIN proteins are 
suggested to be important in mediating the breakdown and oxidation of IMTG.  
We have previously shown that LDs containing either PLIN2 (Shepherd et al, 
2012) or PLIN5 (Shepherd et al, 2013) are preferentially used during 1 h of 
moderate-intensity exercise, and recently reported that HSL targets LDs 
containing PLIN5 for breakdown during exercise (Whytock et al, 2018). PLIN3 is 
associated with fat oxidation in cultured muscle cells (Covington et al, 2015), but 
whether PLIN3 plays a role in the breakdown and oxidation of IMTG in vivo is not 
known.  Therefore, we asked the question whether PLIN3-containing LDs are 
also preferentially targeted for breakdown during exercise. 
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CHO consumption post-exercise will increase circulating insulin concentrations 
which will in turn inhibit systemic lipolysis and reduce plasma free FA 
concentrations.  If no energy is consumed, insulin concentrations will remain low 
and plasma free FA concentrations will be high, thus providing a source of FA to 
be used to rebuild IMTG stores. In this context, we first aimed to investigate the 
hypothesis that post-exercise IMTG resynthesis would be accelerated under 
conditions of acute CHO restriction in elite endurance athletes. To achieve this, 
CHO ingestion was restricted during the initial 4 h recovery period following 
prolonged moderate-intensity exercise. By assessing changes in IMTG content 
in response to exercise and up to 24 h post-exercise, this provided a physiological 
model to further clarify the roles of the PLIN proteins in mediating IMTG utilisation 
and storage.  In this respect, we hypothesised that during exercise there would 
be a preference to use LDs labelled with PLIN proteins, and during recovery from 
prolonged exercise there would be a preferential increase in LDs labelled with 
PLIN proteins. Consequently, the secondary aim of this study was to investigate 
changes in the distribution of PLIN proteins relative to LDs during exercise and 
in the post-exercise period using our previously described immunofluorescence 
microscopy methodology (Shepherd et al, 2017).  Finally, because IMTG 
utilisation during exercise is specific to the IMF region of the fibre (Koh et al, 
2017), we determined changes in IMTG content and the PLIN LD distribution on 








Fourteen elite male triathletes (27.2  0.9 y, 183  2 cm, 75.3  1.4 kg) that had 
competed at national and/or international level were recruited as part of a larger 
study (Gejl et al, 2014). Participants had been elite athletes for 4.8  1.4  y and 
trained on average 16.4  0.9 hours a week. There were no differences between 
experimental groups, other than VO2max where the participants in the CHO 
condition had a significantly higher VO2max (CHO: 68.3  1.4 mL.kg-1.min-1, H2O: 
63.5  1.8 mL.kg-1.min-1, P < 0.05). All participants were fully informed of any risks 
associated with the study before providing informed verbal and written consent. 
Ethical approval was approved by the ethics committee of the Region of Southern 
Denmark (Project ID: S-20090140) and was conducted according to the 
Declaration of Helsinki.  
 
Experimental procedures 
All experimental procedures have been described previously (Gejl et al, 2014; 
Jensen et al, 2015).  Briefly, participants completed 4 h of cycling at an average 
of 73% ± 1% HRmax equating to ~56% of VO2max (determined via pre-experimental 
submaximal incremental test and VO2max test) with an intended HR intensity of 
~75% HRmax. Subjects were provided a standardised breakfast (see “Dietary 
Procedures” below) 90 min before completing the cycle in which they used 
personal equipment of their choice (i.e. bike, shoes and pedals) on mounted turbo 
trainers (Elite Crono Mag ElastoGel Trainer, Fontaniva, Italy). During exercise 
participants were only allowed to consume water (minimum of 1 mL water.kg-1.h-
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1). Following exercise, participants were randomly selected to receive either CHO 
(n = 7) or H2O (n = 7) during the first 4 h of recovery. For the remaining 20 h 
period following exercise all participants consumed a CHO-rich diet. Muscle 
biopsies were collected from participants from the m. vastus lateralis before and 
after exercise, as well as at 4 h and 24 h post-exercise, under local anaesthetic 
(1% lidocaine; Amgros, Copenhagen, Denmark) using a Bergstrom needle 
(Bergstrom, 1975) with suction as discussed in section 3.1. All procedures were 
conducted in laboratories at the Department of Sports Science and Clinical 
Biomechanics, University of Southern Denmark, Odense.  
 
Dietary procedures 
The dietary intake was controlled and corresponded to recommendations 
provided by the American College of Sport Medicine. A breakfast was provided 
90 min prior to exercise and consisted of CHO rich foods (i.e. porridge oats, 
raisins, skimmed milk, orange juice and energy bar; 82 kJ.kg-1 bw). All calorie 
intake was calculated based upon the participant’s body mass and equated to 
65% CHO, 25% fat and 10% protein. During the initial 2 h recovery period 
following exercise, the CHO group consumed a meal consisting of pasta, chicken, 
vegetables and a CHO beverage (1.07 g CHO.kg-1 bw.h-1). and subsequently 
participants were provided with an energy bar and CHO beverage (1.05 g 
CHO.kg-1 bw.h-1) in the following 2 h. During this 4 h period, the H2O group 
remained fasted and only consumed water. After the initial 4 h recovery period, 
both groups received the same standardised meals for the remaining 20 h of 
recovery. In addition, the H2O group received energy corresponding to that of the 
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CHO group during the 4 h recovery period to ensure that the total energy intake 
between groups was equal. Thus, the CHO group received dinner and breakfast 
whereas the H2O group received lunch, an energy bar, dinner and breakfast. In 
total, subjects received 264 kJ.kg-1 bw (10 g CHO.kg-1 bw) on the first 
experimental day.  
 
Immunofluorescence microscopy 
Samples were prepared for immunofluorescence imaging as described in section 
3.2. Staining was conducted using appropriate primary antibodies targeting 
myosin heavy chain type I and myosin heavy chain type IIa alone or in 
combination with antibodies targeting PLIN2, PLIN3 or PLIN5 (see table in 
section 3.2.2 for details).  
 
Image capture, image processing and data analysis  
Images of cross-sectionally orientated sections, used to investigate fibre type-
specific IMTG content and LD morphology, were captured using an inverted 
confocal microscope (Zeiss LSM710; Carl Zeiss AG, Oberkochen, Germany) with 
a 63x 1.4 NA oil immersion objective as described in section 3.2.3. ~20 images 
were captured per time point aiming for an even split across type I and type IIa 
fibres. All other fibres were assumed to be type IIx fibres, and although some 
images were captured, in this data set there was an insufficient number of type 
IIx fibres to perform statistical analysis and therefore the results are not included.  




To investigate co-localisation between LD and PLIN proteins the same 
microscope and magnification were utilised to obtain the digital images, but with 
a 4x digital zoom applied on the straightest edge of an identified cell (Fig. 6.1).  
This first allowed an image to be taken at the peripheral region of the cell and 
subsequently the field of view was manually moved to the centre of the cell to 
generate an image of the central region of the cell. There were ~10 peripheral 
and ~10 central images obtained for each time point per participant, and each 
PLIN protein was investigated individually meaning there was up to 240 images 






















Figure 6.1. Representative colocalisation images of IMTG and PLIN5 visualized 
using immunofluorescence microscopy. 
 
Confocal immunofluorescence microscopy images were obtained at 4x digital 
zoom from the central and peripheral region of each cell, as indicated by the two 
white boxes (A).  IMTG were stained with Bodipy 493/503 (green; B), PLIN5 was 
stained in red (C), and the subsequent co-localisation map (D).  The overlapping 
area of LD and PLIN5 was extracted (D) and used to calculate the fraction of 
PLIN5 co-localising with LD, and the number of PLIN5+ and PLIN5- LD. The white 
dotted line in images B-E represents the 2 μm area that was analysed when 
images at the peripheral region were obtained. White bars represent 25 µm (A) 









Image processing was completed using Image-Pro Plus 5.1 software (Media 
Cybernetics, Rockville, MD, USA) as described in 3.2.5. To assess IMTG content, 
LD morphology and PLIN protein expression on a fibre type and subcellular-
specific basis, each fibre was first separated into a peripheral region to measure 
SS LD (first 2 μm from the cell border) and the central region to measure IMF LD 
(remainder of the cell). This approach of using a fixed 2 μm distance from the 
membrane to represent the subsarcolemmal region has been utilised previously 
to examine IMTG content in differing populations (Van Loon, 2004) and is now 
supported by our findings from chapter 5.  An intensity threshold was uniformly 
selected to represent a positive signal for IMTG. The content of IMTG was 
expressed as the positively stained area relative to the total area of the peripheral 
or central region of each muscle fibre. LD density was expressed as the number 
of LDs relative to the area of the peripheral or central region. The area of 
individual LD’s was used to calculate mean LD size in each region.  
 
Because only significant changes in IMTG content were observed in type I fibres 
(see results), the LD and PLIN co-localisation analysis was only conducted in 
type I fibres. Co-localisation analysis was performed separately for each PLIN 
protein with LDs.  Briefly, an intensity threshold was uniformly selected to 
represent a positive signal for IMTG and the PLIN protein of interest. Based on 
the threshold selected, dual images were generated and subsequently used for 
co-localisation analysis. The overlapping objects within the images were then 
extracted creating a separate image of the co-localised areas. This first allowed 
the identification of the total number of extracted objects, corresponding to the 
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total number of LDs labelled with PLIN2, 3 or 5 protein (PLIN+ LD). Second, the 
number of extracted objects was subtracted from the total number of LD in order 
to quantify the number of LD’s with no PLIN protein associated (PLIN- LD).  
Finally, the number of extracted objects was subtracted from the total number of 
PLIN objects to determine the number of ‘free PLIN’ objects. The number of 
objects identified through each of these analyses were expressed relative to the 
area of interest, thus providing data on changes in the density of PLIN+ LDs, 
PLIN-LDs and free PLIN. The peripheral region was identified within the 
appropriate images by creating a 2 μm wide area of interest, meaning that the 
above analyses were only conducted in this area of the image. Before conducting 
this analysis, numerous controls were performed to check for bleed through and 
non-specific secondary antibody binding before co-localisation analysis was 
conducted, as previously described (Shepherd et al, 2013, 2013   ). 
 
Statistics 
Statistical analyses were performed using SPSS (SPSS; version 23, IBM, USA). 
Linear mixed modelling was used to examine all dependent variables (IMTG 
content, LD morphology, PLIN protein expression and co-localisation analysis) at 
the different time points, with data separated into the two different experimental 
conditions (CHO and H2O) in the recovery period. All main effects and 
interactions were tested using a linear mixed-effects model, with random 
intercepts to account for repeated measurements within subjects to examine 
differences between experimental condition, fibre type and subcellular region. 
Subsequent Bonferroni adjustment post-hoc analysis was used to examine main 
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effects and interactions. Data is presented as mean ± SD. Significance was 





























Pre exercise IMTG content and LD morphology 
 
Before exercise, IMTG content was two-fold greater in type I compared to type 
IIa fibres (main fibre effect; P < 0.001, Table 6.1), and IMTG content was greater 
in the periphery of the cell (within the 2 μm border) when compared to the central 
region (main region effect; P = 0.025). Overall though, the majority of IMTG was 
observed in the central compared to the peripheral region of the cell (main region 
effect; P < 0.001, Table 6.2). Considering the number and size of LD´s, there 
were two-fold greater LD’s in type I fibres compared to type IIa fibres (P = 0.001). 
LD’s in the central region tended to be 12% larger than in the peripheral region 
across both fibre types (P = 0.089, Table 6.1). Thus, pre-exercise fibre type 
differences in IMTG content were predominantly explained by differences in LD 













Table 6.1. Pre-exercise IMTG content and LD morphology. 
 
 Type I fibres Type II fibres P value 
 Peripheral Central Peripheral Central Fibre type  Region 
IMTG content 
(% area stained) 
4.63  1.96* 3.93  1.65* 2.42  1.34 1.94  0.91 0.001 0.025 
LD size 
(μm2) 
0.285  0.049 0.321  0.056 0.269  0.062 0.301  0.063 0.500 0.089 
LD number 
(LD.μm-2) 
0.152  0.057* 0.116  0.036* 0.084  0.043 0.061  0.023 0.001 0.260 
 
IMTG content and LD number are expressed relative to the area of the peripheral or central region. Data are means  SD.  










Effect of exercise on IMTG content and LD morphology 
 
Four hours of steady state moderate-intensity exercise led to a 53% decrease in 
IMTG content in type I fibres (fibre  time interaction; P = 0.002, Fig. 6.2a). No 
significant decrease in IMTG content was observed in type IIa fibres. Moreover, 
when examining exercise-induced changes in type I fibres on a subcellular-
specific basis, IMTG content was reduced by 55% within the central region (time 
 region interaction; P < 0.001), whereas IMTG content was not altered in the 
peripheral region (P = 0.570). Consequently, the relative distribution of IMTG 
across the subcellular regions decreased from ~87% before exercise in the 
central region to ~77% after exercise, with a reciprocal increase in the relative 
distribution of IMTG within the peripheral region from ~13% before exercise to 
~23% after exercise (main time effect; P = 0.022, Table 6.2). 
 
When examining changes in LD morphology in response to exercise, LD number 
was reduced by 46% in type I fibres only (fibre  time interaction; P = 0.043, Fig. 
6.2b). No changes in LD number occurred in type IIa fibres (P = 0.474, Fig. 6.2b), 
and no changes in LD size were observed in either fibre type (Fig. 6.2c). Thus, 
































Figure 6.2. Fibre type and subcellular-specific changes in IMTG content and LD 
morphology in response to prolonged exercise. 
 
IMTG content (a) LD number (b) and LD size (c) in peripheral and central 
subcellular regions before (pre) and after (post) exercise in type I and type IIa 
muscle fibres.  IMTG content and LD number in each region was normalized to 
total cell area. *Significant decreases in IMTG content from pre to post exercise 
in type I fibres only within the central region (P < 0.05). **Significant decreases in 
LD number from pre to post exercise in type I fibres (P = 0.043). mean ± SD. 

















































































Effect of recovery on IMTG content and LD morphology 
 
During recovery from prolonged exercise IMTG content increased significantly in 
the central region of type I fibres from post-exercise to 4 h post-exercise, and 
from post-exercise to 24 h post-exercise (time x fibre x region interaction, P < 
0.001, Fig. 6.3a). Post-hoc analysis revealed that the increase between 4 h and 
24 h post-exercise alone was not significant (P = 0.160). No changes in IMTG 
content occurred in type IIa fibres (Fig. 6.3b).  When comparing CHO and H2O 
groups, IMTG content was lower post-exercise in the H2O condition compared to 
the CHO condition in both fibre types (condition x time interaction; P = 0.029).  In 
the H2O condition, there was an increase in IMTG content from post-exercise to 
4 h post-exercise, and from post-exercise to 24 h post-exercise (P = 0.014). In 
contrast, in the CHO condition IMTG content was not significantly changed from 
post-exercise to 24 h post-exercise (P = 1.000).  Importantly though, by 24 h post-
exercise IMTG content was statistically similar between conditions (P > 0.05). 
When examining subcellular IMTG distribution during recovery, IMTG in the 
central region increased from ~77% post-exercise to ~82% 4 h post-exercise, 
finally returning to pre-exercise distribution by 24 h post-exercise with ~86% of 
IMTG observed in the central region (main time effect; P = 0.005, Table 6.2). This 
was mirrored by changes in IMTG distribution in the peripheral region decreasing 
from ~23% after exercise to ~18% 4 h post-exercise, and finally to ~14% 24 h 
post-exercise (main time effect; P = 0.005, Table 6.2). 
 
When considering LD number and size, LD number increased in type I fibres from 
post-exercise to 4 h post-exercise, and from post-exercise to 24 h post-exercise 
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(time x fibre interaction; P = 0.028).  More specifically, LD number significantly 
increased in the H2O condition from post-exercise to 4 h post-exercise, and from 
post-exercise to 24 h post-exercise (condition x time interaction; P = 0.003, Fig. 
6.3c). No changes in LD number occurred between 4 h post-exercise and 24 h 
post-exercise. Overall no significant changes were observed in LD size 
throughout recovery (P > 0.05, Fig. 6.3e & f). Thus, changes in IMTG content 
through recovery could be explained by increases in LD number, with no 



















Table 6.2. Relative distribution of IMTG between subcellular regions in response to exercise and during recovery. 
 
  % of IMTG 
  Type I fibres Type IIa fibres 
  Peripheral Central* Peripheral Central* 
Pre  12   1 88   1 14   1 86   1 
Post CHO  
Water 
20  4† 
23  4† 
80  4† 
77  4† 
19  2† 
25  8† 
81  2† 
75  8† 
Post 4 h CHO 
Water 
15  2 
22  7 
85  2 
78  7  
16  3 
19  6 
84  3 
81  6 
Post 24 h CHO  
Water  
13  2 
11  3 
87  2 
89  3 
15  3 
16  4 
85   2 
84  4 
 
Data are means  SD. * Significant effect of region across all time points (P < 0.05).  






























Figure 6.3.  Fibre type and subcellular-specific changes in IMTG content and LD 
morphology during recovery from prolonged exercise. 
 
IMTG content (a, b), LD number (c, d) and LD size (e, f) in peripheral and central 
subcellular regions during recovery in type I and type IIa fibres. IMTG content and 
LD number in each region was normalized to total cell area. *IMTG content at 
post-exercise significantly lower in H2O vs. CHO (P = 0.029). ~Significant 
increase from post-exercise in the H2O condition only in type 1 fibres (P < 0.05).  
Values are means ± SD. 
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Figure 6.4. Representative immunofluorescence images of IMTG in response to 
and in recovery from prolonged exercise. 
 
Sections were co-stained for IMTG (stained using Bodipy 493/503; green), fibre 
type (not shown), and wheat germ agglutinin Alex Fluor 350 (WGA) in order to 
identify the cell border (stained blue).  Images depict IMTG content in type I fibres 
at pre and post-exercise, and 4 h and 24 h post-exercise in the H2O and CHO 
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Because significant changes in both IMTG content and LD morphology occurred 
specifically in type I fibres during exercise and recovery, subsequent PLIN protein 
content and co-localisation analysis was limited to type I fibres. Importantly, the 
protein expression of PLIN2, PLIN3 and PLIN5 was unaltered by exercise or 
recovery in either region in both the CHO and H2O conditions (P > 0.05, Fig 6.5 
& 6.6). However, there were regional differences in PLIN protein expression, with 
the central region having greater PLIN content compared to the peripheral region 
(P < 0.05, Table 6.3, Fig 6.5 & 6.6). As well as overall protein content, we 
examined the co-localisation of PLIN proteins and LD by expressing the number 
of overlapping objects relative to the total number of PLIN proteins present. 
Further to this, we examined the number of LD’s that either had PLIN (PLIN+ LD), 
or did not have PLIN associated (PLIN- LD) and also quantified free PLIN (as 
described previously, Shepherd et al, 2013, 2017). The results of these analyses 












Table 6.3. Relative distribution of PLIN proteins between subcellular regions in type I fibres. 
  
  % of PLIN 
  PLIN2 PLIN3 PLIN5 
  Peripheral Central* Peripheral Central* Peripheral Central* 
Pre  13  3 87  9 9  2 91  9 12  1 88  1 
Post CHO 
Water 
13  3 
12  2 
87  3 
88  2 
10  2 
12  3 
90  2 
88  3 
12  3 
25  2 
88  2 
75  2 
Post 4 h CHO 
Water 
13  2 
11  2 
87  2 
75  8 
11  2 
11  2 
90  1 
74  9 
8  1 
19  3 
92  1 
81  4 
Post 24 h CHO 
Water 
13  2 
10  2 
87  2 
78  9 
11  2 
9  2 
90  2 
78  9 
8  14 
19  3 
92  1 
81  3 
 




































Figure 6.5. PLIN protein expression in response to exercise. 
 
No significant changes in overall PLIN2 (a), PLIN3 (b) and PLIN5 (c) content in 



































































































































Figure 6.6. PLIN protein expression content during recovery in type I fibres. 
 
No significant changes in overall PLIN2 (a), PLIN3 (b) and PLIN5 (c) content 
during recovery in either experimental condition (P > 0.05). Values are means ± 
SD. 
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Effect of exercise on PLIN protein and LD co-localisation  
Exercise induced a 62% decrease in the fraction of PLIN2 co-localised with IMTG 
from pre to post-exercise within the central region (time x region interaction; P < 
0.05, Table 6.4), although post-hoc analysis revealed that there was also a trend 
for a decrease of 21% within the peripheral region (P = 0.060). Exercise reduced 
the number of PLIN2+ LD in both the peripheral (-27%; P = 0.006) and central 
region (-71%, P = 0.001, Fig. 6.7a). Further to this, the number of PLIN2- LD was 
also significantly reduced by exercise, which again occurred within both the 
peripheral (-36%, P = 0.003) and central region (-82%, P < 0.001, Fig. 6.7b). Free 
PLIN2 increased by 36% from pre to post-exercise (Pre exercise 0.024  0.005, 
post-exercise 0.034  0.005, P = 0.012). 
 
When examining PLIN3, exercise caused a significant decrease in the fraction of 
PLIN3 co-localised with LD’s within the central region only (-51%, time x region 
interaction; P < 0.05, Table 6.4). Accordingly, the number of PLIN3+ LD’s 
significantly decreased by 67% from pre to post-exercise (main effect of time; P 
< 0.001, Fig. 6.7c). The number of PLIN3- LD’s were also reduced by exercise, 
with a decrease of 56% in the central region and 30% in the peripheral region, 
specific to the CHO condition (main effect of time; P = 0.004, Fig. 6.7d). Free 
PLIN3 was unaffected by exercise (pre exercise 0.032  0.004, post-exercise 
0.031  0.006, P = 0.699). 
 
The fraction of PLIN5 co-localised with LD decreased significantly in response to 
exercise in the central region only (-58%, time x region interaction; P < 0.001, 
199 
 
Table 6.4). The number of PLIN5+ LD’s decreased by 38% in response to 
exercise (main effect of time; P = 0.007, Fig. 6.7e), and there tended to be a 
decrease in the number of PLIN5- LD’s (P = 0.071, Fig. 6.7f). Free PLIN5 
increased by 20% from pre to post exercise (pre exercise 0.034  0.004, post-






















Table 6.4. Changes in PLIN co-localisation with lipid droplets between subcellular regions in response to exercise in type I fibres. 
 
Time Point Region PLIN2 PLIN3 PLIN5 
Pre Peripheral 0.61  0.12 0.57  0.06 0.53  0.09 
Central 0.64  0.11 0.53  0.09 0.64  0.10 
Post Peripheral 0.48  0.20 0.51  0.12 0.50   0.17 
Central 0.24  0.15* 0.26  0.12* 0.27  0.09* 
 












Figure 6.7. Subcellular-specific changes in the number of PLIN+ and PLIN- LDs 
in type I fibres in response to prolonged exercise. 
 
The effect of exercise on a) PLIN2+ LD, b) PLIN2- LD, c) PLIN3+ LD, d) PLIN3- 
LD, e) PLIN5+ LD and f) PLIN5- LD. *Significant decrease in PLIN2+ LD and 
PLIN2- LD in both peripheral and central regions (time x region interaction effect, 
P < 0.05). Significant decrease in PLIN3+ LD, PLIN3- LD and PLIN5+ LD in 



















































































































































































Effect of recovery from prolonged exercise on PLIN protein and LD co-localisation 
 
The fraction of PLIN2 co-localised with LD significantly increased throughout 
recovery, specifically within the central region by 58% from post-exercise to 24 h 
post-exercise (time x region interaction; P < 0.001, Table 6.5). When considering 
condition, the increased co-localisation between PLIN2 and LD’s occurred 
primarily in the H2O condition from post-exercise to 24 h post-exercise (time x 
condition interaction; P = 0.001). PLIN2+ LD’s increased throughout the recovery 
period in the central region only from post-exercise to 24 h post exercise (time x 
region interaction; P = 0.001, Fig. 6.8a). Overall the number of PLIN2+ LD’s was 
63% greater in the peripheral region compared to the central region across all 
time points (main effect of region; P < 0.05). On the other hand, PLIN2- LD’s were 
unchanged during recovery (P = 0.611) and did not differ between conditions (P 
= 0.940). Though when considering region, the number of PLIN2- LD were 
greater in the peripheral region throughout recovery (main effect of region; P < 
0.05, Fig. 6.8b). Free PLIN2 was unaffected throughout the recovery period in 
both conditions (post-exercise 0.032  0.005, post 4 h 0.025  0.005, post 24 h 
0.026  0.005, P = 0.699). 
 
The fraction of PLIN3 co-localised with LD’s increased throughout recovery 
(Table 6.5) in the central region by 49% from post to 24 h post-exercise (time x 
region interaction; P < 0.05). The number of PLIN3+ LD’s increased by 63% from 
post to 24 h post exercise in the central region (P = 0.014), whereas in the 
peripheral region there was no significant difference from post to 24 h post-
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exercise (P = 0.597, Fig. 6.8c). In addition, there was a significant difference 
between regions (main effect of region; P < 0.05) with the number of PLIN3+ LDs 
being ~23% greater in the peripheral region than the central region throughout 
recovery. Condition had no effect on PLIN3+ LD’s during recovery (P = 0.296). 
The number of PLIN3- LD’s was significantly different between conditions post-
exercise, with the H2O condition having 68% more PLIN3- LD’s than the CHO 
condition (P = 0.039). Overall though, the number of PLIN3- LD did not change 
during recovery (P = 0.259, Fig. 6.8d). When examining region, the number of 
PLIN3- LD’s was greater in the central region compared to the peripheral region 
throughout recovery (P < 0.05). Free PLIN3 was unchanged throughout the 
recovery period (post-exercise 0.032  0.006, post 4 h 0.034  0.005, post 24 h 
0.033  0.004, P = 0.787). 
 
The fraction of PLIN5 co-localised with LD’s increased significantly in the central 
region only from post to 24 h post exercise (59%, P < 0.05), though was 
unaffected by condition (P = 0.167). There was a significant increase in the 
number of PLIN5+ LD’s in the central region from post to 24 h post-exercise (62%, 
P = 0.002), and in the peripheral region but only from post to 4 h post exercise 
(20%, P = 0.016, Fig. 6.8e). On the other hand, the number of PLIN5- LD’s were 
unchanged during recovery (P = 0.780), though PLIN5- LD’s were significantly 
greater in the peripheral region than in the central (P < 0.05, Fig. 6.8f). Free PLIN5 
decreases significantly throughout recovery (post-exercise 0.041 0.006, post 4 





























Figure 6.8. Subcellular-specific changes in the number of PLIN+ and PLIN- LDs 
in type I fibres during recovery from prolonged exercise. 
 
The effect of recovery on a) PLIN2+ LD, b) PLIN2- LD, c) PLIN3+ LD, d) PLIN3- 
LD, e) PLIN5+ LD and f) PLIN5- LD. *Significant increase during recovery from 
post-exercise to 24 h post-exercise (P < 0.05) with no difference between 
conditions. Values are means ± SD. 
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Table 6.5. Changes in PLIN co-localisation with lipid droplets between subcellular regions during recovery in type I fibres. 
 
Time Point Condition Region PLIN2 PLIN3 PLIN5 
Post  CHO Peripheral 0.58  0.22 0.53  0.19 0.42  0.24 
Central 0.31  0.17 0.26  0.09 0.23  0.12 
H2O Peripheral 0.46  0.08 0.49  0.06  0.53  0.06 
Central 0.22  0.11 0.36  0.07 0.23  0.07 
Post 4 h  CHO  Peripheral 0.71  0.13 0.54  0.07 0.47  0.23 
Central 0.48  0.16 0.35  0.08 0.40  0.20 
H2O Peripheral 0.49  0.22 0.62  0.12 0.54  0.11 
Central 0.33  0.26 0.45  0.24 0.41  0.21 
Post 24 h CHO  Peripheral 0.62  0.17 0.58   0.06 0.48  0.22 
Central 0.57  0.21 0.49  0.16* 0.58  0.25*  
H2O Peripheral 0.62  0.17  0.56  0.08 0.49  0.06 
Central 0.54  0.21* 0.50  0.11* 0.57  0.21* 
 







The present study aimed to investigate the effect of acute CHO restriction on IMTG 
resynthesis following prolonged exercise, and at the same time explore the dynamic 
behaviour of LDs and PLIN proteins in order to further clarify the role of these proteins 
in skeletal muscle. We report for the first time that IMTG resynthesis occurs rapidly in 
the central region of type I fibres during the first 4 h of recovery following prolonged 
exercise in highly-trained individuals. With regards to the PLIN proteins, two novel 
observations were made: 1) during prolonged exercise LD’s that had both PLIN 
associated (PLIN+ LD’s) or not associated (PLIN- LD’s) were reduced, and 2) during 
recovery from prolonged exercise only the number of PLIN+ LD’s were increased at 
24 h post-exercise.  Given that significant IMTG resynthesis was apparent by 4 h post-
exercise, these data together indicate that the PLIN proteins do not play a key role in 
post-exercise IMTG resynthesis, but are instead re-distributed to the newly-expanded 
LD pool during recovery. 
 
In order to investigate post-exercise IMTG resynthesis, we first aimed to reduce IMTG 
content using 4 h moderate-intensity cycling.  As expected, this exercise bout led to a 
substantial decrease in IMTG content specific to type I fibres, in line with other studies 
which have also investigated IMTG utilisation using cycling protocols lasting ≥3 h (Van 
Loon et al, 2003; Stellingwerff et al, 2006). Moreover, the decrease in IMTG content 
occurred within the central region of the cell primarily due to a reduction in LD number. 
This is in line with a recent study employing TEM to demonstrate decreases in LD 
volume fraction and LD number, but not LD size, in the IMF region of muscle fibres in 
the arms, but not legs, of elite cross-country skiers in response to 1 h of exhaustive 
exercise (Koh et al, 2017). This is also in agreement with data showing a 40% 
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decrease in IMF lipid content following 1 h of moderate intensity cycling exercise, 
whilst SS lipid content did not change (Chee et al, 2016). Our data now extend the 
observed preferential utilisation of the IMF IMTG pool to prolonged cycling, and 
highlight the capacity for immunofluorescence microscopy-based analysis to detect 
changes in IMTG content in specific subcellular compartments.  
 
In the present study, we aimed to identify if restricting CHO in the post-exercise 
recovery period would augment the rate of IMTG resynthesis. On first inspection, the 
data revealed that the rate of IMTG resynthesis was greatest when only H2O, and not 
CHO, was ingested during the first 4 h of recovery from prolonged exercise.  This was 
expected, since CHO ingestion would increase circulating insulin concentrations 
thereby inhibit systemic lipolysis and reducing free fatty acid availability to the muscle.   
However, it is important to state that there was a significant difference in post-exercise 
IMTG content between conditions, despite the experimental treatment only being 
implemented in the post-exercise period.  Since, in this case, the starting IMTG values 
are different between groups, this precludes our ability to draw a firm conclusion as to 
whether acute CHO restriction can truly accelerate IMTG resynthesis.  In this regard, 
it should be noted that in the study by Gejl et al. (2016) from which these muscle 
samples were derived, a small, albeit non-significant, difference in glycogen utilisation 
was observed in the CHO condition (527 mmol/kg dw, 73% reduction) compared to 
the H2O condition (421 mmol/kg dw, 63% reduction). Further to this, Gejl et al. (2016) 
also noted a slightly greater exercise intensity in the CHO condition (74% vs 71% 
HRmax in the H2O condition), although again this was not a significant difference.  We 
believe that the combination of the small differences in exercise intensity and glycogen 
utilisation between the groups may explain, at least partly, the lower IMTG utilisation 
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within the CHO condition in the present study. However, despite the differences in 
IMTG content between conditions at the post-exercise time point, we did observe an 
increase in IMTG content during the first 4 h of recovery from prolonged exercise 
independent of experimental group.  Importantly, this increase in IMTG content was 
sustained, but not improved on, at 24 h post-exercise.  Furthermore, IMTG content at 
24 h post-exercise had returned to baseline levels.  Thus together, these data 
demonstrate that IMTG resynthesis occurs quickly following exercise, at least in 
highly-trained individuals.  Furthermore, this time-course of IMTG resynthesis is the 
first of its kind to be described in the literature, and importantly provides a dynamic 
model of IMTG utilisation during exercise and post-exercise resynthesis that can be 
used to investigate the potential mechanisms underpinning these process.  
 
When investigating changes in IMTG content during the recovery period in more detail, 
we observed that the increase in IMTG content occurred specifically in type I fibres 
and within the central region of the fibre.  Therefore, not only are intermyofibrillar LDs 
targeted for breakdown during exercise, we now report for the first time that this 
subcellular region is an important site for IMTG resynthesis in the post-exercise period.  
Corresponding to the exercise-induced decreases in LD number, the post-exercise 
resynthesis of IMTG was driven by increases in LD number rather than LD size.  This 
could be considered to be an advantage as an increase in LD number would provide 
a greater LD surface area available for the interaction of lipolytic enzymes and 
regulatory proteins (i.e. PLIN proteins) with IMTG.   
 
Both IMTG content and PLIN protein expression exhibit a fibre-specific distribution, 
and therefore are closely related such that PLIN2, PLIN3 and PLIN5 content is directly 
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associated with IMTG content, at least under resting conditions (Amati et al, 2011; 
Minnaard et al, 2009; Peters et al, 2012; Shepherd et al, 2013). By employing 
subcellular-specific analysis, we are now able to demonstrate an apparent uncoupling 
of this relationship, since IMTG content is greatest in the peripheral region of the fibre, 
whereas the PLIN proteins are expressed to a greater extent in the central region of 
the cell. Importantly though, when considering the relative distribution, the majority of 
IMTG and PLIN proteins are observed in the central region. This would support the 
hypothesis that the PLIN proteins play a key role in the utilisation and resynthesis of 
the IMTG pool, given that changes in IMTG content during exercise and recovery were 
specific to the central region.  Critically, we observed changes in IMTG content during 
exercise that occurred in the absence of changes in PLIN protein expression, which is 
in line with previous research (Shepherd et al, 2012, 2013), and we extend this 
observation to the post-exercise recovery period too. This provided the basis to 
investigate changes in the LD distribution of each PLIN protein under the dynamic 
state of exercise and recovery in order to further understand the role of these proteins 
within skeletal muscle.  
 
As reported previously, exercise reduced the number of PLIN2+ LDs and PLIN5+ LDs 
(Shepherd et al, 2012, 2013), and we now report that the number of PLIN3+ LDs also 
decreases in response to exercise. However, in contrast to our previous studies 
demonstrating preferential use of PLIN+ LDs in response to 1 h of exercise (Shepherd 
et al, 2012, 2013), we also observed an exercise-induced decrease in the number of 
PLIN2- and PLIN3- LDs, and PLIN5- LDs also tended to decline.  This is likely due to 
the more prolonged bout of exercise (4 h) employed here than in our previous studies 
(1 h) (Shepherd et al, 2012, 2013), combined with the elite level endurance-trained 
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population studied who notoriously exhibit high rates of IMTG utilisation during 
exercise (Stellingwerff et al, 2007; Rodriguez et al, 2009). Given the decrease in 
PLIN2+ and PLIN5+ LDs during exercise, combined with no change in PLIN2 and 
PLIN5 protein expression, it was no surprise to observe an increase in the quantity of 
(free) PLIN2 and PLIN5 not bound to LDs following exercise.  In contrast, the quantity 
of PLIN3 not bound to LDs was unchanged in response to exercise.  Studies in 
cultured non-muscle cells have demonstrated that PLIN3 is recruited from the cytosolic 
fraction to LDs upon lipid-loading (Skinner et al, 2009; Wolins et al, 2001, 2005), 
suggesting that PLIN3 cycles between the cytosol and LD pool depending on the 
metabolic state of the cell.  Our data now indicates that this ‘cycling’ may be an 
important function of PLIN3 to support IMTG utilisation during exercise.  In our model, 
we speculate that PLIN3 may cycle from each LD that is used and be recruited to a 
PLIN3- LD (and possibly PLIN2- and PLIN5- LDs) to subsequently support continued 
breakdown of the IMTG pool during exercise.   
 
During recovery, we observed an increase in PLIN and LD co-localisation for all PLIN 
proteins within the central region of type I fibres at 24 h post-exercise.  Consequently, 
the number of PLIN2+, PLIN3+ and PLIN5+ LDs all increased during recovery, but 
there was no change in the number of PLIN- LDs.  Given that there was no change in 
the expression of the PLIN proteins during recovery, these data suggest that the pre-
existing PLIN protein pool was redistributed across the expanded LD pool during 
recovery (Figure 6.9).  This corroborates previous studies reporting a redistribution of 
the PLIN proteins in response to prolonged fasting (Gemmink et al, 2016) or a lipid 
infusion (Shepherd et al, 2017).  In order to determine the location from which the 
redistributed PLIN proteins originated, it is important to not only consider LDs either 
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labelled with PLIN or not, but also the cytosolic pool of PLIN proteins.  In this regard, 
when examining the distribution of PLIN2 and PLIN3 throughout recovery increases in 
PLIN2+ and PLIN3+ LDs occurred in the absence of a change in the quantity of 
cytosolic PLIN2 or PLIN3. This suggests there is a redistribution of PLIN2 and PLIN3 
from pre-existing PLIN2+ or PLIN3+ LD to either newly-synthesised LD and/or pre-
existing PLIN- LDs (Figure 6.9).  In contrast, PLIN5+ LDs were increased throughout 
the recovery period with a corresponding decrease in the quantity of cytosolic PLIN5.  
Therefore, unlike PLIN2 and PLIN3, it is the cytosolic pool of PLIN5 that is redistributed 
to either newly-synthesised LDs and/or pre-existing PLIN- LDs occurred during 
recovery (Figure 6.10), underpinning the increased fraction of LDs labelled with PLIN5 









































Figure 6.9. Schematic diagram of the redistribution of PLIN2 and PLIN3 to either 
newly-synthesised LD and/or pre-existing PLIN- LDs during recovery. 
Post exercise PLIN+ and PLIN- LD for both PLIN2 and PLIN3. 
During recovery PLIN redistributes from PLIN+ LD to newly formed LD or 
previously existing PLIN- LD. 





























Figure 6.10. Schematic diagram of cytosolic pool of PLIN5 that is redistributed to 
either newly-synthesised LDs and/or pre-existing PLIN- LDs occurred during recovery. 
PLIN5- LD with free PLIN5 in 
the surrounding cytosol.  
During recovery free PLIN5 
in the cytosol decreases as 
they redistribute to newly 
synthesized or pre-existing 
PLIN5- LD. 
Due to this redistribution of 
free PLIN5 from the cytosol, by 




Previous studies in cultured cells and rodent models have implicated the PLIN proteins 
in supporting FA incorporation into, and storage as, IMTG in LDs (Bosma et al, 2012, 
2013; Kleinert et al, 2016; Laurens et al, 2016). The preferential increase in PLIN+ 
LDs observed during recovery would theoretically support this concept.  However, by 
obtaining muscle samples at both 4 h and 24 h post-exercise we are able to report for 
the first time a separation in the time-course between growth of the IMTG pool (at 4 h 
post-exercise) and increases in coating of LDs with PLIN proteins (at 24 h post-
exercise).  This suggests that the PLIN proteins don’t necessarily play a role in IMTG 
storage in LD’s per se.  Rather, the coverage of newly-synthesised LD with PLIN 
proteins at 24 h post-exercise may be an adaptive response to regulate mobilisation 
and oxidation of IMTG-derived free fatty acids depending on metabolic demand.  In 
this respect, there is a large evidence-base generated in a number of cell types 
supporting a role for the PLIN proteins in restricting lipolysis under basal conditions 
(MacPherson et al, 2012).  Both PLIN3 and PLIN5 may also play a role in IMTG 
oxidation.  Under stimulated conditions, PLIN5 overexpression in cultured cells 
augments triacylglycerol hydrolysis and fat oxidation (Laurens et al, 2016), through 
recruitment of LDs to the mitochondrial network (Wang et al, 2011).  We also recently 
reported that HSL is targeted to PLIN5+ LDs in response to exercise (Whytock et al, 
2018).  Whole-body fat oxidation (Covington et al, 2014) and ex vivo palmitate 
oxidation (Covington et al, 2014, 2015) are both positively associated with PLIN3 
expression, and PLIN3 is expressed in the mitochondrial fraction of sedentary and 
endurance-trained rats (Ramos et al, 2015).  Based on our data, we assert that a 
redistribution of the PLIN proteins in the post-exercise period is an important 
adaptation to preserve the flexibility of the intramuscular LD pool to respond 




A strength of the present study is the use of validated immunofluorescence microscopy 
techniques to examine fibre-type specific changes in IMTG content and LD 
morphology, as well as the associations of PLIN proteins with LDs (Shepherd et al, 
2012, 2013, 2017). However, the co-localisation assays only enable examination of 
the association between LDs and a single PLIN protein. A partial overlap between 
PLIN2 and PLIN5 has been recorded in rat skeletal muscle (MacPherson et al, 2012), 
and both PLIN2 and PLIN5 can be found on the same LD in human skeletal muscle 
(Gemmink et al, 2018).  Thus, it is likely that LD’s will have more than one PLIN protein 
associated with the LD surface, meaning that decreases in PLIN- LD we observed 
during exercise could actually be labelled with an alternative PLIN protein.  
Alternatively, the observed decrease in PLIN- LD’s could be newly-formed LDs that 
have insufficient PLIN protein associated with the phospholipid monolayer to surpass 
the lower detection limit of the microscope.  In the same context, objects quantified as 
free PLIN could also be small LDs which do not exceed the lower limits of detection, 
although it has been established, at least in cultured cells, that cytosolic pools (i.e. 
non-LD bound) of PLIN proteins do exist (Wolins et al, 2005).  We also acknowledge 
that future work should determine whether PLIN4 plays a role in IMTG utilisation 
and/or resynthesis, given that PLIN4 is highly expressed, at least at the mRNA level, 
in skeletal muscle of healthy individuals (Pourteymour et al, 2015).  
 
In conclusion, this study demonstrates that IMTG resynthesis occurs rapidly in the 
central region of type I fibres following prolonged exercise in highly-trained individuals.  
Whilst our previous report of LDs labelled with PLIN proteins being preferentially 
utilised (Shepherd et al, 2012, 2013) is not substantiated when exercise is >1 h in 
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duration, our data do highlight a novel role of PLIN3 in supporting IMTG utilisation.  
Moreover, during recovery from prolonged exercise the IMTG pool appears to first be 
resynthesized, after which PLIN2, PLIN3 and PLIN5 are redistributed to the newly-
synthesised LD pool.  Given the disparity in the time-course between growth of the 
IMTG pool and coating of LDs with PLIN proteins, our data do not support a role for 




























































































It is well-documented that nutritional status influences intramuscular substrate 
turnover, and to date, the main aim of the current CHO guidelines is to augment 
performance via sparing muscle glycogen, maintaining plasma glucose and CHO 
oxidation rates, followed by appropriate strategies to maximise glycogen 
replenishment following exercise (Burke et al, 2018). However, CHO is not the only 
fuel for exercise, particularly during moderate-intensity exercise where IMTG has been 
identified as a key fuel source (Van Loon, 2004). Despite this, the importance of post-
exercise IMTG repletion to maintain endurance performance, particularly during 
periods where optimal performance is required on multiple consecutive days of 
competition has been somewhat overlooked. Overall, there is a lack of data on the 
post-exercise replenishment of IMTG and therefore, a lack of understanding of the 
mechanisms governing IMTG resynthesis following exercise. Further to this, substrate 
availability in muscle is dependent on 1) fibre type, with type I fibres containing three-
fold greater lipid content than type II muscle fibres (Essen et al, 1975; Malenfant et al, 
2001, Van Loon et al, 2003), and 2) the subcellular location of substrates within the 
muscle fibre. This has been demonstrated to be important in the context of storage 
and utilisation during exercise (Ørtenblad & Nielsen, 2015). Microscopy methods can 
be used to examine both on a fibre and subcellular-specific basis, though the level of 
agreement between different microscopy methods was not known.  Initially this thesis 
aimed to assess both muscle glycogen and lipid utilisation during two field-based 
training sessions (that differ by exercise intensity) typical of middle-to-long distance 
runners. Both confocal immunofluorescence microscopy and TEM were then used to 
investigate exercise-induced changes in muscle lipids within a competitive endurance 
event. Finally, as there is considerably more focus in literature to date on the effect of 
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CHO availability to support glycogen resynthesis post-exercise, the key mechanisms 
underpinning post-exercise IMTG resynthesis were investigated. Overall, this thesis 
provides an insight into the field-based demands of training and competition on fibre 
type and subcellular-specific substrate utilization, whilst also providing key insights 
into the regulatory mechanisms underpinning IMTG resynthesis. 
 
7.2 Fibre and subcellular-specific substrate utilisation  
 
 
From laboratory studies it is well-documented that CHO and lipid utilisation is 
dependent on exercise intensity and duration. With the rationale of aiming to 
understand more field-based CHO demands during training, Impey et al, (2020) 
recently investigated the utilisation of glycogen during different habitual run training 
sessions undertaken in a field-based training environment. Overall, they reported a 
greater utilisation of glycogen in the gastrocnemius in comparison to the vastus 
lateralis, and a greater glycogen requirement during prolonged moderate-intensity 
running compared to a shorter, interval running session. In chapter 4, this thesis now 
extends such findings examining field-based training substrate utilisation through the 
use of TEM. First, it was found that glycogen was preferentially utilised from the INTRA 
region in both type I and type II fibres.  Furthermore, glycogen utilisation tended to be 
greater in type I compared to type II fibres. This was only during the 10-mile trial rather 
than the 8x800 trial. This is in agreement with previous research also reporting greater 
glycogen utilisation in type I compared to type II fibres during exercise (Gollnick et al, 
1973; 1974; Stellingwerff et al, 2007; Branth et al, 2009; Jensen et al, 2020).  Further 
to this, our findings of less glycogen utilisation in the 8x800 trial is in line with whole 
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muscle homogenate data from Impey et al, (2020), demonstrating a lesser 
requirement for glycogen in the shorter, interval running session.  
 
The preferential utilisation of glycogen in the INTRA region is in line with previous 
research in moderately or well-trained subjects during either prolonged cycling or 
cross-country ski racing (Marchand et al, 2007; Nielsen et al, 2011).  However, our 
data extends such findings to two different exercise intensities and two different 
muscles.  In this regard, we show that INTRA glycogen utilisation in the gastrocnemius 
was similar between exercise trials, whereas INTRA glycogen utilisation in the vastus 
lateralis was greater in the 8x800 trial compared to the 10-mile trial. An explanation 
for the differences in muscle here stems from mechanistic investigations identifying a 
link between INTRA glycogen and SR Ca2+ release in skinned rat muscle fibres 
(Nielsen et al, 2009), isolated human SR vesicles (Ørtenblad et al, 2011) and intact 
mouse muscle fibres (Nielsen et al, 2014).  Specifically, it seems INTRA glycogen 
likely has a key role in energy provision for muscle contraction and the high intensity 
nature of the 8x800 trial (compared to the 10-mile trial) requires recruitment of a 
greater total muscle mass in the legs, which would in-turn require greater rates of SR 
Ca2+ release to support the high frequency of muscle contraction. Therefore, our data 
alongside previous literature supports the concept of the relationship between 
glycogen and muscular fatigue, likely originating through a connection between the 
INTRA glycogen store and sarcoplasmic reticulum (SR) Ca2+ release (Ørtenblad et al, 
2011; Nielsen et al, 2014). 
 
Similar to glycogen, IMTG-containing LD are also distributed on a fibre and subcellular 
specific basis (Nielsen et al, 2010; Koh et al, 2017; 2018).  It is now well known that 
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moderate-intensity exercise leads to a decrease in IMTG content specifically in type I 
fibres (Van Loon, 2004), and there is some evidence that IMF LDs are specifically 
reduced (Chee et al, 206; Koh et al, 2017). In chapter 4, we observed lipid utilisation 
in both exercise trials, with a 51% reduction in LD volume fraction following the 10-
mile trial and a smaller reduction of 22% following the 8x800 trial. In the 10-mile trial, 
this was specifically from the IMF region in type I fibres, although there also tended to 
be a reduction in IMF LD volume fraction in type II fibres. In the SS region, there was 
no significant reductions in LD volume fraction in response to exercise. Further to this, 
in chapter 6, 4 h moderate-intensity cycling bout led to reductions in IMTG content 
specific to type I fibres specifically from the central region of the cell. This supports the 
concept of there being a compartmentalised energy demand for lipid utilisation in 
skeletal muscle. Considering the location of LD in close proximity to the mitochondria, 
therefore supporting ATP production for the contracting myofibrils (Hood, 2001), this 
explains why IMF LD may be preferentially used over SS LD during exercise. Our data 
from chapter 4 using recreationally trained runners and also our data from chapter 6 
using elite male triathletes, supports other data collected in a field-based environment, 
where elite cross-country skiers who completed a time trial demonstrated reductions 
in IMF lipid, although this was specific to the triceps brachii (Koh et al, 2017). Further 
to this, young subjects who completed 1 h moderate-intensity cycling bout also lead 
to specific reductions in IMF LD with no change in SS lipid (Chee et al, 2016). 
Together, these data suggest that, at least in healthy individuals, there is a preferential 
utilisation of IMF lipid during exercise. As such, Chee et al, (2016) did not observe a 
decrease in IMF lipids during exercise in older lean active and older overweight 
inactive individuals. In addition to this preferential use of IMF lipid in healthy 
individuals, in chapter 6 we also investigated changes in IMTG content during 
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recovery, where we observed that the increase in IMTG content occurred specifically 
in type I fibres and within the central region of the fibre.  Therefore, not only are IMF 
LDs targeted for breakdown during exercise, we can now report for the first time that 
this subcellular pool of lipid is an important site for IMTG resynthesis in the post-
exercise period. 
 
7.3 Lipid droplet morphology and exercise 
 
 
LDs are known to be distributed between myofibrils as IMF LD or just below the surface 
membrane as SS LD, both of which are closely associated with muscle mitochondria 
(Tarnopolsky et al, 2007; Shaw et al, 2008; Koh et al, 2018). Given their location 
between the myofibrils, IMF LD are likely to be an important energy source to support 
muscle contraction, an assertion based on reductions in the LD pool during exercise 
(Chee et al, 2016; Koh et al, 2017). Reductions in IMF LD volume fraction (or central 
IMTG content, when determined using immunofluorescence microscopy) can occur 
via changes in LD number and/or LD size. The size, number and location of LD is 
heavily influenced by metabolic state and exercise training (Nielsen et al, 2010, 2017; 
Chee et al, 2016; Koh et al, 2018). In general, the diameter of LD in the muscle of 
healthy untrained individuals is ~ 500 nm (range 200-1400 nm), with enhanced LD 
number rather than size, driving the greater IMTG content in type I fibres (Nielsen et 
al, 2017). In chapter 5 the TEM data demonstrates the diameter of LD in highly-trained 
individuals was ~440 nm before exercise (range 420 – 460 nm), which is as expected 
to be smaller in highly-trained individuals. However, we also examined the size of 
individual LD area and observed that the frequency of LDs 100 nm2 in size to be 
greater in the central compared to the peripheral region.  Conversely, there was a 
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greater frequency of LDs 200 nm2 in size in the peripheral compared to the central 
region. Measuring the frequency of LD across a range of sizes is likely to be more 
informative as having a large pool of smaller LD is proposed to be a metabolic 
advantage, due to overall greater surface area of LD providing greater availability for 
interaction between LD proteins and lipases. Moreover, considering the subcellular 
location of these LD will likely determine their role in cell function.   Together, this 
suggests that considering the size of individual LDs is more informative than simply 
measuring average LD size.  
 
In chapter 4, the utilisation of IMF lipid in type I fibres during the 10-mile trial can be 
attributed to reductions in LD size. This finding opposes other work attributing 
reductions in IMF lipid to reductions in LD number (Koh et al, 2017). However, we also 
observed a tendency for IMF LD number (but not LD size) to be reduced in response 
to high-intensity interval running (8x800 trial). Together, these data initially highlight 
an intriguing possibility that exercise that is of a higher intensity (8x800 trial in chapter 
4, and 1 h competitive cross-country skiing time trial in Koh et al, 2017) may specifically 
result in a reduction in LD number, whereas moderate-intensity exercise (10-mile trial 
in chapter 4) may induce reductions in LD size. However, in chapter 5 the decrease in 
IMTG content in response to 1 h of a competitive cross-country skiing time trial was 
attributed to a reduction in both LD number and size, whereas in chapter 6 a decrease 
in LD number (but not size) was observed during 4 h of moderate-intensity.  These 
contrasting observations could be related to the microscopy method used. Due to the 
greater magnification capabilities, TEM may be the preferred method to investigate LD 
morphology. Whereas immunofluorescence microscopy will allow a better estimate of 
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exercise-induced changes in IMTG content, due to the greater number of fibres that 
can be analysed.      
 
It should also be considered that these contrasting observations could be related to 
training status, given that in chapter 4 the subjects were recreationally active, whereas 
in chapter 6 they were elite level athletes.  What appears to be developing from the 
observations from this thesis, and previously published work, is that exercise-induced 
changes in LD morphology are at least dependent on exercise intensity, duration, and 
training status of the individuals being studied. A summary of acute exercise-induced 
changes in LD morphology of individuals on a subcellular-basis from this thesis and 
previous literature is presented in table 7.1.     
 
The general belief is that small LDs have a greater surface area for the interaction of 
lipolytic enzymes with the IMTG substrate and regulatory proteins located on the LD 
surface (Bickel et al, 2009; Morales et al, 2017). Consequently, the frequency of very 
small LDs we observed in the central region in chapter 5 may be an adaptation to 
support the greater utilisation of IMF LDs during exercise reported in previous studies 
(Koh et al, 2017), and in this thesis (chapters 4, 5 and 6). Further to this, we would 
then speculate that the smaller LD’s would be targeted for utilisation first, as they are 
highly abundant in both the central and peripheral regions of the cell (Chapter 5, Figure 
4). However, by examining differences in the frequency of specific LDs (based on 
size), it seems that more moderately sized LD of 400 and 600 nm2 were reduced from 
pre to post-exercise. A possible explanation for the smaller LDs not being preferentially 
targeted for breakdown could be that they are newly-formed or nascent LDs, and are 
therefore not yet labelled with the appropriate LD-associated PLIN protein isoforms. 
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This also supports the decrease in LD size we observed in chapter 4, with the 
possibility that LD that are larger in size have a greater circumference, therefore 
providing more space for docking sites for LD-associated proteins, such as the perilipin 
(PLIN) proteins and therefore increasing their likelihood to be utilised during exercise. 
However, it could be that the smaller LD (e.g. 100 and 200 nm2) were targeted for 
breakdown during exercise, but concomitant decreases in the size of moderately-sized 
LD of 400 and 600 nm2 meant that they shrunk to become LDs of 100 and 200 nm2 in 
size.  This would explain why no reduction in smaller-sized LD was observed. 
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Outcome  Conclusions  






10 mile steady 




• 51% reduction in lipid from 10-mile 
trial, specific to type I fibres, IMF 
region. Tendency for a 12% 
reduction in IMF LD size. 
• 22% reduction in lipid from 8x800 
trial. Attributed to a reduction in LD 
number in IMF (-5%) and SS (-35%) 
region. 
• Lipid utilisation occurs 
primarily in the IMF region of 
type I fibres, but changes in 
LD morphology maybe related 
to exercise intensity and 
duration. 









• Reduction in IMTG content from 
both the central and peripheral 
regions in both type I and type II 
fibres. 
• Attributed to reductions in both LD 
number and size of 35% and 14%, 
respectively. 
• ~1 hour of cross-country skiing 
reduced IMTG content in both 
type I and type IIa fibres, 
across both the peripheral and 
central regions of the muscle 
fibres due to a reduction in 
both LD size and number. 




4 hr prolonged 
cycling bout at ~ 




• Reduction in IMTG content in type I 
fibres, central region, attributed to 
46%  reduction in LD number. 
• IMTG repletion specific to central 
region of type I fibres. 
• IMTG resynthesis occurs 
rapidly in the central region of 
type I fibres following 
prolonged exercise in highly-
trained individuals.   
• Highlight a novel role of PLIN3 
in supporting IMTG utilisation. 
Koh et al, 
2017 









• Reduction in IMCL in arms (IMF 
region) but not legs. 
• Attributed to 36% reductions in LD 
number not size. 
• Distributions of LD in the 
muscles of upper and lower 
limbs differ and LD utilisation 
differs depending on their 
subcellular location. 
Chee et al, 
2016 
7 young and 
lean, 7 old and 








VO2max for 1 h 
• Reduction in IMCL attributed to 28% 
reduction in LD number. 
• In the overweight/old group, LD size 
increased by 25% in both the SS 
and IMF region. 
• Increased FA delivery causes 
increased IMTG in SS region 





When considering SS LD, they are considered as a supply for SS mitochondria, 
providing energy for membrane related processes (Hood, 2001). Ferreira et al, (2010) 
separated SS and IMF mitochondria to find proteomic differences and respiratory 
chain activity between the two subcellular pools of mitochondria. SS mitochondria 
specifically, had less oxidative phosphorylation proteins, and less activity of the 
respiratory chain complex than IMF mitochondria (Ferreira et al, 2010). This therefore, 
supports the concept of IMF mitochondria specialising in energy production for muscle 
contraction and supports the preferential use of IMF LD (or central) during energy 
demand in this thesis and previous literature (Chee et al, 2016; Koh et al, 2017). 
However, overall lipid content is often greater in the SS region (Nielsen et al, 2017; 
Koh et al, 2018) and even if training did not significantly change the overall SS or IMF 
LD volume fraction within muscle, training in general enhances LD number and 
reduces LD size in the SS region (Nielsen et al, 2017).  Although the majority of 
changes observed across all three experimental chapters in this thesis were in IMF 
lipid, there was a tendency for a reduction in SS LD number in response to exercise 
in chapter 4. Alongside this slight decrease in LD number, there was also small (albeit 
non-significant) increases in LD size in both type I (6%) and type II (3%) fibres. These 
opposing changes in SS LD size and number may explain why there was no reduction 
in overall SS LD volume fraction. Koh et al. (2017) also observed reductions in the 
number of LD in the SS region, in the absence of a reduction in SS LD volume fraction.  
Therefore, exercise-induced decreases in SS LD number appear to be a consistent 
finding, although the importance of this is yet to be determined.  It is possible that the 
close proximity of SS LD to nuclei means that this pool of LDs supports nuclear 
processes.  Much of what is known to date about LD signalling to the nucleus relates 
to transcriptional regulation of mitochondrial biogenesis and FA oxidation. For 
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example, it is known that IMTG-derived fatty acids can act as ligands to support 
transcriptional processes, thereby supporting the adaptive response to exercise 
(Seibert et al, 2020).  To reconcile the lack of a change in overall SS LD volume 
fraction we witnessed in chapter 4, it could be speculated that FA coming into the 
muscle during exercise may subsequently be directed to pre-existing SS LD, thereby 
resulting in small increases in LD size.  Future work should aim to identify the roles 
that each LD pool play in cell function.  
 
As discussed in section 2.2.2, both immunofluorescence microscopy and TEM provide 
methods to visualise and quantify IMTG utilisation and changes in LD morphology on 
a fibre-type and subcellular specific basis, though to date, no comparison between the 
two microscopy methods in quantifying IMTG utilisation has been made. In chapter 5, 
when examining the correlations between TEM and immunofluorescence microscopy, 
we observed significant correlations for IMTG content in both subcellular regions, 
though only a substantial agreement according to Lins Concordance coefficient (LCC) 
within the peripheral/SS region. In this chapter, we used a fixed 2 μm distance from 
the membrane to represent the SS region, which has been utilised previously to 
examine IMTG content in differing populations (Van Loon, 2004). Although this 2 μm 
distance could be considered representative of the SS region, this method does not 
take into account variations in the width of the SS region which are frequently observed 
when using TEM. However, the substantial agreement between the two methods we 
observed in chapter 5 (see table 5.3) strongly supports the use of a 2 μm band around 
the extracted cell membrane in order to define the peripheral region when using 
immunofluorescence microscopy.  Thus, it does seem to be possible to use 
immunofluorescence microscopy to investigate changes in IMTG content and LDs at 
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a subcellular level.  This has clear implications for investigating the subcellular 
distribution of proteins associated with LD. 
 
7.4 Perilipin proteins 
 
 
The LD coating PLIN proteins are believed to play a key role in LD turnover through 
the interaction with lipases such as ATGL, HSL and their co-activators (discussed in 
2.3.4). PLIN2, PLIN3 and PLIN5 are the main PLINs present in human skeletal muscle 
(Gemmink et al, 2017). PLIN2 negatively regulates ATGL-mediated LD lipolysis by 
inhibiting ATGL access to the LD surface (Feng et al, 2017). PLIN3 coats nascent LD 
and its expression is associated with fat oxidation rates (Covington et al, 2015), and 
PLIN5 regulates lipolytic rate in an energy-dependent way to match LD FA release 
with mitochondrial FA oxidation (Gemmink et al, 2017). As outlined above, the general 
belief is that a greater number of small LDs can be seen as a training adaptation, since 
this leads to a greater surface area for the interaction of lipolytic enzymes with the 
IMTG substrate and regulatory proteins located on the LD surface, such as the PLIN 
proteins (Bickel et al, 2009; Morales et al, 2017). To this end, it is a known endurance 
training itself augments IMTG content simultaneous to increases in PLIN2, PLIN5  
(Shaw et al, 2012; Shepherd et al, 2013) and PLIN3 expression (Shepherd et al, 
2017). Our investigations in chapter 6 employing a subcellular-specific analysis, 
enable us to demonstrate that the majority of IMTG and PLIN proteins are observed 
in the central region of the cell.  We also provided novel data to show that both 
exercise-induced reductions, and post-exercise increases in IMTG content were 
specific to the central region.  These observations support the hypothesis that the 
PLIN proteins play a key role in the utilisation and resynthesis of the IMTG pool. The 
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changes we observed in IMTG content during exercise also occurred in the absence 
of changes in PLIN protein expression, which is in line with previous research 
(Shepherd et al, 2012, 2013), and we now extend this observation to the post-exercise 
recovery period too. Our study design provided a novel basis to investigate changes 
in the LD distribution of PLIN2, PLIN3 and PLIN5 under the dynamic state of exercise 
and recovery in order to further understand the role of these proteins within skeletal 
muscle.  
 
Our data extends the findings of previous literature, which reported that exercise 
augments a reduction in the number of PLIN2+ LDs and PLIN5+ LDs (Shepherd et al, 
2012, 2013) and now also the number of PLIN3+ LDs. However, the data from chapter 
6 opposes previous work demonstrating preferential use of PLIN+ LDs in response to 
1 h of exercise (Shepherd et al, 2012, 2013), since we also observed an exercise-
induced decrease in the number of PLIN2- and PLIN3- LDs, and PLIN5- LDs also 
tended to decline.  The likely explanation for this is the more prolonged bout of 
exercise (4 h) employed here than in previous studies (1 h) (Shepherd et al, 2012, 
2013), combined with the elite level endurance-trained population studied who 
notoriously exhibit high rates of IMTG utilisation during exercise (Stellingwerff et al, 
2007; Rodriguez et al, 2009). Further to this, given the reduction observed in PLIN2+ 
and PLIN5+ LDs during exercise, and no change in the overall PLIN2 and PLIN5 
protein expression, it was no surprise to observe an increase in the quantity of (free) 
PLIN2 and PLIN5 not bound to LDs following exercise. However, this did not apply to 
free PLIN3, with no change in response to exercise being observed, despite the 
reduction in PLIN3+ LDs. A potential explanation for the lack of change in free PLIN3 
that we observed stems from research in cultured non-muscle cells which have 
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demonstrated that PLIN3 is recruited from the cytosolic fraction to LDs upon lipid-
loading (Skinner et al, 2009; Wolins et al, 2001, 2005), suggesting that PLIN3 cycles 
between the cytosol and LD pool depending on the metabolic state of the cell.  Thus, 
our data could indicate that this ‘cycling’ of PLIN3 between the cytosol and LDs may 
be an important function of PLIN3 to support IMTG utilisation during exercise, and may 
only occur in highly-trained individuals.  In our model, we speculate that PLIN3 may 
cycle from each LD that is used and be recruited to previously PLIN3- LD (and possibly 
PLIN2- and PLIN5- LDs) to subsequently support continued breakdown of the IMTG 
pool during exercise.   
 
Previous research in cultured cells and rodent models have implicated the PLIN 
proteins in supporting fatty acid incorporation into, and storage as, IMTG in LDs 
(Bosma et al, 2012, 2013; Kleinert et al, 2016; Laurens et al, 2016). The preferential 
increase in PLIN+ LDs observed during recovery would theoretically support this 
concept. However, in chapter 6 we gained a novel insight into the time-course of 
recovery through obtaining muscle samples at both 4 h and 24 h post-exercise. This 
enabled us to separate the resynthesis of the IMTG pool (at 4 h post-exercise) and 
increases in coating of LDs with PLIN proteins (at 24 h post-exercise).  The findings 
suggest that the PLIN proteins don’t necessarily play a role in IMTG storage in LD’s 
per se.  Rather, the coverage of newly-synthesised LD with PLIN proteins at 24 h post-
exercise may be an adaptive response to regulate mobilisation and oxidation of IMTG-
derived free fatty acids depending on subsequent metabolic demand.  Further to this, 
at this 24 h post-exercise time point, our results demonstrated increases in PLIN and 
LD co-localisation for all PLIN proteins were specific to the central region of type I 
fibres.  Consequently, the number of PLIN2+, PLIN3+ and PLIN5+ LDs all increased 
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during recovery, but there was no change in the number of PLIN- LDs. Previous 
literature has suggested the PLIN proteins can re-distribute in response to prolonged 
fasting (Gemmink et al, 2016) or a lipid infusion (Shepherd et al, 2017).  Our data, 
demonstrated no change in the expression of the PLIN proteins during recovery, 
therefore supporting the concept of pre-existing PLIN protein pool being redistributed 
across the expanded LD pool during the recovery period. Thereby extending the 
findings from previous literature to include the re-distribution of PLIN post-prolonged 
exercise in elite athletes.  Further to this, to enable the location from which the 
redistributed PLIN proteins originated, it is important to consider both LDs labelled with 
PLIN and the cytosolic pool of ‘free’ PLIN proteins.  To this extent, when examining 
the distribution of PLIN2 and PLIN3 throughout recovery increases in PLIN2+ and 
PLIN3+ LDs occurred in the absence of a change in the quantity of cytosolic PLIN2 or 
PLIN3. Thereby suggesting a redistribution of PLIN2 and PLIN3 from pre-existing 
PLIN2+ or PLIN3+ LD to either newly-synthesised LD and/or pre-existing PLIN- LDs.  
On the other hand, PLIN5+ LDs were increased throughout the recovery period with 
a corresponding decrease in the quantity of cytosolic PLIN5.  Therefore, unlike PLIN2 
and PLIN3, it is likely that the cytosolic pool of PLIN5 that is redistributed to either 
newly-synthesised LDs and/or pre-existing PLIN- LDs occurred during recovery, 
underpinning the increased fraction of LDs labelled with PLIN5 at 24 h post-exercise 
and suggesting that the PLIN proteins act uniquely during resynthesis.  
 
7.5 Future research directions   
 
 
In summary, this thesis highlights the interaction between muscle fibre recruitment, 
relative exercise intensity and training duration in modulating the subcellular specific-
glycogen and lipid utilisation with specific field-based exercise protocols. We have 
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highlighted in chapter 4 and 5 that detailed analysis, investigating not only fibre type 
but subcellular-specific substrate utilisation can be conducted in field-based situations, 
representing either the training or racing environment. Future research should 
continue to consider if such approaches are possible, as this as a whole will make the 
research more applicable to the practice of individuals and/or athletes, that our data 
informs.  
 
Whilst chapter 4 did highlight differences in intramuscular substrate utilisation 
dependent on exercise intensity and duration, one factor that was not considered in 
this thesis was the effect of sex. Indeed, in the original study from which the muscle 
samples used in chapter 4 were obtained (Impey et al, 2020), it was reported that 
females had reduced resting muscle glycogen concentrations and absolute glycogen 
utilisation during exercise when compared to males. In response to exercise, it seems 
females exhibit a lower respiratory exchange ratio, therefore leading to less reliance 
on CHO metabolism during sub-maximal steady state exercise (Carter et al, 2001; 
Roepstorff et al, 2002). Females are also known to have greater IMTG storage in 
comparison to males (Moro et al, 2009) and show greater IMTG utilisation under fasted 
conditions (Steffensen et al, 2002). However due to methodology used in such 
literature (muscle homogenates or tracers), there is a lack of data on a fibre-type or 
subcellular basis. As we know subcellular location of glycogen is vastly important, 
investigations could consider which subcellular regions these gender differences lie.  
 
The field-based theme to this thesis allows data to be more applicable to the habitual 
fuel utilisation of training and competition, however there are further factors that could 
be quantified by future research, for example in chapter 4 we examined both the 
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vastus lateralis and the gastrocnemius and found INTRA glycogen utilisation to be 
greater in the 8x800m trial compared to the 10-mile trial within the vastus lateralis only. 
Suggesting in the vastus lateralis, greater use of the INTRA glycogen pool appears to 
be required to meet the elevated metabolic demand during high intensity exercise. 
Though, other studies in running specifically, could gain further insight muscle-
differences by measuring running style i.e. forefoot vs. heel-strike runners and muscle 
length in order to assess if these factors may alter the activation of the vastus lateralis 
and gastrocnemius, and therefore influence muscle-specific substrate utilisation.  
 
The importance of being able to analyse substrate utilisation on a fibre and subcellular 
region-specific basis is also highlighted, therefore emphasising the importance of 
future research being able to use suitable methodology that enables analysis at this 
level. As such, when evaluating the agreement between immunofluorescence 
microscopy and TEM (Chapter 5), immunofluorescence microscopy appears to 
provide an economical option to quantify fibre-specific IMTG content but not 
necessarily LD size and number. However, the use of immunofluorescence 
microscopy in Chapter 6 provides valuable insight into the potential role of the PLIN 
proteins in skeletal muscle.  Taken together, it could be suggested that 
immunofluorescence microscopy is most beneficial when research aims to understand 
the mechanisms regulating IMTG metabolism on a fibre-specific basis, such as, for 
example, investigations into proteins related to the regulation of LDs and IMTG 
turnover. However, research which aims to investigate LD morphology may benefit 





Finally, a theme that runs throughout this thesis is the importance of IMTG during 
exercise, but in Chapter 6, although we were unsuccessful in determining whether 
CHO feeding immediately post-exercise (in line with current guidelines) would 
suppress IMTG resynthesis, we do highlight the importance of post-exercise IMTG 
resynthesis.  More specifically, we demonstrate that despite their previously proposed 
role in the synthesis and storage of IMTG in LD (MacPherson et al, 2015; Morales et 
al, 2017), the PLIN proteins do not appear to play a key role in post-exercise IMTG 
resynthesis. 
 
Based on the observations from the studies in this thesis, there are several potential 
areas of future research that have emerged, and which are outlined below:  
 
1. Differences in LD morphology in response to exercise were evident throughout 
this thesis. It seems that a combination or exercise intensity, duration and 
training status of the individual will directly influence changes in LD morphology 
(summarised in table 1), though we clearly lack a complete understanding in 
which factors are most critical in determining changes in LD morphology. In the 
first instance, further investigations should be conducted to examine changes 
in LD morphology under more controlled conditions (i.e. within a laboratory) 
where exercise intensity and duration can be closely monitored.  Subsequent 
studies could also consider how sex and training status influence these 
responses. Within these studies, a combination of immunofluorescence 
microscopy (to measure IMTG content) and TEM (to ensure the most accurate 
measures of both LD number and size) should be employed. 
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2. In chapter 4, we observed reductions in SS LD number despite no change in 
overall SS LD volume fraction, as also observed by Koh et al, (2017). A possible 
explanation for these independent observations is that alongside the significant 
decreases in SS LD number were small (albeit non-significant) increases in LD 
size, thereby resulting in no significant changes in LD volume fraction. If this is 
true, it could be that FA coming into the muscle during exercise may 
subsequently be directed to pre-existing SS LD, thereby resulting in small 
increases in LD size (rather than being used to create new LD).  One possible 
approach to test this would be to use a pharmacological inhibitor of adipose 
tissue lipolysis (Acipimox) which would in turn inhibit FA coming into the muscle. 
As a result, and if the above hypothesis is true, this would preclude pre-existing 
LD from increasing in size (in comparison to a placebo control trial).  
 
3. In chapter 5, we build on emerging data that LD of certain sizes may be targeted 
for breakdown during exercise, rather than the LD pool as a whole (which would 
manifest as a decrease in mean LD size).  This adds to the current literature 
suggesting that LD are heterogenous in nature, and their function may be 
determined by their individual protein coat. In regard to such proteins, 
investigations into whether there is a difference in PLIN protein isoforms located 
on different subpopulations of LD i.e. IMF or SS LD, would enable insights into 
the specific function of these LD.  Such investigations could be done by 
comparing individual LD size following acute exercise in combination with 
staining for PLIN proteins in trained individuals and untrained/sedentary and 
should consider advanced microscopes such as super-resolution microscopy 
as used by Gemmink et al, (2018; 2020). The advantage of using such a 
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microscope is being able to visualise and quantify the abundance of, and 
examine the distribution of key proteins such as PLIN or ATGL in individual 
organelles. As such Gemmink et al, (2018) demonstrated PLIN2 and PLIN5 to 
localise to distinct LD docking sites with greater PLIN5 at LD-mitochondria 
tethering sites.  
 
4. In chapter 6, we observed IMTG utilisation from both PLIN+ and PLIN- LD 
following prolonged exercise, which differed from previous literature 
demonstrating utilisation of PLIN+ LD after 1 h of exercise (Shepherd et al, 
2012, 2013). In this respect, Watt et al, (2002) demonstrated IMTG utilisation 
to be greatest within the first 1 – 2 h of prolonged exercise, therefore it could 
be speculated that first PLIN+ LD were utilised, and then as exercise 
progressed PLIN- LD were targeted. As such, a time-course study, with 
biopsies obtained during (e.g. after 1 h), as well as before and after prolonged 
(i.e. 4 h) exercise should be considered in order to generate a more complete 
understanding of the pattern of PLIN+ and PLIN- LDs during exercise. 
 
 
5. Further to point 4, another possible explanation for the utilisation on PLIN- LD 
could be the possibility of more than one PLIN protein being associated with 
one LD, as demonstrated in human skeletal muscle with PLIN2 and PLIN5 by 
Gemmink et al (2018). The development of an assay which would enable us to 
identify LD with more than one PLIN attached, would allow investigations into 
the utilisation of these PLIN+ LD, and would ultimately provide information 




7.6 Closing thoughts 
 
 
In summary, this thesis has leveraged two forms of microscopy in order to generate 
novel data which first demonstrates a unique insight into fibre type and subcellular-
specific substrate utilisation in field-based exercise settings.  Specifically, running 
elicits a preferential use of INTRA glycogen during exercise, independent of intensity, 
and both running and cross-country skiing stimulate a breakdown of IMF LDs, primarily 
in type I fibres.  Second, this thesis generates novel information concerning the 
potential role of the PLIN proteins in skeletal muscle, demonstrating that the coating 
of LDs with PLIN proteins is secondary to the resynthesis of the IMTG pool. This thesis 
expands our knowledge on the effect of exercise intensity and duration on substrate 
utilisation through investigations at a fibre and subcellular level, alongside deepening 
our understanding of the proposed role of PLIN proteins during IMTG breakdown and 
resynthesis.  From a research perspective, it is hoped that this thesis will elicit further 
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